www.marketbeat.com
Open in
urlscan Pro
2606:4700:3108::ac42:28f2
Public Scan
Submitted URL: https://email.analystratings.net/ls/click?upn=u001.WeKo-2BCuHku2kJmVIsYmGxteRO-2BqdkFdZns7E8OZ0trhtkhRYqlbI8foLBzBFs1T92rPb9PyRZI...
Effective URL: https://www.marketbeat.com/compare-stocks/pharmaceutical-stocks/?AccountID=11404962&hash=54155C44E1BA582367DE39E87C49FED266...
Submission: On December 24 via api from BE — Scanned from US
Effective URL: https://www.marketbeat.com/compare-stocks/pharmaceutical-stocks/?AccountID=11404962&hash=54155C44E1BA582367DE39E87C49FED266...
Submission: On December 24 via api from BE — Scanned from US
Form analysis
2 forms found in the DOMGET /pages/search.aspx
<form id="headerSearchForm" class="input-group dark-bkg ml-lg-2 mr-md-2" method="get" action="/pages/search.aspx" role="search" aria-label="Site search">
<input aria-label="Search" id="headerSearch" type="text" name="query" class="autocomplete form-control ui-autocomplete-input" placeholder="Search stocks, news, and tools..." style="font-size:.9em;" autocomplete="off">
<span id="mainAutocompleteList">
<ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul>
</span>
<span class="input-group-append position-relative">
<span id="headerSearchLoading" style="width: 20px; height: 20px; position: absolute; left: -1.7em; top: 0.4em; display: none;">
<img style="filter: brightness(1.5);" src="/images/loading-gif.gif?v=2" alt="" loading="lazy" width="20" height="20"></span>
<button class="clear-button" type="submit" aria-label="Search" style="color: var(--white); text-transform: uppercase;"><span class="fa-regular fa-magnifying-glass"></span><span class="sr-only">Search</span></button>
</span>
</form>
POST ./?AccountID=11404962&hash=54155C44E1BA582367DE39E87C49FED2667478813F80DF261F8865C4866EA1CFAA87097611AF0C87213F14E55C1F6DD753850FFB8F73AB7F52849A0A689CBD51&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick
<form method="post"
action="./?AccountID=11404962&hash=54155C44E1BA582367DE39E87C49FED2667478813F80DF261F8865C4866EA1CFAA87097611AF0C87213F14E55C1F6DD753850FFB8F73AB7F52849A0A689CBD51&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick"
onsubmit="javascript:return WebForm_OnSubmit();" id="form1">
<div class="aspNetHidden">
<input type="hidden" name="__EVENTTARGET" id="__EVENTTARGET" value="">
<input type="hidden" name="__EVENTARGUMENT" id="__EVENTARGUMENT" value="">
<input type="hidden" name="__LASTFOCUS" id="__LASTFOCUS" value="">
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE"
value="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">
</div>
<script type="text/javascript">
//<![CDATA[
var theForm = document.forms['form1'];
if (!theForm) {
theForm = document.form1;
}
function __doPostBack(eventTarget, eventArgument) {
if (!theForm.onsubmit || (theForm.onsubmit() != false)) {
theForm.__EVENTTARGET.value = eventTarget;
theForm.__EVENTARGUMENT.value = eventArgument;
theForm.submit();
}
}
//]]>
</script>
<script src="/WebResource.axd?d=TGE6mH29_tpsdHwhewvfnZZ1XtMYSVXLm0Jql1RT8Gt0UJpBTCqqFxYSJ6nYrV4lmQxbdhmD7ckA_eQodaniwZjAfL41&t=638610691965203766" type="text/javascript"></script>
<script src="/WebResource.axd?d=4lMJGuquWOjOpKNx9jHWfLxmhW6qp2tPeqMu9eSv61Q3BBcp_u6tm-OawELVd8SzmA8FxOpK8saMz-cLgDs6BCGGHE41&t=638610691965203766" type="text/javascript"></script>
<script type="text/javascript">
//<![CDATA[
function WebForm_OnSubmit() {
if (typeof(ValidatorOnSubmit) == "function" && ValidatorOnSubmit() == false) return false;
return true;
}
//]]>
</script>
<div class="aspNetHidden">
<input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="0ED62D94">
<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION"
value="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">
</div>
<h1 id="pageTitle" class="PageTitleHOne"> Pharmaceutical Stocks List </h1>
<div class="row">
<div class="col-12 col-lg-9">
<p> Compare pharmaceutical stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment,
price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). </p>
</div>
<div class="dropdown col-12 col-lg-3 ml-auto mb-3 text-left text-lg-right">
<button class="btn btn-secondary dropdown-toggle" type="button" id="dropdownMenuLink" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
<span class="fa-regular fa-lightbulb" aria-hidden="true"></span> Comparison Ideas </button>
<ul class="dropdown-menu nice-scroll allow-focus m-0 p-0" aria-labelledby="dropdownMenuLink">
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/agriculture-stocks/">Agriculture Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/airline-stocks/">Airline Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/apparel-stocks/">Apparel Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/artificial-intelligence-stocks/">Artificial Intelligence Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/automotive-stocks/">Automotive Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/bank-stocks/">Bank Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/bitcoin-stocks/">Bitcoin Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/blockchain-stocks/">Blockchain Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/canadian-stocks/">Canadian Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/cannabis-and-marijuana-stocks/">Cannabis Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/casino-stocks/">Casino Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/chatgpt-stocks/">ChatGPT Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/chinese-stocks/">Chinese Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/cloud-storage/">Cloud Storage Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/coronavirus-therapeutics-stocks/">Coronavirus Therapeutics Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/cryptocurrency-stocks/">Cryptocurrency Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/cybersecurity-stocks/">Cybersecurity Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/defense-stocks/">Defense Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/digital-media-stocks/">Digital Media Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/dividend-stocks/">Dividend Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/dow-30-stocks/">Dow 30 Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/ecommerce-stocks/">Ecommerce Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/electric-vehicles-stocks/">Electric Vehicles Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/energy-stocks/">Energy Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/entertainment-stocks/">Entertainment Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/esports-stocks/">eSports Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/ev-charging-stocks/">EV Charging Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/fertilizer-stocks/">Fertilizer Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/gold-stocks/">Gold Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/grocery-stocks/">Grocery Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/growth-stocks/">Growth Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/healthcare-stocks/">Healthcare Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/high-dividend-stocks/">High Dividend Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/home-office-stocks/">Home Office Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/hotel-stocks/">Hotel Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/large-cap-stocks/">Large Cap Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/leisure-stocks/">Leisure Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/lithium-stocks/">Lithium Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/magnificent-seven-stocks/">Magnificent Seven Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/matana-stocks/">MATANA Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/mega-cap-stocks/">Mega Cap Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/meme-stocks/">Meme Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/metaverse-stocks/">Metaverse Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/mid-cap-stocks/">Mid Cap Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/mining-stocks/">Mining Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/music-industry-stocks/">Music Industry Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/nanotechnology-stocks/">Nanotechnology Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/non-fungible-token-stocks/">NFT Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/oil-stocks/">Oil Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/outdoor-stocks/">Outdoor Activities Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/pharmaceutical-stocks/">Pharmaceutical Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/renewable-energy-stocks/">Renewable Energy Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/restaurant-stocks/">Restaurant Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/retail-stocks/">Retail Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/semiconductor-stocks/">Semiconductor Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/social-media-stocks/">Social Media Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/solar-stocks/">Solar Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/space-stocks/">Space Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/stay-at-home-stocks/">Stay-At-Home Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/technology-stocks/">Technology Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/telecom-stocks/">Telecom Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/toy-stocks/">Toy Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/utility-stocks/">Utility Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/vaccine-stocks/">Vaccine Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/video-game-stocks/">Video Game Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/virtual-reality-stocks/">Virtual Reality Stocks</a></li>
<li class="p-0"><a class="d-block w-100 p-2" href="/compare-stocks/wallstreetbets-stocks/">WallStreetBets Stocks</a></li>
</ul>
</div>
</div>
<div class="bg-light-gray pb-2 px-3 pt-3 mb-3">
<div class="row narrow-gutter-row align-items-center">
<div class="col-12 col-md-3 mb-3 pr-md-0">
<div class="top-label-wrapper input-group">
<div class="input-group-prepend">
<span class="input-group-text">
<span class="fa-regular fa-building" aria-hidden="true"></span>
</span>
</div>
<input name="ctl00$cphPrimaryContent$txtStocks" type="text"
value="NYSE:ABBV,NYSE:BMY,NYSE:GSK,NYSE:MRK,NASDAQ:MRNA,NYSE:PFE,NYSE:JNJ,NYSE:LLY,NYSE:NVO,OTCMKTS:RHHBY,NASDAQ:AZN,NYSE:NVS,NASDAQ:AMGN,NASDAQ:SNY,NASDAQ:REGN,NASDAQ:VRTX,NASDAQ:GILD,NYSE:ZTS,NYSE:TAK,NYSE:HLN,NASDAQ:ALNY,NASDAQ:ARGX,NASDAQ:BIIB,OTCMKTS:BAYRY,OTCMKTS:ALPMY,NASDAQ:BGNE,NYSE:TEVA,NASDAQ:BNTX,NASDAQ:GMAB,NASDAQ:BMRN"
onchange="javascript:setTimeout('__doPostBack(\'ctl00$cphPrimaryContent$txtStocks\',\'\')', 0)" onkeypress="if (WebForm_TextBoxKeyHandler(event) == false) return false;" id="cphPrimaryContent_txtStocks" class="top-labeled-input mb-0"
placeholder="Enter comma separated list of Symbols" data-lpignore="true">
<label for="cphPrimaryContent_txtStocks" class="top-label">Stocks to Compare</label>
</div>
</div>
<div class="col-12 col-md-3 mb-3 pr-md-0">
<div class="btn-group w-100" role="group">
<div class="top-label-wrapper input-group dropdown" id="customizeSectionGroup">
<button class="btn dropdown-toggle top-labeled-input" style="padding-left: .7rem;" type="button" id="dropdownSection" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
<span class="top-label">Sections</span>
<span class="top-label-selected"> All Sections Selected</span>
</button>
<ul class="dropdown-menu nice-scroll allow-focus" id="sectionGroup" aria-labelledby="dropdownSection">
<li class="checkbox-line custom-control custom-checkbox pt-1 drop-down-item ui-state-default">
<input id="cphPrimaryContent_chkSection_Performance" type="checkbox" name="ctl00$cphPrimaryContent$chkSection_Performance" checked="checked"><label for="cphPrimaryContent_chkSection_Performance">Performance Chart</label>
</li>
<li class="checkbox-line custom-control custom-checkbox pt-1 drop-down-item ui-state-default">
<input id="cphPrimaryContent_chkSection_PriceVolume" type="checkbox" name="ctl00$cphPrimaryContent$chkSection_PriceVolume" checked="checked"><label for="cphPrimaryContent_chkSection_PriceVolume">Price & Volume</label>
</li>
<li class="checkbox-line custom-control custom-checkbox pt-1 drop-down-item ui-state-default">
<input id="cphPrimaryContent_chkSection_MarketRank" type="checkbox" name="ctl00$cphPrimaryContent$chkSection_MarketRank" checked="checked"><label for="cphPrimaryContent_chkSection_MarketRank">MarketRank</label>
</li>
<li class="checkbox-line custom-control custom-checkbox pt-1 drop-down-item ui-state-default">
<input id="cphPrimaryContent_chkSection_Ratings" type="checkbox" name="ctl00$cphPrimaryContent$chkSection_Ratings" checked="checked"><label for="cphPrimaryContent_chkSection_Ratings">Analyst Ratings</label>
</li>
<li class="checkbox-line custom-control custom-checkbox pt-1 drop-down-item ui-state-default">
<input id="cphPrimaryContent_chkSection_SalesBook" type="checkbox" name="ctl00$cphPrimaryContent$chkSection_SalesBook" checked="checked"><label for="cphPrimaryContent_chkSection_SalesBook">Sales & Book Value</label>
</li>
<li class="checkbox-line custom-control custom-checkbox pt-1 drop-down-item ui-state-default">
<input id="cphPrimaryContent_chkSection_Profitability" type="checkbox" name="ctl00$cphPrimaryContent$chkSection_Profitability" checked="checked"><label for="cphPrimaryContent_chkSection_Profitability">Profitability &
Earnings</label>
</li>
<li class="checkbox-line custom-control custom-checkbox pt-1 drop-down-item ui-state-default">
<input id="cphPrimaryContent_chkSection_Dividend" type="checkbox" name="ctl00$cphPrimaryContent$chkSection_Dividend" checked="checked"><label for="cphPrimaryContent_chkSection_Dividend">Dividends</label>
</li>
<li class="checkbox-line custom-control custom-checkbox pt-1 drop-down-item ui-state-default">
<input id="cphPrimaryContent_chkSection_Debt" type="checkbox" name="ctl00$cphPrimaryContent$chkSection_Debt" checked="checked"><label for="cphPrimaryContent_chkSection_Debt">Debt</label>
</li>
<li class="checkbox-line custom-control custom-checkbox pt-1 drop-down-item ui-state-default">
<input id="cphPrimaryContent_chkSection_Ownership" type="checkbox" name="ctl00$cphPrimaryContent$chkSection_Ownership" checked="checked"><label for="cphPrimaryContent_chkSection_Ownership">Ownership</label>
</li>
<li class="checkbox-line custom-control custom-checkbox pt-1 drop-down-item ui-state-default">
<input id="cphPrimaryContent_chkSection_Misc" type="checkbox" name="ctl00$cphPrimaryContent$chkSection_Misc" checked="checked"><label for="cphPrimaryContent_chkSection_Misc">Miscellaneous</label>
</li>
<li class="checkbox-line custom-control custom-checkbox pt-1 drop-down-item ui-state-default">
<input id="cphPrimaryContent_chkSection_Headlines" type="checkbox" name="ctl00$cphPrimaryContent$chkSection_Headlines" checked="checked"><label for="cphPrimaryContent_chkSection_Headlines">Headlines</label>
</li>
<li class="checkbox-line custom-control custom-checkbox pt-1 drop-down-item ui-state-default">
<input id="cphPrimaryContent_chkSection_About" type="checkbox" name="ctl00$cphPrimaryContent$chkSection_About" checked="checked"><label for="cphPrimaryContent_chkSection_About">About</label>
</li>
</ul>
</div>
</div>
</div>
<div class="col-auto h-100 mb-3">
<a id="cphPrimaryContent_btnCompare" class="sbbutton m-0 c-white" href="javascript:__doPostBack('ctl00$cphPrimaryContent$btnCompare','')" style="vertical-align: middle;"><span class="fa-regular fa-arrow-right-arrow-left mr-1" aria-hidden="true"></span>Compare</a>
</div>
<div class="col-auto ml-md-auto pl-md-0 mb-3 text-left text-md-right byline-row border-0">
<div class="share-button-wrapper align-items-stretch d-none" id="webShareButtonWrapper"><button id="webShareButton" class="d-none" type="button" disabled="" title="Share Compare Pharmaceutical Stocks"><span
class="fa-regular fa-share-nodes"></span><span class="share-title"> Share</span></button>
<script>
const shareOpts = {
title: 'Compare Pharmaceutical Stocks',
text: '',
url: 'https://www.marketbeat.com/compare-stocks/pharmaceutical-stocks/'
};
</script>
</div>
<div class="share-button-wrapper align-items-stretch d-inline-flex" id="shareButtonWrapper">
<div id="shareButton" class="share-button position-relative">
<a title="Share on Facebook" href="https://www.facebook.com/sharer/sharer.php?u=https://www.marketbeat.com/compare-stocks/pharmaceutical-stocks/" target="_blank" rel="nofollow noopener" class="btn btn-share"><span class="fa-brands fa-facebook-f"></span></a><a title="Share on Twitter" href="https://twitter.com/intent/tweet?text=Compare+Pharmaceutical+Stocks%20https://www.marketbeat.com/compare-stocks/pharmaceutical-stocks/" target="_blank" rel="nofollow noopener" class="btn btn-share"><span class="fa-brands fa-x-twitter"></span></a><a title="Share on LinkedIn" onclick="window.open('https://www.linkedin.com/cws/share?mini=true&url=https://www.marketbeat.com/compare-stocks/pharmaceutical-stocks/', 'name','width=600,height=600')" href="https://www.linkedin.com/cws/share?mini=true&url=https://www.marketbeat.com/compare-stocks/pharmaceutical-stocks/" target="popup" rel="nofollow noopener" class="btn btn-share"><span class="fa-brands fa-linkedin-in"></span></a><a title="Share on StockTwits" href="https://api.stocktwits.com/widgets/share?via=MarketBeat&body=Compare+Pharmaceutical+Stocks%20https://www.marketbeat.com/compare-stocks/pharmaceutical-stocks/" target="_blank" rel="nofollow noopener" class="btn btn-share"><span class="fa-kit fa-stocktwits-mark"></span></a><a title="Print this page" href="javascript:window.print()" class="btn btn-share"><span class="fa-regular fa-print"></span></a><a title="Email this page" href="mailto:?subject=Compare%20Pharmaceutical%20Stocks&body=Check%20out%20this%20stock%3A%20https://www.marketbeat.com/compare-stocks/pharmaceutical-stocks/%0D%0A%0D%0AFor%20real-time%20financial%20news%20and%20analysis%2C%20visit%20https%3A%2F%2Fwww.marketbeat.com%2F%20." class="btn btn-share"><span class="fa-regular fa-envelope"></span></a><a title="Copy the URL of this page to the clipboard" href="https://www.marketbeat.com/compare-stocks/pharmaceutical-stocks/" class="btn btn-share shareCopy"><span class="fa-regular fa-link"></span></a>
<div class="fixed-notification alert alert-success" aria-live="polite" aria-atomic="true" role="alert">Link copied to clipboard.</div>
</div>
</div>
</div>
</div>
<div class="row">
<div id="pnlStockList">
<div class="col-12">
<a onclick="stockButtonClick('NASDAQ:ALNY');" id="btnRemoveSymbolALNY" class="stock-button btn btn-secondary d-inline-block py-1 px-2 pr-4 mr-1 mb-2">NASDAQ:ALNY<span class="fa-regular fa-xmark position-absolute"></span></a><a onclick="stockButtonClick('NASDAQ:AMGN');" id="btnRemoveSymbolAMGN" class="stock-button btn btn-secondary d-inline-block py-1 px-2 pr-4 mr-1 mb-2">NASDAQ:AMGN<span class="fa-regular fa-xmark position-absolute"></span></a><a onclick="stockButtonClick('NASDAQ:ARGX');" id="btnRemoveSymbolARGX" class="stock-button btn btn-secondary d-inline-block py-1 px-2 pr-4 mr-1 mb-2">NASDAQ:ARGX<span class="fa-regular fa-xmark position-absolute"></span></a><a onclick="stockButtonClick('NASDAQ:AZN');" id="btnRemoveSymbolAZN" class="stock-button btn btn-secondary d-inline-block py-1 px-2 pr-4 mr-1 mb-2">NASDAQ:AZN<span class="fa-regular fa-xmark position-absolute"></span></a><a onclick="stockButtonClick('NASDAQ:BGNE');" id="btnRemoveSymbolBGNE" class="stock-button btn btn-secondary d-inline-block py-1 px-2 pr-4 mr-1 mb-2">NASDAQ:BGNE<span class="fa-regular fa-xmark position-absolute"></span></a><a onclick="stockButtonClick('NASDAQ:BIIB');" id="btnRemoveSymbolBIIB" class="stock-button btn btn-secondary d-inline-block py-1 px-2 pr-4 mr-1 mb-2">NASDAQ:BIIB<span class="fa-regular fa-xmark position-absolute"></span></a><a onclick="stockButtonClick('NASDAQ:BMRN');" id="btnRemoveSymbolBMRN" class="stock-button btn btn-secondary d-inline-block py-1 px-2 pr-4 mr-1 mb-2">NASDAQ:BMRN<span class="fa-regular fa-xmark position-absolute"></span></a><a onclick="stockButtonClick('NASDAQ:BNTX');" id="btnRemoveSymbolBNTX" class="stock-button btn btn-secondary d-inline-block py-1 px-2 pr-4 mr-1 mb-2">NASDAQ:BNTX<span class="fa-regular fa-xmark position-absolute"></span></a><a onclick="stockButtonClick('NASDAQ:GILD');" id="btnRemoveSymbolGILD" class="stock-button btn btn-secondary d-inline-block py-1 px-2 pr-4 mr-1 mb-2">NASDAQ:GILD<span class="fa-regular fa-xmark position-absolute"></span></a><a onclick="stockButtonClick('NASDAQ:GMAB');" id="btnRemoveSymbolGMAB" class="stock-button btn btn-secondary d-inline-block py-1 px-2 pr-4 mr-1 mb-2">NASDAQ:GMAB<span class="fa-regular fa-xmark position-absolute"></span></a>
</div>
</div>
</div>
</div>
<div class="row">
<div class="col-12 order-1 increase-tab-index">
<div class="row mb-3">
<div class="col-12">
<h2 class="h3 mt-0">Comparative Price Performance Over Time</h2>
<div class="w-100 border rounded p-3">
<div class="text-right performanceChartOptions position-relative mb-2 w-100"><button type="button" class="draw-performance-chart btn btn-secondary mr-1" id="draw1">1 day</button><button type="button"
class="draw-performance-chart btn btn-secondary mr-1" id="draw7">7 days</button><button type="button" class="draw-performance-chart btn btn-primary mr-1" id="draw30">30 days</button><button type="button"
class="draw-performance-chart btn btn-secondary mr-1" id="draw90">90 days</button><button type="button" class="draw-performance-chart btn btn-secondary mr-1" id="draw365">365 days</button></div>
<div class="dv-chart-wrapper w-100">
<div id="competitorPricePerformance" class="dv-chart mt-3" style="height: 450px;"><svg id="svgcompetitorPricePerformance" width="1326" height="450" aria-label="Price Performance Comparison" data-pastpercentage="1" data-margintop="20"
data-marginleft="40">
<g class="underGroup">
<g class="y axis" transform="translate(40,20)" fill="none" font-size="10" font-family="sans-serif" text-anchor="end">
<path class="domain" stroke="#000" d="M1216,370.5H0.5V0.5H1216"></path>
<g class="tick" opacity="1" transform="translate(0,310.6779554797125)">
<line stroke="#000" x2="1216"></line><text fill="#000" x="-40" dy="0.32em"></text>
</g>
<g class="tick g-baseline" opacity="1" transform="translate(0,188.31496069502182)">
<line stroke="#000" x2="1216"></line><text fill="#000" x="-40" dy="0.32em"></text>
</g>
<g class="tick" opacity="1" transform="translate(0,65.95196591033113)">
<line stroke="#000" x2="1216"></line><text fill="#000" x="-40" dy="0.32em"></text>
</g>
</g>
</g>
<g class="shadowGroup" transform="translate(40,20)" width="1216" height="370" clip-path="url(#competitorPricePerformanceclip)"></g>
<g class="mainGroup" transform="translate(40,20)" width="1216" height="0" clip-path="url(#competitorPricePerformanceclip)">
<clipPath class="clip" id="competitorPricePerformanceclip">
<rect transform="translate(-15,-20)" width="1246" height="450"></rect>
</clipPath>
<path class="invisible-line"
d="M107.29411764705883,0C143.05882352941177,0,178.8235294117647,0,214.58823529411765,0C226.50980392156862,0,238.4313725490196,0,250.35294117647058,0C262.27450980392155,0,274.19607843137254,0,286.11764705882354,0C298.03921568627453,0,309.96078431372547,0,321.88235294117646,0C333.80392156862746,0,345.72549019607845,0,357.64705882352945,0C393.4117647058824,0,429.17647058823525,0,464.9411764705882,0C476.86274509803917,0,488.78431372549016,0,500.70588235294116,0C512.6274509803922,0,524.5490196078431,0,536.4705882352941,0C548.3921568627451,0,560.3137254901961,0,572.2352941176471,0C584.156862745098,0,596.0784313725491,0,608,0C643.7647058823529,0,679.529411764706,0,715.2941176470589,0C727.2156862745098,0,739.1372549019609,0,751.0588235294118,0C762.9803921568628,0,774.9019607843138,0,786.8235294117648,0C798.7450980392157,0,810.6666666666667,0,822.5882352941177,0C834.5098039215686,0,846.4313725490197,0,858.3529411764706,0C894.1176470588235,0,929.8823529411765,0,965.6470588235294,0C977.5686274509803,0,989.4901960784314,0,1001.4117647058823,0C1013.3333333333334,0,1025.2549019607843,0,1037.1764705882354,0C1049.0980392156864,0,1061.0196078431372,0,1072.9411764705883,0C1084.8627450980393,0,1096.7843137254902,0,1108.7058823529412,0">
</path>
<g class="x axis quarter-labels" transform="translate(0,425)" fill="none" font-size="10" font-family="sans-serif" text-anchor="middle">
<path class="domain" stroke="#000" d="M0.5,2V0.5H1216.5V2"></path>
<g class="tick" opacity="1" transform="translate(0.5,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(36.26470588235294,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(72.02941176470588,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(107.79411764705883,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">22</text>
</g>
<g class="tick" opacity="1" transform="translate(143.55882352941177,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(179.32352941176472,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(215.08823529411765,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">25</text>
</g>
<g class="tick" opacity="1" transform="translate(250.85294117647058,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(286.61764705882354,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(322.38235294117646,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(358.14705882352945,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(393.9117647058824,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(429.6764705882353,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">Dec 1</text>
</g>
<g class="tick" opacity="1" transform="translate(465.4411764705882,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(501.20588235294116,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(536.9705882352941,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">4</text>
</g>
<g class="tick" opacity="1" transform="translate(572.7352941176471,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(608.5,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(644.2647058823529,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">7</text>
</g>
<g class="tick" opacity="1" transform="translate(680.0294117647059,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(715.7941176470589,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(751.5588235294118,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">10</text>
</g>
<g class="tick" opacity="1" transform="translate(787.3235294117648,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(823.0882352941177,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(858.8529411764706,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">13</text>
</g>
<g class="tick" opacity="1" transform="translate(894.6176470588236,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(930.3823529411764,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(966.1470588235294,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">16</text>
</g>
<g class="tick" opacity="1" transform="translate(1001.9117647058823,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(1037.6764705882354,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(1073.4411764705883,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">19</text>
</g>
<g class="tick" opacity="1" transform="translate(1109.2058823529412,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(1144.9705882352941,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(1180.735294117647,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(1216.5,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em"></text>
</g>
</g>
<g class="info-slider" transform="translate(1108.7059326171875,0)">
<line class="x-hover-line" stroke-width="2" stroke="#ddd" y1="10" y2="370"></line>
</g>
<g class="x axis year-lines" transform="translate(0,390)" fill="none" font-size="10" font-family="sans-serif" text-anchor="middle">
<path class="domain" stroke="#000" d="M0.5,2V0.5H1216.5V2"></path>
<g class="tick" opacity="1" transform="translate(0.5,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 134.118;"></line>
</g>
<g class="tick" opacity="1" transform="translate(107.79411764705883,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 134.118;"></line>
</g>
<g class="tick" opacity="1" transform="translate(215.08823529411765,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 134.118;"></line>
</g>
<g class="tick" opacity="1" transform="translate(322.38235294117646,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 134.118;"></line>
</g>
<g class="tick" opacity="1" transform="translate(429.6764705882353,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 134.118;"></line>
</g>
<g class="tick" opacity="1" transform="translate(536.9705882352941,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 134.118;"></line>
</g>
<g class="tick" opacity="1" transform="translate(644.2647058823529,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 134.118;"></line>
</g>
<g class="tick" opacity="1" transform="translate(751.5588235294118,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 134.118;"></line>
</g>
<g class="tick" opacity="1" transform="translate(858.8529411764706,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 134.118;"></line>
</g>
<g class="tick" opacity="1" transform="translate(966.1470588235294,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 134.118;"></line>
</g>
<g class="tick" opacity="1" transform="translate(1073.4411764705883,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 134.118;"></line>
</g>
<g class="tick" opacity="1" transform="translate(1180.735294117647,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 134.118;"></line>
</g>
</g>
<path class="ARGX-line chart-line"
d="M107.29411764705883,187.81496069502182C143.05882352941177,188.0596866845912,178.8235294117647,188.30441267416057,214.58823529411765,188.30441267416057C226.50980392156862,188.30441267416057,238.4313725490196,187.32550871588305,250.35294117647058,185.367700799328C262.27450980392155,183.40989288277294,274.19607843137254,170.317052440811,286.11764705882354,170.317052440811C298.03921568627453,170.317052440811,309.96078431372547,170.317052440811,321.88235294117646,170.317052440811C333.80392156862746,170.317052440811,345.72549019607845,166.8365050336021,357.64705882352945,166.40143660770096C393.4117647058824,165.09623132999758,429.17647058823525,164.4436286911459,464.9411764705882,164.4436286911459C476.86274509803917,164.4436286911459,488.78431372549016,186.7136937419596,500.70588235294116,186.7136937419596C512.6274509803922,186.7136937419596,524.5490196078431,150.94291159990166,536.4705882352941,149.39298033262892C548.3921568627451,147.84304906535618,560.3137254901961,147.0680834317198,572.2352941176471,147.0680834317198C584.156862745098,147.0680834317198,596.0784313725491,150.88512907458664,608,153.06387017616962C643.7647058823529,159.6000934809185,679.529411764706,173.75341321101448,715.2941176470589,177.5364691331078C727.2156862745098,178.79748777380559,739.1372549019609,178.31143476674416,751.0588235294118,179.8613660340169C762.9803921568628,181.41129730128964,774.9019607843138,185.75518361614618,786.8235294117648,187.9373236898065C798.7450980392157,190.11946376346683,810.6666666666667,192.95420647597882,822.5882352941177,192.95420647597882C834.5098039215686,192.95420647597882,846.4313725490197,188.60012324489023,858.3529411764706,185.24533780454328C894.1176470588235,175.18098148350245,929.8823529411765,146.762175944758,965.6470588235294,133.85287999497316C977.5686274509803,129.5497813450449,989.4901960784314,122.35075848521228,1001.4117647058823,122.35075848521228C1013.3333333333334,122.35075848521228,1025.2549019607843,150.9836992648299,1037.1764705882354,150.9836992648299C1049.0980392156864,150.9836992648299,1061.0196078431372,147.1904464265045,1072.9411764705883,147.1904464265045C1084.8627450980393,147.1904464265045,1096.7843137254902,149.45416183002126,1108.7058823529412,151.71787723353802"
stroke-width="3" stroke="#005882" fill="none" opacity="1" stroke-dashoffset="0" stroke-dasharray="1061.5491943359375"></path>
<path class="GILD-line chart-line"
d="M107.29411764705883,187.81496069502182C143.05882352941177,187.14196422370603,178.8235294117647,186.46896775239023,214.58823529411765,183.77698186712703C226.50980392156862,182.87965323870597,238.4313725490196,176.37402068265322,250.35294117647058,172.0301343677967C262.27450980392155,167.6862480529402,274.19607843137254,157.7136639779879,286.11764705882354,157.7136639779879C298.03921568627453,157.7136639779879,309.96078431372547,157.7136639779879,321.88235294117646,157.7136639779879C333.80392156862746,157.7136639779879,345.72549019607845,156.51382683468245,357.64705882352945,155.38876707707877C393.4117647058824,152.01358780426773,429.17647058823525,135.8106879115283,464.9411764705882,135.8106879115283C476.86274509803917,135.8106879115283,488.78431372549016,151.10606225961462,500.70588235294116,156.61239702492568C512.6274509803922,162.11873179023675,524.5490196078431,168.84869650339476,536.4705882352941,168.84869650339476C548.3921568627451,168.84869650339476,560.3137254901961,144.37609754645663,572.2352941176471,144.37609754645663C584.156862745098,144.37609754645663,596.0784313725491,156.85712301449504,608,161.5069168163133C643.7647058823529,175.45629822176807,679.529411764706,182.43098892449544,715.2941176470589,182.43098892449544C727.2156862745098,182.43098892449544,739.1372549019609,159.10044458554773,751.0588235294118,158.69256793626542C762.9803921568628,158.2846912869831,774.9019607843138,158.08075296234196,786.8235294117648,158.08075296234196C798.7450980392157,158.08075296234196,810.6666666666667,158.08075296234196,822.5882352941177,158.08075296234196C834.5098039215686,158.08075296234196,846.4313725490197,165.17780665985404,858.3529411764706,165.17780665985404C894.1176470588235,165.17780665985404,929.8823529411765,164.3212656963612,965.6470588235294,162.60818376937553C977.5686274509803,162.03715646038032,989.4901960784314,152.45205520224619,1001.4117647058823,152.45205520224619C1013.3333333333334,152.45205520224619,1025.2549019607843,181.0849959818638,1037.1764705882354,181.0849959818638C1049.0980392156864,181.0849959818638,1061.0196078431372,179.24955106009344,1072.9411764705883,175.57866121655272C1084.8627450980393,171.907771373012,1096.7843137254902,163.70945072243774,1108.7058823529412,155.51113007186348"
stroke-width="3" stroke="#0B824D" fill="none" opacity="0.5" stroke-dashoffset="0" stroke-dasharray="1060.6258544921875"></path>
<path class="BMRN-line chart-line"
d="M107.29411764705883,187.81496069502182C143.05882352941177,179.92254753140926,178.8235294117647,172.0301343677967,214.58823529411765,172.0301343677967C226.50980392156862,172.0301343677967,238.4313725490196,176.06811319569152,250.35294117647058,176.06811319569152C262.27450980392155,176.06811319569152,274.19607843137254,165.6672586389928,286.11764705882354,165.6672586389928C298.03921568627453,165.6672586389928,309.96078431372547,165.6672586389928,321.88235294117646,165.6672586389928C333.80392156862746,165.6672586389928,345.72549019607845,154.1651371292319,357.64705882352945,154.1651371292319C393.4117647058824,154.1651371292319,429.17647058823525,160.44643752817936,464.9411764705882,173.00903832607426C476.86274509803917,177.19657192537258,488.78431372549016,208.24958082406516,500.70588235294116,208.24958082406516C512.6274509803922,208.24958082406516,524.5490196078431,144.9879125203801,536.4705882352941,144.9879125203801C548.3921568627451,144.9879125203801,560.3137254901961,151.59551423875337,572.2352941176471,151.59551423875337C584.156862745098,151.59551423875337,596.0784313725491,140.8819542509382,608,140.58284470813118C643.7647058823529,139.6855160797101,679.529411764706,139.23685176549958,715.2941176470589,139.23685176549958C727.2156862745098,139.23685176549958,739.1372549019609,143.78467640499727,751.0588235294118,146.45626845779634C762.9803921568628,149.1278605105954,774.9019607843138,155.26640408229406,786.8235294117648,155.26640408229406C798.7450980392157,155.26640408229406,810.6666666666667,149.760069316983,822.5882352941177,149.760069316983C834.5098039215686,149.760069316983,846.4313725490197,153.09106195278846,858.3529411764706,154.53222611358595C894.1176470588235,158.85571859597837,929.8823529411765,163.46472473286838,965.6470588235294,163.46472473286838C977.5686274509803,163.46472473286838,989.4901960784314,132.01743507320282,1001.4117647058823,132.01743507320282C1013.3333333333334,132.01743507320282,1025.2549019607843,179.6166400444475,1037.1764705882354,179.6166400444475C1049.0980392156864,179.6166400444475,1061.0196078431372,176.82268499686376,1072.9411764705883,173.74321629478237C1084.8627450980393,170.663747592701,1096.7843137254902,165.90178771233008,1108.7058823529412,161.1398278319592"
stroke-width="3" stroke="#117169" fill="none" opacity="0.5" stroke-dashoffset="0" stroke-dasharray="1111.2833251953125"></path>
<path class="ALNY-line chart-line"
d="M107.29411764705883,187.81496069502182C143.05882352941177,178.25535172746785,178.8235294117647,168.69574275991388,214.58823529411765,157.34657499363382C226.50980392156862,153.56351907154047,238.4313725490196,146.9049327720069,250.35294117647058,145.59972749430352C262.27450980392155,144.29452221660014,274.19607843137254,143.64191957774844,286.11764705882354,143.64191957774844C298.03921568627453,143.64191957774844,309.96078431372547,143.64191957774844,321.88235294117646,143.64191957774844C333.80392156862746,143.64191957774844,345.72549019607845,146.89133688369745,357.64705882352945,146.9457204369351C393.4117647058824,147.10887109664804,429.17647058823525,147.02729576679155,464.9411764705882,147.1904464265045C476.86274509803917,147.24482997974215,488.78431372549016,153.06387017616962,500.70588235294116,153.06387017616962C512.6274509803922,153.06387017616962,524.5490196078431,138.74739978636083,536.4705882352941,138.74739978636083C548.3921568627451,138.74739978636083,560.3137254901961,153.18623317095435,572.2352941176471,153.18623317095435C584.156862745098,153.18623317095435,596.0784313725491,131.03853111492532,608,131.03853111492532C643.7647058823529,131.03853111492532,679.529411764706,131.65034608884878,715.2941176470589,132.87397603669567C727.2156862745098,133.28185268597795,739.1372549019609,142.7853786142556,751.0588235294118,142.7853786142556C762.9803921568628,142.7853786142556,774.9019607843138,141.5617486664087,786.8235294117648,141.5617486664087C798.7450980392157,141.5617486664087,810.6666666666667,185.97951577325145,822.5882352941177,185.97951577325145C834.5098039215686,185.97951577325145,846.4313725490197,185.1229748097586,858.3529411764706,185.1229748097586C894.1176470588235,185.1229748097586,929.8823529411765,192.34239150205536,965.6470588235294,192.34239150205536C977.5686274509803,192.34239150205536,989.4901960784314,179.37191405487815,1001.4117647058823,179.37191405487815C1013.3333333333334,179.37191405487815,1025.2549019607843,222.68841420865866,1037.1764705882354,222.68841420865866C1049.0980392156864,222.68841420865866,1061.0196078431372,221.09769527645767,1072.9411764705883,217.91625741205573C1084.8627450980393,214.73481954765379,1096.7843137254902,199.9288971787062,1108.7058823529412,185.1229748097586"
stroke-width="3" stroke="#262682" fill="none" opacity="0.5" stroke-dashoffset="0" stroke-dasharray="1085.894775390625"></path>
<path class="BNTX-line chart-line"
d="M107.29411764705883,187.81496069502182C143.05882352941177,146.57863145258102,178.8235294117647,105.34230221014025,214.58823529411765,105.34230221014025C226.50980392156862,105.34230221014025,238.4313725490196,129.32544918793965,250.35294117647058,129.32544918793965C262.27450980392155,129.32544918793965,274.19607843137254,105.70939119449434,286.11764705882354,105.70939119449434C298.03921568627453,105.70939119449434,309.96078431372547,105.70939119449434,321.88235294117646,105.70939119449434C333.80392156862746,105.70939119449434,345.72549019607845,128.0610315751645,357.64705882352945,130.9161681201406C393.4117647058824,139.481577755069,429.17647058823525,135.1988729376048,464.9411764705882,143.76428257253318C476.86274509803917,146.6194191175093,488.78431372549016,156.75515385217446,500.70588235294116,161.2621908267439C512.6274509803922,165.76922780131335,524.5490196078431,170.8065044199498,536.4705882352941,170.8065044199498C548.3921568627451,170.8065044199498,560.3137254901961,138.66582445650442,572.2352941176471,126.02164832875303C584.156862745098,113.37747220100165,596.0784313725491,94.94144765344151,608,94.94144765344151C643.7647058823529,94.94144765344151,679.529411764706,98.16367318277172,715.2941176470589,104.60812424143211C727.2156862745098,106.75627459431891,739.1372549019609,147.55753541085855,751.0588235294118,147.55753541085855C762.9803921568628,147.55753541085855,774.9019607843138,127.55118576356163,786.8235294117648,120.63767655822662C798.7450980392157,113.7241673528916,810.6666666666667,106.07648017884844,822.5882352941177,106.07648017884844C834.5098039215686,106.07648017884844,846.4313725490197,107.17774713191064,858.3529411764706,109.38028103803504C894.1176470588235,115.98788275640823,929.8823529411765,176.06811319569152,965.6470588235294,176.06811319569152C977.5686274509803,176.06811319569152,989.4901960784314,141.68411166119338,1001.4117647058823,141.68411166119338C1013.3333333333334,141.68411166119338,1025.2549019607843,202.25379407961532,1037.1764705882354,204.21160199617037C1049.0980392156864,206.16940991272543,1061.0196078431372,207.14831387100296,1072.9411764705883,207.14831387100296C1084.8627450980393,207.14831387100296,1096.7843137254902,197.72636327258175,1108.7058823529412,188.30441267416057"
stroke-width="3" stroke="#005882" fill="none" opacity="0.5" stroke-dashoffset="0" stroke-dasharray="1215.7901611328125"></path>
<path class="AZN-line chart-line"
d="M107.29411764705883,187.81496069502182C143.05882352941177,180.65672550011743,178.8235294117647,173.498490305213,214.58823529411765,173.498490305213C226.50980392156862,173.498490305213,238.4313725490196,174.23266827392115,250.35294117647058,174.23266827392115C262.27450980392155,174.23266827392115,274.19607843137254,158.57020494148074,286.11764705882354,158.57020494148074C298.03921568627453,158.57020494148074,309.96078431372547,158.57020494148074,321.88235294117646,158.57020494148074C333.80392156862746,158.57020494148074,345.72549019607845,150.73897327526052,357.64705882352945,150.73897327526052C393.4117647058824,150.73897327526052,429.17647058823525,161.5069168163133,464.9411764705882,161.5069168163133C476.86274509803917,161.5069168163133,488.78431372549016,142.66301561947094,500.70588235294116,142.66301561947094C512.6274509803922,142.66301561947094,524.5490196078431,166.40143660770096,536.4705882352941,166.40143660770096C548.3921568627451,166.40143660770096,560.3137254901961,156.75515385217446,572.2352941176471,152.32969220746148C584.156862745098,147.9042305627485,596.0784313725491,141.39859800669578,608,139.84866673942304C643.7647058823529,135.1988729376048,679.529411764706,132.87397603669567,715.2941176470589,132.87397603669567C727.2156862745098,132.87397603669567,739.1372549019609,158.93729392583478,751.0588235294118,158.93729392583478C762.9803921568628,158.93729392583478,774.9019607843138,154.7769521031553,786.8235294117648,154.7769521031553C798.7450980392157,154.7769521031553,810.6666666666667,160.7931326800693,822.5882352941177,163.3423617380837C834.5098039215686,165.8915907960981,846.4313725490197,168.60397051382532,858.3529411764706,170.07232645124162C894.1176470588235,174.47739426349054,929.8823529411765,176.67992816961498,965.6470588235294,176.67992816961498C977.5686274509803,176.67992816961498,989.4901960784314,158.93729392583478,1001.4117647058823,158.93729392583478C1013.3333333333334,158.93729392583478,1025.2549019607843,203.84451301181628,1037.1764705882354,206.2917729075101C1049.0980392156864,208.73903280320394,1061.0196078431372,209.96266275105086,1072.9411764705883,209.96266275105086C1084.8627450980393,209.96266275105086,1096.7843137254902,201.51961611090718,1108.7058823529412,193.0765694707635"
stroke-width="3" stroke="#9D2A2D" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="1073.6524658203125"></path>
<path class="GMAB-line chart-line"
d="M107.29411764705883,187.81496069502182C143.05882352941177,183.65461887234233,178.8235294117647,179.49427704966286,214.58823529411765,179.49427704966286C226.50980392156862,179.49427704966286,238.4313725490196,187.81496069502182,250.35294117647058,187.81496069502182C262.27450980392155,187.81496069502182,274.19607843137254,157.5913009832032,286.11764705882354,157.5913009832032C298.03921568627453,157.5913009832032,309.96078431372547,157.5913009832032,321.88235294117646,157.5913009832032C333.80392156862746,157.5913009832032,345.72549019607845,141.8608582092158,357.64705882352945,137.40140684372926C393.4117647058824,124.02305274726973,429.17647058823525,117.33387569903996,464.9411764705882,117.33387569903996C476.86274509803917,117.33387569903996,488.78431372549016,123.77832675770034,500.70588235294116,125.65455934439893C512.6274509803922,127.53079193109753,524.5490196078431,128.5912712192315,536.4705882352941,128.5912712192315C548.3921568627451,128.5912712192315,560.3137254901961,116.7220607251165,572.2352941176471,116.7220607251165C584.156862745098,116.7220607251165,596.0784313725491,119.04695762602566,608,119.04695762602566C643.7647058823529,119.04695762602566,679.529411764706,101.30432338224551,715.2941176470589,101.30432338224551C727.2156862745098,101.30432338224551,739.1372549019609,112.41896207518823,751.0588235294118,117.94569067296342C762.9803921568628,123.47241927073861,774.9019607843138,123.45202543827449,786.8235294117648,134.46469496889662C798.7450980392157,145.47736449951876,810.6666666666667,174.19188060899293,822.5882352941177,187.81496069502182C834.5098039215686,201.43804078105072,846.4313725490197,214.2181757918962,858.3529411764706,216.20317548507006C894.1176470588235,222.1581745645917,929.8823529411765,225.1356741043525,965.6470588235294,225.1356741043525C977.5686274509803,225.1356741043525,989.4901960784314,224.93173577971135,1001.4117647058823,224.52385913042903C1013.3333333333334,224.11598248114672,1025.2549019607843,218.03862040684044,1037.1764705882354,218.03862040684044C1049.0980392156864,218.03862040684044,1061.0196078431372,220.975332281673,1072.9411764705883,220.975332281673C1084.8627450980393,220.975332281673,1096.7843137254902,214.49009355808437,1108.7058823529412,208.00485483449577"
stroke-width="3" stroke="#935912" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="1080.28466796875"></path>
<path class="BIIB-line chart-line"
d="M107.29411764705883,187.81496069502182C143.05882352941177,184.69470432801222,178.8235294117647,181.5744479610026,214.58823529411765,181.5744479610026C226.50980392156862,181.5744479610026,238.4313725490196,189.4056796272228,250.35294117647058,189.4056796272228C262.27450980392155,189.4056796272228,274.19607843137254,172.88667533128955,286.11764705882354,172.88667533128955C298.03921568627453,172.88667533128955,309.96078431372547,172.88667533128955,321.88235294117646,172.88667533128955C333.80392156862746,172.88667533128955,345.72549019607845,168.98125641441152,357.64705882352945,166.64616259727035C393.4117647058824,159.64088114584683,429.17647058823525,138.74739978636083,464.9411764705882,138.74739978636083C476.86274509803917,138.74739978636083,488.78431372549016,164.93308067028465,500.70588235294116,164.93308067028465C512.6274509803922,164.93308067028465,524.5490196078431,164.4436286911459,536.4705882352941,164.4436286911459C548.3921568627451,164.4436286911459,560.3137254901961,173.23337048317953,572.2352941176471,177.29174314353844C584.156862745098,181.35011580389735,596.0784313725491,186.5369471939373,608,188.79386465329935C643.7647058823529,195.56461703138555,679.529411764706,197.27769895837125,715.2941176470589,198.94999322042867C727.2156862745098,199.50742464111448,739.1372549019609,200.05126017349087,751.0588235294118,200.05126017349087C762.9803921568628,200.05126017349087,774.9019607843138,191.24112454899313,786.8235294117648,191.24112454899313C798.7450980392157,191.24112454899313,810.6666666666667,198.1750275867923,822.5882352941177,207.7601288449264C834.5098039215686,217.34523010306052,846.4313725490197,248.7517320977978,858.3529411764706,248.7517320977978C894.1176470588235,248.7517320977978,929.8823529411765,246.3248660345681,965.6470588235294,245.20320524904176C977.5686274509803,244.829318320533,989.4901960784314,244.10193829597955,1001.4117647058823,244.10193829597955C1013.3333333333334,244.10193829597955,1025.2549019607843,273.9585090234441,1037.1764705882354,273.9585090234441C1049.0980392156864,273.9585090234441,1061.0196078431372,269.30871522162585,1072.9411764705883,269.30871522162585C1084.8627450980393,269.30871522162585,1096.7843137254902,272.85724207038186,1108.7058823529412,276.4057689191379"
stroke-width="3" stroke="#0B824D" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="1064.8905029296875"></path>
<path class="BGNE-line chart-line"
d="M107.29411764705883,187.81496069502182C143.05882352941177,188.4879571663376,178.8235294117647,189.1609536376534,214.58823529411765,189.1609536376534C226.50980392156862,189.1609536376534,238.4313725490196,185.28612546947153,250.35294117647058,177.5364691331078C262.27450980392155,169.78681279674407,274.19607843137254,87.35494197679071,286.11764705882354,87.35494197679071C298.03921568627453,87.35494197679071,309.96078431372547,87.35494197679071,321.88235294117646,87.35494197679071C333.80392156862746,87.35494197679071,345.72549019607845,30.578512396694236,357.64705882352945,30.578512396694236C393.4117647058824,30.578512396694236,429.17647058823525,89.92456486726928,464.9411764705882,89.92456486726928C476.86274509803917,89.92456486726928,488.78431372549016,88.21148294028359,500.70588235294116,88.21148294028359C512.6274509803922,88.21148294028359,524.5490196078431,132.75161304191099,536.4705882352941,132.75161304191099C548.3921568627451,132.75161304191099,560.3137254901961,123.22769328116921,572.2352941176471,116.23260874597773C584.156862745098,109.23752421078625,596.0784313725491,93.63624237573822,608,90.7811058307621C643.7647058823529,82.21569619583373,679.529411764706,77.93299137836954,715.2941176470589,77.93299137836954C727.2156862745098,77.93299137836954,739.1372549019609,193.76995977454345,751.0588235294118,207.14831387100296C762.9803921568628,220.52666796746246,774.9019607843138,219.46618867932847,786.8235294117648,227.21584501569222C798.7450980392157,234.96550135205598,810.6666666666667,249.73063605607535,822.5882352941177,253.64625188918544C834.5098039215686,257.5618677222955,846.4313725490197,257.5142821132126,858.3529411764706,259.5196756388506C894.1176470588235,265.5358562157645,929.8823529411765,278.8530288148317,965.6470588235294,278.8530288148317C977.5686274509803,278.8530288148317,989.4901960784314,261.35512056062095,1001.4117647058823,261.35512056062095C1013.3333333333334,261.35512056062095,1025.2549019607843,277.13994688784607,1037.1764705882354,281.7897406896643C1049.0980392156864,286.43953449148256,1061.0196078431372,289.25388337153043,1072.9411764705883,289.25388337153043C1084.8627450980393,289.25388337153043,1096.7843137254902,283.50282261664995,1108.7058823529412,277.7517618617695"
stroke-width="3" stroke="#117169" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="1285.0240478515625"></path>
<path class="AMGN-line chart-line"
d="M107.29411764705883,187.81496069502182C143.05882352941177,188.1820496793759,178.8235294117647,188.54913866372996,214.58823529411765,190.01749460114624C226.50980392156862,190.506946580285,238.4313725490196,248.13991712387434,250.35294117647058,248.13991712387434C262.27450980392155,248.13991712387434,274.19607843137254,247.89519113430498,286.11764705882354,247.89519113430498C298.03921568627453,247.89519113430498,309.96078431372547,247.89519113430498,321.88235294117646,247.89519113430498C333.80392156862746,247.89519113430498,345.72549019607845,236.27070662975933,357.64705882352945,236.27070662975933C393.4117647058824,236.27070662975933,429.17647058823525,256.09351178487924,464.9411764705882,256.09351178487924C476.86274509803917,256.09351178487924,488.78431372549016,255.11460782660168,500.70588235294116,255.11460782660168C512.6274509803922,255.11460782660168,524.5490196078431,255.19618315645815,536.4705882352941,255.35933381617107C548.3921568627451,255.522484475884,560.3137254901961,267.8199654517455,572.2352941176471,271.7559751173197C584.156862745098,275.6919847828939,596.0784313725491,278.9753918096164,608,278.9753918096164C643.7647058823529,278.9753918096164,679.529411764706,258.0513197014343,715.2941176470589,258.0513197014343C727.2156862745098,258.0513197014343,739.1372549019609,262.96623332528605,751.0588235294118,265.8825513676545C762.9803921568628,268.798869410023,774.9019607843138,275.54922795564505,786.8235294117648,275.54922795564505C798.7450980392157,275.54922795564505,810.6666666666667,272.85724207038186,822.5882352941177,272.85724207038186C834.5098039215686,272.85724207038186,846.4313725490197,283.3668637335559,858.3529411764706,287.1737124601907C894.1176470588235,298.5942586400951,929.8823529411765,301.225063027966,965.6470588235294,304.30453173004736C977.5686274509803,305.3310212974078,989.4901960784314,305.0387096987555,1001.4117647058823,306.5070656361718C1013.3333333333334,307.97542157358805,1025.2549019607843,336.3636363636364,1037.1764705882354,336.3636363636364C1049.0980392156864,336.3636363636364,1061.0196078431372,329.51130865569365,1072.9411764705883,326.3298707912917C1084.8627450980393,323.1484329268897,1096.7843137254902,320.21172105205716,1108.7058823529412,317.2750091772246"
stroke-width="3" stroke="#262682" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="1069.363037109375"></path>
<g class="fade-edges">
<rect transform="translate(-16,-20)" width="1250" height="450" mask="url(#competitorPricePerformancemask)" style="fill: rgb(255, 255, 255);"></rect>
</g>
<rect transform="translate(0,0)" class="overlay" width="1216" height="415"></rect>
</g>
<g class="bottomGroup" transform="translate(40,20)" width="1216" height="0" clip-path="url(#competitorPricePerformanceclip)"></g>
<g class="yTextGroup">
<g class="y axis top" transform="translate(40,20)" fill="none" font-size="10" font-family="sans-serif" text-anchor="end">
<path class="domain" stroke="#000" d="M1216,370.5H0.5V0.5H1216"></path>
<g class="tick" opacity="1" transform="translate(0,310.6779554797125)">
<line stroke="#000" x2="1216"></line><text fill="#000" x="-12" dy="0.32em">-10%</text>
</g>
<g class="tick g-baseline" opacity="1" transform="translate(0,188.31496069502182)">
<line stroke="#000" x2="1216"></line><text fill="#000" x="-12" dy="0.32em">0%</text>
</g>
<g class="tick" opacity="1" transform="translate(0,65.95196591033113)">
<line stroke="#000" x2="1216"></line><text fill="#000" x="-12" dy="0.32em">10%</text>
</g>
</g>
<g transform="translate(1306,20)"><text text-anchor="end" class="footnote-top">Dec 20</text></g>
<g class="footnote" transform="translate(1256,45)">
<rect height="5" width="10" fill="#005882" opacity="1" x="5"></rect><text height="30" width="95" fill="#005882" x="18" y="8">ARGX</text><text class="footnote-details" height="30" width="95" fill="#005882" x="18" y="24"></text>
</g>
<g class="footnote" transform="translate(1256,85)">
<rect height="5" width="10" fill="#0B824D" opacity="0.5" x="5"></rect><text height="30" width="95" fill="#0B824D" x="18" y="8">GILD</text><text class="footnote-details" height="30" width="95" fill="#0B824D" x="18" y="24"></text>
</g>
<g class="footnote" transform="translate(1256,125)">
<rect height="5" width="10" fill="#117169" opacity="0.5" x="5"></rect><text height="30" width="95" fill="#117169" x="18" y="8">BMRN</text><text class="footnote-details" height="30" width="95" fill="#117169" x="18" y="24"></text>
</g>
<g class="footnote" transform="translate(1256,165)">
<rect height="5" width="10" fill="#262682" opacity="0.5" x="5"></rect><text height="30" width="95" fill="#262682" x="18" y="8">ALNY</text><text class="footnote-details" height="30" width="95" fill="#262682" x="18" y="24"></text>
</g>
<g class="footnote" transform="translate(1256,205)">
<rect height="5" width="10" fill="#005882" opacity="0.5" x="5"></rect><text height="30" width="95" fill="#005882" x="18" y="8">BNTX</text><text class="footnote-details" height="30" width="95" fill="#005882" x="18" y="24"></text>
</g>
<g class="footnote" transform="translate(1256,245)">
<rect height="5" width="10" fill="#9D2A2D" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#9D2A2D" x="18" y="8">AZN</text><text class="footnote-details" height="30" width="95" fill="#9D2A2D" x="18" y="24"></text>
</g>
<g class="footnote" transform="translate(1256,285)">
<rect height="5" width="10" fill="#935912" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#935912" x="18" y="8">GMAB</text><text class="footnote-details" height="30" width="95" fill="#935912" x="18" y="24"></text>
</g>
<g class="footnote" transform="translate(1256,325)">
<rect height="5" width="10" fill="#0B824D" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#0B824D" x="18" y="8">BIIB</text><text class="footnote-details" height="30" width="95" fill="#0B824D" x="18" y="24"></text>
</g>
<g class="footnote" transform="translate(1256,365)">
<rect height="5" width="10" fill="#117169" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#117169" x="18" y="8">BGNE</text><text class="footnote-details" height="30" width="95" fill="#117169" x="18" y="24"></text>
</g>
<g class="footnote" transform="translate(1256,405)">
<rect height="5" width="10" fill="#262682" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#262682" x="18" y="8">AMGN</text><text class="footnote-details" height="30" width="95" fill="#262682" x="18" y="24"></text>
</g>
</g>
<g class="overGroup" transform="translate(40,20)" width="1216" height="370" clip-path="url(#competitorPricePerformanceclip)"></g>
<defs>
<linearGradient id="competitorPricePerformancepastFutureGradient" x1="0%" x2="100%" y1="100%" y2="100%">
<stop class="start" offset="0%" stop-color="var(--blue-8)" stop-opacity="1"></stop>
<stop class="middle" offset="100%" stop-color="var(--blue-8)"></stop>
<stop class="othermiddle" offset="100%" stop-color="#ccc" stop-opacity="0"></stop>
<stop class="end" offset="100%" stop-color="#ccc" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="competitorPricePerformancefutureBarGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="#888888" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="#888888" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#888888" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="competitorPricePerformancepastBarGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="var(--blue-8)" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="var(--blue-8)" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="var(--blue-8)" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="boughtGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="#0B824D" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="#0B824D" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#0B824D" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="competitorPricePerformancesoldGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="#E84B56" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="#E84B56" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#E84B56" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="competitorPricePerformanceLightBlueGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="var(--blue-2)" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="var(--blue-2)" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="var(--blue-2)" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="competitorPricePerformancefadeGradient" x1="0%" x2="100%" y1="100%" y2="100%">
<stop class="start" offset="0%" stop-color="#fff" stop-opacity="1"></stop>
<stop class="middle" offset="1.2335526315789473%" stop-color="#000" stop-opacity="1"></stop>
<stop class="othermiddle" offset="98.76644736842105%" stop-color="#000" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#fff" stop-opacity="1"></stop>
</linearGradient>
<mask id="competitorPricePerformancemask">
<rect x="0" y="0" width="1256" height="450" style="fill: url("#competitorPricePerformancefadeGradient"); opacity: 1;"></rect>
</mask>
<filter id="competitorPricePerformanceinnerShadow" x0="-50%" y0="-50%" width="200%" height="200%">
<feGaussianBlur in="SourceAlpha" stdDeviation="5" result="blur"></feGaussianBlur>
<feOffset dy="10" dx="3"></feOffset>
<feComposite in2="SourceAlpha" operator="arithmetic" k2="-1" k3="1" result="shadowDiff"></feComposite>
<feFlood flood-color="#75a0bb" flood-opacity="0.3"></feFlood>
<feComposite in2="shadowDiff" operator="in"></feComposite>
<feComposite in2="SourceGraphic" operator="over" result="firstfilter"></feComposite>
<feGaussianBlur in="firstfilter" stdDeviation="3" result="blur2"></feGaussianBlur>
<feOffset dy="-10" dx="-3"></feOffset>
<feComposite in2="firstfilter" operator="arithmetic" k2="-1" k3="1" result="shadowDiff"></feComposite>
<feFlood flood-color="#75a0bb" flood-opacity="0.3"></feFlood>
<feComposite in2="shadowDiff" operator="in"></feComposite>
<feComposite in2="firstfilter" operator="over"></feComposite>
</filter>
</defs>
</svg></div>
</div>
</div>
</div>
</div>
<script>
document.addEventListener("DOMContentLoaded", function() {
if (document.getElementById("competitorPricePerformance")) {
document.getElementById("competitorPricePerformance").classList.add("loading-message");
setTimeout(function() {
loadAndDrawCompetitorLineGraphFromCSV("", "competitorPricePerformance", "Day",
"NASDAQ:ALNY:USD:245.44:245.44:245.44:244.89:271.83:191.02|NASDAQ:AMGN:USD:263.38:263.38:270.62:294.53:335.61:284.16|NASDAQ:ARGX:USD:623.82:623.82:607.21:605.92:528.5:372.9|NASDAQ:AZN:USD:65.35:65.35:66.58:65.63:77.14:66.29|NASDAQ:BGNE:USD:176.5:176.5:179.35:190.51:201.31:176.11|NASDAQ:BIIB:USD:146.47:146.47:150.03:157.9:195.81:257.97|NASDAQ:BMRN:USD:65.66:65.66:66.01:64.26:69.13:96.21|NASDAQ:BNTX:USD:113.08:113.08:120.38:113.13:113.05:105.33|NASDAQ:GILD:USD:92.57:92.57:91.855:90.19:83.99:79.66|NASDAQ:GMAB:USD:20.31:20.31:20.17:20.65:24.14:31.44",
"PricePerformanceCompetitorsCSV.ashx?scrp=" + ScrpRestrict, "30")
}, 300);
}
});
</script>
<h2 class="h3 mt-4">Compare Stocks - Price & Volume</h2>
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper" style="padding-top: 50.5625px;">
<table class="scroll-table sort-table price-table fixed-header">
<thead class="hide-scrollbar" style="width: 1448px; position: absolute; top: 0px;">
<tr>
<th data-sort="string" data-clean="Symbol|Company" style="min-width: 283.812px; max-width: 283.812px;">Company</th>
<th data-sort="float" data-clean="Current Price|Price Change" style="min-width: 134.031px; max-width: 134.031px;">Current Price</th>
<th data-sort="float" style="min-width: 134.031px; max-width: 134.031px;">50-Day Moving Average</th>
<th data-sort="float" data-clean="52-Week Low|52-Week High" style="min-width: 261.281px; max-width: 261.281px;">52-Week Range</th>
<th data-sort="float" style="min-width: 134.031px; max-width: 134.031px;">Market Cap</th>
<th data-sort="float" style="min-width: 134.031px; max-width: 134.031px;">Beta</th>
<th data-sort="int" style="min-width: 183.359px; max-width: 183.359px;">Avg. Volume</th>
<th data-sort="int" style="min-width: 183.422px; max-width: 183.422px;">Today's Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td data-clean="ALNY|Alnylam Pharmaceuticals">
<a class="profile-link" title="Alnylam Pharmaceuticals stock price and analysis" href="/stocks/NASDAQ/ALNY/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="22" width="80" src="https://www.marketbeat.com/logos/thumbnail/alnylam-pharma-logo.png" alt="Alnylam Pharmaceuticals, Inc. stock logo"></div><div class="ticker-area">ALNY</div><div class="title-area">Alnylam Pharmaceuticals</div></a>
</td>
<td data-clean="$242.26|-1.3%" data-sort-value="242.26">$242.26<br><span class="c-red">-1.3%</span></td>
<td data-sort-value="263.01">$263.01</td>
<td data-clean="$141.98|$304.39" data-sort-value="141.98">
<div class="range-meter-wrapper d-block">
<div class="range-meter w-100">$141.98<div class="range"><span class="range-marker" style="left:62%"><span class="range-arrow">▼</span></span></div>$304.39</div>
</div>
</td>
<td data-sort-value="31657.098">$31.66B</td>
<td>0.32</td>
<td data-sort-value="860843">860,843 shs</td>
<td data-sort-value="860843">718,087 shs</td>
</tr>
<tr>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen stock price and analysis" href="/stocks/NASDAQ/AMGN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td data-clean="$264.00|0.2%" data-sort-value="264">$264.00<br><span class="c-green">+0.2%</span></td>
<td data-sort-value="296.2">$296.20</td>
<td data-clean="$253.30|$346.85" data-sort-value="253.3">
<div class="range-meter-wrapper d-block">
<div class="range-meter w-100">$253.30<div class="range"><span class="range-marker" style="left:11%"><span class="range-arrow">▼</span></span></div>$346.85</div>
</div>
</td>
<td data-sort-value="141908.712">$141.91B</td>
<td>0.55</td>
<td data-sort-value="2695077">2.70 million shs</td>
<td data-sort-value="2695077">3.03 million shs</td>
</tr>
<tr>
<td data-clean="ARGX|argenx">
<a class="profile-link" title="argenx stock price and analysis" href="/stocks/NASDAQ/ARGX/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/argenx-se---american-depositary-shares-logo.jpg" alt="argenx SE stock logo"></div><div class="ticker-area">ARGX</div><div class="title-area">argenx</div></a>
</td>
<td data-clean="$628.32|0.7%" data-sort-value="628.32">$628.32<br><span class="c-green">+0.7%</span></td>
<td data-sort-value="592.94">$592.94</td>
<td data-clean="$349.86|$644.97" data-sort-value="349.86">
<div class="range-meter-wrapper d-block">
<div class="range-meter w-100">$349.86<div class="range"><span class="range-marker" style="left:94%"><span class="range-arrow">▼</span></span></div>$644.97</div>
</div>
</td>
<td data-sort-value="37658.764">$37.66B</td>
<td>0.59</td>
<td data-sort-value="308013">308,013 shs</td>
<td data-sort-value="308013">153,614 shs</td>
</tr>
<tr>
<td data-clean="AZN|AstraZeneca">
<a class="profile-link" title="AstraZeneca stock price and analysis" href="/stocks/NASDAQ/AZN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/astrazeneca-plc-logo.png?v=20231213131257" alt="AstraZeneca PLC stock logo"></div><div class="ticker-area">AZN</div><div class="title-area">AstraZeneca</div></a>
</td>
<td data-clean="$66.63|2.0%" data-sort-value="66.63">$66.63<br><span class="c-green">+2.0%</span></td>
<td data-sort-value="69.02">$69.02</td>
<td data-clean="$60.47|$87.68" data-sort-value="60.47">
<div class="range-meter-wrapper d-block">
<div class="range-meter w-100">$60.47<div class="range"><span class="range-marker" style="left:23%"><span class="range-arrow">▼</span></span></div>$87.68</div>
</div>
</td>
<td data-sort-value="206595.243">$206.60B</td>
<td>0.45</td>
<td data-sort-value="5354368">5.35 million shs</td>
<td data-sort-value="5354368">8.18 million shs</td>
</tr>
<tr>
<td data-clean="BGNE|BeiGene">
<a class="profile-link" title="BeiGene stock price and analysis" href="/stocks/NASDAQ/BGNE/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="14" width="80" src="https://www.marketbeat.com/logos/thumbnail/beigene-ltd-logo.png?v=20221103144100" alt="BeiGene, Ltd. stock logo"></div><div class="ticker-area">BGNE</div><div class="title-area">BeiGene</div></a>
</td>
<td data-clean="$177.70|0.7%" data-sort-value="177.7">$177.70<br><span class="c-green">+0.7%</span></td>
<td data-sort-value="200">$200.00</td>
<td data-clean="$126.97|$248.16" data-sort-value="126.97">
<div class="range-meter-wrapper d-block">
<div class="range-meter w-100">$126.97<div class="range"><span class="range-marker" style="left:42%"><span class="range-arrow">▼</span></span></div>$248.16</div>
</div>
</td>
<td data-sort-value="17328.949">$17.33B</td>
<td>0.57</td>
<td data-sort-value="284673">284,673 shs</td>
<td data-sort-value="284673">230,640 shs</td>
</tr>
<tr>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen stock price and analysis" href="/stocks/NASDAQ/BIIB/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td data-clean="$149.38|2.0%" data-sort-value="149.38">$149.38<br><span class="c-green">+2.0%</span></td>
<td data-sort-value="167.48">$167.48</td>
<td data-clean="$145.07|$268.30" data-sort-value="145.07">
<div class="range-meter-wrapper d-block">
<div class="range-meter w-100">$145.07<div class="range"><span class="range-marker" style="left:3%"><span class="range-arrow">▼</span></span></div>$268.30</div>
</div>
</td>
<td data-sort-value="21767.504">$21.77B</td>
<td>-0.08</td>
<td data-sort-value="1218156">1.22 million shs</td>
<td data-sort-value="1218156">1.53 million shs</td>
</tr>
<tr>
<td data-clean="BMRN|BioMarin Pharmaceutical">
<a class="profile-link" title="BioMarin Pharmaceutical stock price and analysis" href="/stocks/NASDAQ/BMRN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="60" width="80" src="https://www.marketbeat.com/logos/thumbnail/biomarin-pharm-logo.png" alt="BioMarin Pharmaceutical Inc. stock logo"></div><div class="ticker-area">BMRN</div><div class="title-area">BioMarin Pharmaceutical</div></a>
</td>
<td data-clean="$66.27|0.9%" data-sort-value="66.27">$66.27<br><span class="c-green">+0.9%</span></td>
<td data-sort-value="66.58">$66.58</td>
<td data-clean="$61.15|$99.25" data-sort-value="61.15">
<div class="range-meter-wrapper d-block">
<div class="range-meter w-100">$61.15<div class="range"><span class="range-marker" style="left:13%"><span class="range-arrow">▼</span></span></div>$99.25</div>
</div>
</td>
<td data-sort-value="12629.935">$12.63B</td>
<td>0.29</td>
<td data-sort-value="1806043">1.81 million shs</td>
<td data-sort-value="1806043">1.11 million shs</td>
</tr>
<tr>
<td data-clean="BNTX|BioNTech">
<a class="profile-link" title="BioNTech stock price and analysis" href="/stocks/NASDAQ/BNTX/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/biontech-se-logo.png?v=20231226132334" alt="BioNTech SE stock logo"></div><div class="ticker-area">BNTX</div><div class="title-area">BioNTech</div></a>
</td>
<td data-clean="$113.51|0.4%" data-sort-value="113.51">$113.51<br><span class="c-green">+0.4%</span></td>
<td data-sort-value="113.25">$113.25</td>
<td data-clean="$76.53|$131.49" data-sort-value="76.53">
<div class="range-meter-wrapper d-block">
<div class="range-meter w-100">$76.53<div class="range"><span class="range-marker" style="left:67%"><span class="range-arrow">▼</span></span></div>$131.49</div>
</div>
</td>
<td data-sort-value="26984.278">$26.98B</td>
<td>0.22</td>
<td data-sort-value="808219">808,219 shs</td>
<td data-sort-value="808219">413,831 shs</td>
</tr>
<tr>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences stock price and analysis" href="/stocks/NASDAQ/GILD/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td data-clean="$93.40|0.9%" data-sort-value="93.4">$93.40<br><span class="c-green">+0.9%</span></td>
<td data-sort-value="90.64">$90.64</td>
<td data-clean="$62.07|$98.90" data-sort-value="62.07">
<div class="range-meter-wrapper d-block">
<div class="range-meter w-100">$62.07<div class="range"><span class="range-marker" style="left:85%"><span class="range-arrow">▼</span></span></div>$98.90</div>
</div>
</td>
<td data-sort-value="115366.84">$115.37B</td>
<td>0.18</td>
<td data-sort-value="7123546">7.12 million shs</td>
<td data-sort-value="7123546">4.81 million shs</td>
</tr>
<tr>
<td data-clean="GMAB|Genmab A/S">
<a class="profile-link" title="Genmab A/S stock price and analysis" href="/stocks/NASDAQ/GMAB/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="59" width="80" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div><div class="ticker-area">GMAB</div><div class="title-area">Genmab A/S</div></a>
</td>
<td data-clean="$20.76|2.2%" data-sort-value="20.76">$20.76<br><span class="c-green">+2.2%</span></td>
<td data-sort-value="21.8">$21.80</td>
<td data-clean="$19.85|$32.88" data-sort-value="19.85">
<div class="range-meter-wrapper d-block">
<div class="range-meter w-100">$19.85<div class="range"><span class="range-marker" style="left:7%"><span class="range-arrow">▼</span></span></div>$32.88</div>
</div>
</td>
<td data-sort-value="13738.304">$13.74B</td>
<td>0.96</td>
<td data-sort-value="753579">753,579 shs</td>
<td data-sort-value="753579">1.38 million shs</td>
</tr>
</tbody>
</table>
</div>
</div>
<div style="max-width:950px;width:100%;margin-left:auto;margin-right:auto;" class="my-4">
<div class="bg-light-blue rounded">
<div class="row align-content-center justify-content-center ">
<div class="col-12 col-sm-4 col-md-3 position-relative pr-sm-0 pb-1 d-flex justify-content-center align-items-start"><img loading="lazy" decoding="async" height="209" width="170"
src="https://www.marketbeat.com/logos/premium-reports/small_20230630130800_reportpreview2023-06-investment-strategies-retirem.png" class="mt-2 position-relative"
style="max-width:100%;height:auto;z-index:1;margin-top:-0.75em!important;" alt="Investing Strategies To Help Grow Your Retirement Income Cover"></div>
<div class="col-12 col-sm-8 col-md-9 px-0 pr-sm-3 pl-sm-0">
<div class="p-4 p-sm-3 h-100 text-center text-sm-left">
<div class="nounderline mt-2 h4" style="line-height:1.1em;">
<a href="https://marketbeat.com/newsletter/pdfoffer.aspx?offer=retirementincome&RegistrationCode=CompareStocks-FreeReport" class="c-dark-blue">Investing Strategies To Help Grow Your Retirement Income</a></div>
<p class="font-small mb-2" style="line-height:1.3em;">Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.</p>
<a class="upper-link" style="text-decoration:none; color:var(--blue); font-size:1rem;" href="https://marketbeat.com/newsletter/pdfoffer.aspx?offer=retirementincome&RegistrationCode=CompareStocks-FreeReport">Get This Free Report</a>
</div>
</div>
</div>
</div>
</div>
<h2 class="mt-5">Price Performance</h2>
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper" style="padding-top: 33.2812px;">
<table class="scroll-table sort-table price-table fixed-header">
<thead class="hide-scrollbar" style="width: 1448px; position: absolute; top: 0px;">
<tr>
<th data-sort="string" data-clean="Symbol|Company" style="min-width: 430.781px; max-width: 430.781px;">Company</th>
<th data-sort="float" style="min-width: 203.438px; max-width: 203.438px;">1-Day Performance</th>
<th data-sort="float" style="min-width: 203.438px; max-width: 203.438px;">7-Day Performance</th>
<th data-sort="float" style="min-width: 203.438px; max-width: 203.438px;">30-Day Performance</th>
<th data-sort="float" style="min-width: 203.438px; max-width: 203.438px;">90-Day Performance</th>
<th data-sort="float" style="min-width: 203.469px; max-width: 203.469px;">1-Year Performance</th>
</tr>
</thead>
<tbody>
<tr>
<td data-clean="ALNY|Alnylam Pharmaceuticals">
<a class="profile-link" title="Alnylam Pharmaceuticals stock price and analysis" href="/stocks/NASDAQ/ALNY/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="22" width="80" src="https://www.marketbeat.com/logos/thumbnail/alnylam-pharma-logo.png" alt="Alnylam Pharmaceuticals, Inc. stock logo"></div><div class="ticker-area">ALNY</div><div class="title-area">Alnylam Pharmaceuticals</div></a>
</td>
<td class="c-black">0.00%</td>
<td class="c-black">0.00%</td>
<td class="c-green">+0.22%</td>
<td class="c-red">-9.71%</td>
<td class="c-green">+28.49%</td>
</tr>
<tr>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen stock price and analysis" href="/stocks/NASDAQ/AMGN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td class="c-black">0.00%</td>
<td class="c-red">-2.68%</td>
<td class="c-red">-10.58%</td>
<td class="c-red">-21.52%</td>
<td class="c-red">-7.31%</td>
</tr>
<tr>
<td data-clean="ARGX|argenx">
<a class="profile-link" title="argenx stock price and analysis" href="/stocks/NASDAQ/ARGX/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/argenx-se---american-depositary-shares-logo.jpg" alt="argenx SE stock logo"></div><div class="ticker-area">ARGX</div><div class="title-area">argenx</div></a>
</td>
<td class="c-black">0.00%</td>
<td class="c-green">+2.74%</td>
<td class="c-green">+2.95%</td>
<td class="c-green">+18.04%</td>
<td class="c-green">+67.29%</td>
</tr>
<tr>
<td data-clean="AZN|AstraZeneca">
<a class="profile-link" title="AstraZeneca stock price and analysis" href="/stocks/NASDAQ/AZN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/astrazeneca-plc-logo.png?v=20231213131257" alt="AstraZeneca PLC stock logo"></div><div class="ticker-area">AZN</div><div class="title-area">AstraZeneca</div></a>
</td>
<td class="c-black">0.00%</td>
<td class="c-red">-1.85%</td>
<td class="c-red">-0.43%</td>
<td class="c-red">-15.28%</td>
<td class="c-red">-1.42%</td>
</tr>
<tr>
<td data-clean="BGNE|BeiGene">
<a class="profile-link" title="BeiGene stock price and analysis" href="/stocks/NASDAQ/BGNE/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="14" width="80" src="https://www.marketbeat.com/logos/thumbnail/beigene-ltd-logo.png?v=20221103144100" alt="BeiGene, Ltd. stock logo"></div><div class="ticker-area">BGNE</div><div class="title-area">BeiGene</div></a>
</td>
<td class="c-black">0.00%</td>
<td class="c-red">-1.59%</td>
<td class="c-red">-7.35%</td>
<td class="c-red">-12.32%</td>
<td class="c-green">+0.22%</td>
</tr>
<tr>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen stock price and analysis" href="/stocks/NASDAQ/BIIB/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td class="c-black">0.00%</td>
<td class="c-red">-2.37%</td>
<td class="c-red">-7.24%</td>
<td class="c-red">-25.20%</td>
<td class="c-red">-43.22%</td>
</tr>
<tr>
<td data-clean="BMRN|BioMarin Pharmaceutical">
<a class="profile-link" title="BioMarin Pharmaceutical stock price and analysis" href="/stocks/NASDAQ/BMRN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="60" width="80" src="https://www.marketbeat.com/logos/thumbnail/biomarin-pharm-logo.png" alt="BioMarin Pharmaceutical Inc. stock logo"></div><div class="ticker-area">BMRN</div><div class="title-area">BioMarin Pharmaceutical</div></a>
</td>
<td class="c-black">0.00%</td>
<td class="c-red">-0.53%</td>
<td class="c-green">+2.18%</td>
<td class="c-red">-5.02%</td>
<td class="c-red">-31.75%</td>
</tr>
<tr>
<td data-clean="BNTX|BioNTech">
<a class="profile-link" title="BioNTech stock price and analysis" href="/stocks/NASDAQ/BNTX/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/biontech-se-logo.png?v=20231226132334" alt="BioNTech SE stock logo"></div><div class="ticker-area">BNTX</div><div class="title-area">BioNTech</div></a>
</td>
<td class="c-black">0.00%</td>
<td class="c-red">-6.06%</td>
<td class="c-red">-0.04%</td>
<td class="c-green">+0.03%</td>
<td class="c-green">+7.36%</td>
</tr>
<tr>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences stock price and analysis" href="/stocks/NASDAQ/GILD/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td class="c-black">0.00%</td>
<td class="c-green">+0.78%</td>
<td class="c-green">+2.64%</td>
<td class="c-green">+10.22%</td>
<td class="c-green">+16.21%</td>
</tr>
<tr>
<td data-clean="GMAB|Genmab A/S">
<a class="profile-link" title="Genmab A/S stock price and analysis" href="/stocks/NASDAQ/GMAB/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="59" width="80" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div><div class="ticker-area">GMAB</div><div class="title-area">Genmab A/S</div></a>
</td>
<td class="c-black">0.00%</td>
<td class="c-green">+0.69%</td>
<td class="c-red">-1.65%</td>
<td class="c-red">-15.87%</td>
<td class="c-red">-35.40%</td>
</tr>
</tbody>
</table>
</div>
</div>
<div style="max-width:750px;width:100%;margin-left:auto;margin-right:auto;">
<a target="_blank" rel="sponsored noopener" style="font-weight:normal;text-decoration:none;" href="https://www.marketbeat.com/scripts/redirect.aspx?TriggeredCampaignID=10701&UserID=11404962&Placement=NativeDisplay&Source=NativeDisplay&interstitial=1&noskip=1&email=verdacht@safeonweb.be"><div class="border rounded bg-white" style="width:100%;padding:22px 25px;margin-top:20px;margin-bottom:20px;text-align:center;"><div class="h2 m-0 mb-3" style="font-size: 28px;line-height:1.4;text-decoration:none;font-weight:normal;color:#444;">Crypto’s hidden gem + greatest crypto bull run in history = $$$? <span style="font-size:10pt;font-weight:normal;">(Ad)</span></div><p style="text-align:center;color:#444;">You don’t actually want to buy Bitcoin this time around.
That’s because there’s a better way to take advantage of this new bull market…
One market expert calls it Crypto’s Hidden Gem
And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin…
That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky…
This is a much safer and better approach to ride this years’ crypto bull run.
Because believe it or not…
The 2024 crypto bull run is one you DON’T want to miss.<img loading="lazy" src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10701&Placement=NativeDisplay&Source=NativeDisplay" alt="" height="1" width="1"></p><div class="btn btn-tertiary" style="font-weight:600;font-size:larger;text-align:center;">Click Here to get the full details about Crypto’s Hidden Gem</div></div></a>
</div>
<h2 class="mt-5">MarketRank™</h2>
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper" style="padding-top: 50.5625px;">
<table class="scroll-table sort-table marketrank-table fixed-header">
<thead class="hide-scrollbar" style="width: 1448px; position: absolute; top: 0px;">
<tr>
<th data-sort="string" data-clean="Symbol|Company" style="min-width: 303.047px; max-width: 303.047px;">Company</th>
<th data-sort="float" style="min-width: 143.109px; max-width: 143.109px;">Overall Score</th>
<th data-sort="float" style="min-width: 143.109px; max-width: 143.109px;">Analyst's Opinion</th>
<th data-sort="float" style="min-width: 143.109px; max-width: 143.109px;">Short Interest Score</th>
<th data-sort="float" style="min-width: 143.109px; max-width: 143.109px;">Dividend Strength</th>
<th data-sort="float" title="Environmental, Sustainability, and Governance" style="min-width: 143.109px; max-width: 143.109px;">ESG Score</th>
<th data-sort="float" style="min-width: 143.109px; max-width: 143.109px;">News and Social Media Sentiment</th>
<th data-sort="float" style="min-width: 143.109px; max-width: 143.109px;">Company Ownership</th>
<th data-sort="float" style="min-width: 143.188px; max-width: 143.188px;">Earnings & Valuation</th>
</tr>
</thead>
<tbody>
<tr>
<td data-clean="ALNY|Alnylam Pharmaceuticals">
<a class="profile-link" title="Alnylam Pharmaceuticals stock price and analysis" href="/stocks/NASDAQ/ALNY/"><div class="company-thumbnail"><img loading="lazy" height="22" width="80" src="https://www.marketbeat.com/logos/thumbnail/alnylam-pharma-logo.png" alt="Alnylam Pharmaceuticals, Inc. stock logo"></div><div class="ticker-area">ALNY</div><div class="title-area">Alnylam Pharmaceuticals</div></a>
</td>
<td data-clean="87" data-sort-value="4.3477">
<a title="87th percentile - view scoring details" class="nounderline" style="line-height:1em" href="/stocks/NASDAQ/ALNY/#marketrank"><div class="d-inline-block" style="font-size:0.8em;line-height:1em;"><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span style="position:relative;display:inline-block;vertical-align:top;width:1em;"><span style="width:0.35em" class="fa-solid fa-star c-gold first-half-icon" aria-hidden="true"></span><span class="fa-solid fa-star second-half-icon c-gray-3" aria-hidden="true"></span></span></div><span class="sr-only">4.3477 of 5 stars</span></a>
</td>
<td>3.4</td>
<td>4.0</td>
<td>0.0</td>
<td>4.3</td>
<td>2.0</td>
<td>2.5</td>
<td>0.6</td>
</tr>
<tr>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen stock price and analysis" href="/stocks/NASDAQ/AMGN/"><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td data-clean="89" data-sort-value="4.4613">
<a title="89th percentile - view scoring details" class="nounderline" style="line-height:1em" href="/stocks/NASDAQ/AMGN/#marketrank"><div class="d-inline-block" style="font-size:0.8em;line-height:1em;"><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span style="position:relative;display:inline-block;vertical-align:top;width:1em;"><span style="width:0.46em" class="fa-solid fa-star c-gold first-half-icon" aria-hidden="true"></span><span class="fa-solid fa-star second-half-icon c-gray-3" aria-hidden="true"></span></span></div><span class="sr-only">4.4613 of 5 stars</span></a>
</td>
<td>3.2</td>
<td>2.0</td>
<td>1.7</td>
<td>3.9</td>
<td>2.4</td>
<td>1.7</td>
<td>1.9</td>
</tr>
<tr>
<td data-clean="ARGX|argenx">
<a class="profile-link" title="argenx stock price and analysis" href="/stocks/NASDAQ/ARGX/"><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/argenx-se---american-depositary-shares-logo.jpg" alt="argenx SE stock logo"></div><div class="ticker-area">ARGX</div><div class="title-area">argenx</div></a>
</td>
<td data-clean="60" data-sort-value="2.9927">
<a title="60th percentile - view scoring details" class="nounderline" style="line-height:1em" href="/stocks/NASDAQ/ARGX/#marketrank"><div class="d-inline-block" style="font-size:0.8em;line-height:1em;"><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span style="position:relative;display:inline-block;vertical-align:top;width:1em;"><span style="width:0.99em" class="fa-solid fa-star c-gold first-half-icon" aria-hidden="true"></span><span class="fa-solid fa-star second-half-icon c-gray-3" aria-hidden="true"></span></span><span class="fa-solid fa-star align-top c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star align-top c-gray-3" aria-hidden="true"></span></div><span class="sr-only">2.9927 of 5 stars</span></a>
</td>
<td>2.5</td>
<td>4.0</td>
<td>0.0</td>
<td>0.0</td>
<td>3.3</td>
<td>1.7</td>
<td>1.9</td>
</tr>
<tr>
<td data-clean="AZN|AstraZeneca">
<a class="profile-link" title="AstraZeneca stock price and analysis" href="/stocks/NASDAQ/AZN/"><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/astrazeneca-plc-logo.png?v=20231213131257" alt="AstraZeneca PLC stock logo"></div><div class="ticker-area">AZN</div><div class="title-area">AstraZeneca</div></a>
</td>
<td data-clean="81" data-sort-value="4.0482">
<a title="81st percentile - view scoring details" class="nounderline" style="line-height:1em" href="/stocks/NASDAQ/AZN/#marketrank"><div class="d-inline-block" style="font-size:0.8em;line-height:1em;"><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span style="position:relative;display:inline-block;vertical-align:top;width:1em;"><span style="width:0.05em" class="fa-solid fa-star c-gold first-half-icon" aria-hidden="true"></span><span class="fa-solid fa-star second-half-icon c-gray-3" aria-hidden="true"></span></span></div><span class="sr-only">4.0482 of 5 stars</span></a>
</td>
<td>3.5</td>
<td>5.0</td>
<td>2.5</td>
<td>0.0</td>
<td>1.9</td>
<td>0.0</td>
<td>2.5</td>
</tr>
<tr>
<td data-clean="BGNE|BeiGene">
<a class="profile-link" title="BeiGene stock price and analysis" href="/stocks/NASDAQ/BGNE/"><div class="company-thumbnail"><img loading="lazy" height="14" width="80" src="https://www.marketbeat.com/logos/thumbnail/beigene-ltd-logo.png?v=20221103144100" alt="BeiGene, Ltd. stock logo"></div><div class="ticker-area">BGNE</div><div class="title-area">BeiGene</div></a>
</td>
<td data-clean="52" data-sort-value="2.6172">
<a title="52nd percentile - view scoring details" class="nounderline" style="line-height:1em" href="/stocks/NASDAQ/BGNE/#marketrank"><div class="d-inline-block" style="font-size:0.8em;line-height:1em;"><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span style="position:relative;display:inline-block;vertical-align:top;width:1em;"><span style="width:0.62em" class="fa-solid fa-star c-gold first-half-icon" aria-hidden="true"></span><span class="fa-solid fa-star second-half-icon c-gray-3" aria-hidden="true"></span></span><span class="fa-solid fa-star align-top c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star align-top c-gray-3" aria-hidden="true"></span></div><span class="sr-only">2.6172 of 5 stars</span></a>
</td>
<td>3.4</td>
<td>3.0</td>
<td>0.0</td>
<td>0.0</td>
<td>2.8</td>
<td>1.7</td>
<td>0.6</td>
</tr>
<tr>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen stock price and analysis" href="/stocks/NASDAQ/BIIB/"><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td data-clean="93" data-sort-value="4.6305">
<a title="93rd percentile - view scoring details" class="nounderline" style="line-height:1em" href="/stocks/NASDAQ/BIIB/#marketrank"><div class="d-inline-block" style="font-size:0.8em;line-height:1em;"><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span style="position:relative;display:inline-block;vertical-align:top;width:1em;"><span style="width:0.63em" class="fa-solid fa-star c-gold first-half-icon" aria-hidden="true"></span><span class="fa-solid fa-star second-half-icon c-gray-3" aria-hidden="true"></span></span></div><span class="sr-only">4.6305 of 5 stars</span></a>
</td>
<td>4.2</td>
<td>3.0</td>
<td>0.0</td>
<td>3.7</td>
<td>1.7</td>
<td>1.7</td>
<td>1.9</td>
</tr>
<tr>
<td data-clean="BMRN|BioMarin Pharmaceutical">
<a class="profile-link" title="BioMarin Pharmaceutical stock price and analysis" href="/stocks/NASDAQ/BMRN/"><div class="company-thumbnail"><img loading="lazy" height="60" width="80" src="https://www.marketbeat.com/logos/thumbnail/biomarin-pharm-logo.png" alt="BioMarin Pharmaceutical Inc. stock logo"></div><div class="ticker-area">BMRN</div><div class="title-area">BioMarin Pharmaceutical</div></a>
</td>
<td data-clean="100" data-sort-value="4.9837">
<a title="100th percentile - view scoring details" class="nounderline" style="line-height:1em" href="/stocks/NASDAQ/BMRN/#marketrank"><div class="d-inline-block" style="font-size:0.8em;line-height:1em;"><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span style="position:relative;display:inline-block;vertical-align:top;width:1em;"><span style="width:0.98em" class="fa-solid fa-star c-gold first-half-icon" aria-hidden="true"></span><span class="fa-solid fa-star second-half-icon c-gray-3" aria-hidden="true"></span></span></div><span class="sr-only">4.9837 of 5 stars</span></a>
</td>
<td>4.4</td>
<td>3.0</td>
<td>0.0</td>
<td>3.3</td>
<td>2.8</td>
<td>2.5</td>
<td>4.4</td>
</tr>
<tr>
<td data-clean="BNTX|BioNTech">
<a class="profile-link" title="BioNTech stock price and analysis" href="/stocks/NASDAQ/BNTX/"><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/biontech-se-logo.png?v=20231226132334" alt="BioNTech SE stock logo"></div><div class="ticker-area">BNTX</div><div class="title-area">BioNTech</div></a>
</td>
<td data-clean="40" data-sort-value="2.0236">
<a title="40th percentile - view scoring details" class="nounderline" style="line-height:1em" href="/stocks/NASDAQ/BNTX/#marketrank"><div class="d-inline-block" style="font-size:0.8em;line-height:1em;"><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span style="position:relative;display:inline-block;vertical-align:top;width:1em;"><span style="width:0.02em" class="fa-solid fa-star c-gold first-half-icon" aria-hidden="true"></span><span class="fa-solid fa-star second-half-icon c-gray-3" aria-hidden="true"></span></span><span class="fa-solid fa-star align-top c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star align-top c-gray-3" aria-hidden="true"></span></div><span class="sr-only">2.0236 of 5 stars</span></a>
</td>
<td>3.4</td>
<td>4.0</td>
<td>0.0</td>
<td>0.0</td>
<td>1.8</td>
<td>0.8</td>
<td>0.0</td>
</tr>
<tr>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences stock price and analysis" href="/stocks/NASDAQ/GILD/"><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td data-clean="88" data-sort-value="4.4175">
<a title="88th percentile - view scoring details" class="nounderline" style="line-height:1em" href="/stocks/NASDAQ/GILD/#marketrank"><div class="d-inline-block" style="font-size:0.8em;line-height:1em;"><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span style="position:relative;display:inline-block;vertical-align:top;width:1em;"><span style="width:0.42em" class="fa-solid fa-star c-gold first-half-icon" aria-hidden="true"></span><span class="fa-solid fa-star second-half-icon c-gray-3" aria-hidden="true"></span></span></div><span class="sr-only">4.4175 of 5 stars</span></a>
</td>
<td>2.3</td>
<td>3.0</td>
<td>1.7</td>
<td>4.1</td>
<td>2.6</td>
<td>2.5</td>
<td>1.9</td>
</tr>
<tr>
<td data-clean="GMAB|Genmab A/S">
<a class="profile-link" title="Genmab A/S stock price and analysis" href="/stocks/NASDAQ/GMAB/"><div class="company-thumbnail"><img loading="lazy" height="59" width="80" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div><div class="ticker-area">GMAB</div><div class="title-area">Genmab A/S</div></a>
</td>
<td data-clean="85" data-sort-value="4.2425">
<a title="85th percentile - view scoring details" class="nounderline" style="line-height:1em" href="/stocks/NASDAQ/GMAB/#marketrank"><div class="d-inline-block" style="font-size:0.8em;line-height:1em;"><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span class="fa-solid fa-star c-gold align-top" aria-hidden="true"></span><span style="position:relative;display:inline-block;vertical-align:top;width:1em;"><span style="width:0.24em" class="fa-solid fa-star c-gold first-half-icon" aria-hidden="true"></span><span class="fa-solid fa-star second-half-icon c-gray-3" aria-hidden="true"></span></span></div><span class="sr-only">4.2425 of 5 stars</span></a>
</td>
<td>3.3</td>
<td>5.0</td>
<td>0.0</td>
<td>0.0</td>
<td>2.3</td>
<td>0.0</td>
<td>4.4</td>
</tr>
</tbody>
</table>
</div>
</div>
<script>
var comparisonRatingSeries = "Symbol,Sell,Hold,Buy,Strong Buy\nALNY,1,5,18,0\nAMGN,2,12,10,1\nARGX,0,3,18,1\nAZN,0,3,6,2\nBGNE,0,2,6,0\nBIIB,0,16,13,0\nBMRN,0,7,15,1\nBNTX,0,4,12,1\nGILD,0,12,12,3\nGMAB,1,2,6,0";
</script>
<h2 class="mt-5">Analyst Ratings</h2>
<div class="row">
<div class="col-12 col-md-7 mb-3">
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper" style="padding-top: 50.5625px;">
<table class="scroll-table sort-table analystratings-table fixed-header">
<thead class="hide-scrollbar" style="width: 831.328px; position: absolute; top: 0px;">
<tr>
<th data-sort="string" data-clean="Symbol|Company" style="min-width: 251.016px; max-width: 251.016px;">Company</th>
<th data-sort="float" style="min-width: 118.547px; max-width: 118.547px;">Consensus Rating Score</th>
<th data-sort="string" style="min-width: 147.844px; max-width: 147.844px;">Consensus Rating</th>
<th data-sort="float" style="min-width: 118.547px; max-width: 118.547px;">Consensus Price Target</th>
<th data-sort="float" style="min-width: 195.375px; max-width: 195.375px;">% Upside from Current Price</th>
</tr>
</thead>
<tbody>
<tr>
<td data-clean="ALNY|Alnylam Pharmaceuticals">
<a class="profile-link" title="Alnylam Pharmaceuticals stock forecast and price target" href="/stocks/NASDAQ/ALNY/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="22" width="80" src="https://www.marketbeat.com/logos/thumbnail/alnylam-pharma-logo.png" alt="Alnylam Pharmaceuticals, Inc. stock logo"></div><div class="ticker-area">ALNY</div><div class="title-area">Alnylam Pharmaceuticals</div></a>
</td>
<td data-sort-value="2.71" data-clean="2.71">
<div class="text-center" style="max-width:50px;">
<div style="aspect-ratio: 127 / 73; margin:0 auto;">
<svg style="width:100%;height:100%;" width="127" height="73" viewBox="0 0 127 73" fill="none" xmlns="http://www.w3.org/2000/svg">
<path class="speedometer-pointer" fill-rule="evenodd" clip-rule="evenodd"
d="M62.8053 22.5363C63.2746 22.5335 63.66 22.9063 63.6728 23.3755L64.8044 64.9676C65.2233 65.1826 65.6047 65.4872 65.9183 65.8782C67.1107 67.3649 66.8722 69.5366 65.3856 70.729C63.899 71.9214 61.7272 71.6829 60.5348 70.1963C59.3424 68.7097 59.5809 66.5379 61.0676 65.3455C61.1458 65.2828 61.2259 65.224 61.3076 65.1692L61.9479 23.3857C61.9551 22.9165 62.336 22.5391 62.8053 22.5363Z"
fill="#4F545A" style=" transform: rotate(7.50000000000001deg); transform-origin:bottom center;"></path>
<path d="M4 63.6605C4 30.7109 30.7941 4 63.8463 4C84.1833 4 101.779 14.1126 112.594 29.5688C119.356 39.2324 123.321 50.9848 123.321 63.6605" stroke="url(#gradient0_top)" stroke-width="7"></path>
<path d="M112.594 29.5688C119.355 39.2324 123.321 50.9848 123.321 63.6606" stroke="#C3CACD" stroke-width="7"></path>
<path opacity="0.5" d="M11.0186 63.6604C11.0186 34.5872 34.6194 11.0188 63.7326 11.0188C81.6116 11.0188 97.4117 19.9075 106.943 33.5012" stroke="url(#gradient1_top)" stroke-width="7"></path>
<defs>
<linearGradient id="gradient0_top" x1="123.693" y1="63.6605" x2="4" y2="63.6605" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
<linearGradient id="gradient1_top" x1="107.242" y1="63.6604" x2="11.0186" y2="63.6604" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
</defs>
</svg>
</div><strong>2.71</strong>
</div>
</td>
<td><strong><span class="c-green ">Moderate Buy</span></strong></td>
<td data-sort-value="298.090909090909">$298.09</td>
<td class="c-green" data-sort-clean="0.2305"><span class="fa-regular fa-arrow-up mr-2" aria-hidden="true"></span>23.05% Upside</td>
</tr>
<tr>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen stock forecast and price target" href="/stocks/NASDAQ/AMGN/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td data-sort-value="2.40" data-clean="2.40">
<div class="text-center" style="max-width:50px;">
<div style="aspect-ratio: 127 / 73; margin:0 auto;">
<svg style="width:100%;height:100%;" width="127" height="73" viewBox="0 0 127 73" fill="none" xmlns="http://www.w3.org/2000/svg">
<path class="speedometer-pointer" fill-rule="evenodd" clip-rule="evenodd"
d="M62.8053 22.5363C63.2746 22.5335 63.66 22.9063 63.6728 23.3755L64.8044 64.9676C65.2233 65.1826 65.6047 65.4872 65.9183 65.8782C67.1107 67.3649 66.8722 69.5366 65.3856 70.729C63.899 71.9214 61.7272 71.6829 60.5348 70.1963C59.3424 68.7097 59.5809 66.5379 61.0676 65.3455C61.1458 65.2828 61.2259 65.224 61.3076 65.1692L61.9479 23.3857C61.9551 22.9165 62.336 22.5391 62.8053 22.5363Z"
fill="#4F545A" style=" transform: rotate(-3.60000000000001deg); transform-origin:bottom center;"></path>
<path d="M4 63.6605C4 30.7109 30.7941 4 63.8463 4C84.1833 4 101.779 14.1126 112.594 29.5688C119.356 39.2324 123.321 50.9848 123.321 63.6605" stroke="url(#gradient0_top)" stroke-width="7"></path>
<path d="M112.594 29.5688C119.355 39.2324 123.321 50.9848 123.321 63.6606" stroke="#C3CACD" stroke-width="7"></path>
<path opacity="0.5" d="M11.0186 63.6604C11.0186 34.5872 34.6194 11.0188 63.7326 11.0188C81.6116 11.0188 97.4117 19.9075 106.943 33.5012" stroke="url(#gradient1_top)" stroke-width="7"></path>
<defs>
<linearGradient id="gradient0_top" x1="123.693" y1="63.6605" x2="4" y2="63.6605" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
<linearGradient id="gradient1_top" x1="107.242" y1="63.6604" x2="11.0186" y2="63.6604" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
</defs>
</svg>
</div><strong>2.40</strong>
</div>
</td>
<td><strong><span class="c-dark-gray ">Hold</span></strong></td>
<td data-sort-value="319.666666666667">$319.67</td>
<td class="c-green" data-sort-clean="0.2109"><span class="fa-regular fa-arrow-up mr-2" aria-hidden="true"></span>21.09% Upside</td>
</tr>
<tr>
<td data-clean="ARGX|argenx">
<a class="profile-link" title="argenx stock forecast and price target" href="/stocks/NASDAQ/ARGX/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/argenx-se---american-depositary-shares-logo.jpg" alt="argenx SE stock logo"></div><div class="ticker-area">ARGX</div><div class="title-area">argenx</div></a>
</td>
<td data-sort-value="2.91" data-clean="2.91">
<div class="text-center" style="max-width:50px;">
<div style="aspect-ratio: 127 / 73; margin:0 auto;">
<svg style="width:100%;height:100%;" width="127" height="73" viewBox="0 0 127 73" fill="none" xmlns="http://www.w3.org/2000/svg">
<path class="speedometer-pointer" fill-rule="evenodd" clip-rule="evenodd"
d="M62.8053 22.5363C63.2746 22.5335 63.66 22.9063 63.6728 23.3755L64.8044 64.9676C65.2233 65.1826 65.6047 65.4872 65.9183 65.8782C67.1107 67.3649 66.8722 69.5366 65.3856 70.729C63.899 71.9214 61.7272 71.6829 60.5348 70.1963C59.3424 68.7097 59.5809 66.5379 61.0676 65.3455C61.1458 65.2828 61.2259 65.224 61.3076 65.1692L61.9479 23.3857C61.9551 22.9165 62.336 22.5391 62.8053 22.5363Z"
fill="#4F545A" style=" transform: rotate(14.7272727272727deg); transform-origin:bottom center;"></path>
<path d="M4 63.6605C4 30.7109 30.7941 4 63.8463 4C84.1833 4 101.779 14.1126 112.594 29.5688C119.356 39.2324 123.321 50.9848 123.321 63.6605" stroke="url(#gradient0_top)" stroke-width="7"></path>
<path d="M112.594 29.5688C119.355 39.2324 123.321 50.9848 123.321 63.6606" stroke="#C3CACD" stroke-width="7"></path>
<path opacity="0.5" d="M11.0186 63.6604C11.0186 34.5872 34.6194 11.0188 63.7326 11.0188C81.6116 11.0188 97.4117 19.9075 106.943 33.5012" stroke="url(#gradient1_top)" stroke-width="7"></path>
<defs>
<linearGradient id="gradient0_top" x1="123.693" y1="63.6605" x2="4" y2="63.6605" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
<linearGradient id="gradient1_top" x1="107.242" y1="63.6604" x2="11.0186" y2="63.6604" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
</defs>
</svg>
</div><strong>2.91</strong>
</div>
</td>
<td><strong><span class="c-green ">Moderate Buy</span></strong></td>
<td data-sort-value="639.777777777778">$639.78</td>
<td class="c-green" data-sort-clean="0.0182"><span class="fa-regular fa-arrow-up mr-2" aria-hidden="true"></span>1.82% Upside</td>
</tr>
<tr>
<td data-clean="AZN|AstraZeneca">
<a class="profile-link" title="AstraZeneca stock forecast and price target" href="/stocks/NASDAQ/AZN/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/astrazeneca-plc-logo.png?v=20231213131257" alt="AstraZeneca PLC stock logo"></div><div class="ticker-area">AZN</div><div class="title-area">AstraZeneca</div></a>
</td>
<td data-sort-value="2.91" data-clean="2.91">
<div class="text-center" style="max-width:50px;">
<div style="aspect-ratio: 127 / 73; margin:0 auto;">
<svg style="width:100%;height:100%;" width="127" height="73" viewBox="0 0 127 73" fill="none" xmlns="http://www.w3.org/2000/svg">
<path class="speedometer-pointer" fill-rule="evenodd" clip-rule="evenodd"
d="M62.8053 22.5363C63.2746 22.5335 63.66 22.9063 63.6728 23.3755L64.8044 64.9676C65.2233 65.1826 65.6047 65.4872 65.9183 65.8782C67.1107 67.3649 66.8722 69.5366 65.3856 70.729C63.899 71.9214 61.7272 71.6829 60.5348 70.1963C59.3424 68.7097 59.5809 66.5379 61.0676 65.3455C61.1458 65.2828 61.2259 65.224 61.3076 65.1692L61.9479 23.3857C61.9551 22.9165 62.336 22.5391 62.8053 22.5363Z"
fill="#4F545A" style=" transform: rotate(14.7272727272727deg); transform-origin:bottom center;"></path>
<path d="M4 63.6605C4 30.7109 30.7941 4 63.8463 4C84.1833 4 101.779 14.1126 112.594 29.5688C119.356 39.2324 123.321 50.9848 123.321 63.6605" stroke="url(#gradient0_top)" stroke-width="7"></path>
<path d="M112.594 29.5688C119.355 39.2324 123.321 50.9848 123.321 63.6606" stroke="#C3CACD" stroke-width="7"></path>
<path opacity="0.5" d="M11.0186 63.6604C11.0186 34.5872 34.6194 11.0188 63.7326 11.0188C81.6116 11.0188 97.4117 19.9075 106.943 33.5012" stroke="url(#gradient1_top)" stroke-width="7"></path>
<defs>
<linearGradient id="gradient0_top" x1="123.693" y1="63.6605" x2="4" y2="63.6605" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
<linearGradient id="gradient1_top" x1="107.242" y1="63.6604" x2="11.0186" y2="63.6604" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
</defs>
</svg>
</div><strong>2.91</strong>
</div>
</td>
<td><strong><span class="c-green ">Moderate Buy</span></strong></td>
<td data-sort-value="89.75">$89.75</td>
<td class="c-green" data-sort-clean="0.3470"><span class="fa-regular fa-arrow-up mr-2" aria-hidden="true"></span>34.70% Upside</td>
</tr>
<tr>
<td data-clean="BGNE|BeiGene">
<a class="profile-link" title="BeiGene stock forecast and price target" href="/stocks/NASDAQ/BGNE/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="14" width="80" src="https://www.marketbeat.com/logos/thumbnail/beigene-ltd-logo.png?v=20221103144100" alt="BeiGene, Ltd. stock logo"></div><div class="ticker-area">BGNE</div><div class="title-area">BeiGene</div></a>
</td>
<td data-sort-value="2.75" data-clean="2.75">
<div class="text-center" style="max-width:50px;">
<div style="aspect-ratio: 127 / 73; margin:0 auto;">
<svg style="width:100%;height:100%;" width="127" height="73" viewBox="0 0 127 73" fill="none" xmlns="http://www.w3.org/2000/svg">
<path class="speedometer-pointer" fill-rule="evenodd" clip-rule="evenodd"
d="M62.8053 22.5363C63.2746 22.5335 63.66 22.9063 63.6728 23.3755L64.8044 64.9676C65.2233 65.1826 65.6047 65.4872 65.9183 65.8782C67.1107 67.3649 66.8722 69.5366 65.3856 70.729C63.899 71.9214 61.7272 71.6829 60.5348 70.1963C59.3424 68.7097 59.5809 66.5379 61.0676 65.3455C61.1458 65.2828 61.2259 65.224 61.3076 65.1692L61.9479 23.3857C61.9551 22.9165 62.336 22.5391 62.8053 22.5363Z"
fill="#4F545A" style=" transform: rotate(9.00000000000001deg); transform-origin:bottom center;"></path>
<path d="M4 63.6605C4 30.7109 30.7941 4 63.8463 4C84.1833 4 101.779 14.1126 112.594 29.5688C119.356 39.2324 123.321 50.9848 123.321 63.6605" stroke="url(#gradient0_top)" stroke-width="7"></path>
<path d="M112.594 29.5688C119.355 39.2324 123.321 50.9848 123.321 63.6606" stroke="#C3CACD" stroke-width="7"></path>
<path opacity="0.5" d="M11.0186 63.6604C11.0186 34.5872 34.6194 11.0188 63.7326 11.0188C81.6116 11.0188 97.4117 19.9075 106.943 33.5012" stroke="url(#gradient1_top)" stroke-width="7"></path>
<defs>
<linearGradient id="gradient0_top" x1="123.693" y1="63.6605" x2="4" y2="63.6605" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
<linearGradient id="gradient1_top" x1="107.242" y1="63.6604" x2="11.0186" y2="63.6604" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
</defs>
</svg>
</div><strong>2.75</strong>
</div>
</td>
<td><strong><span class="c-green ">Moderate Buy</span></strong></td>
<td data-sort-value="253.6875">$253.69</td>
<td class="c-green" data-sort-clean="0.4276"><span class="fa-regular fa-arrow-up mr-2" aria-hidden="true"></span>42.76% Upside</td>
</tr>
<tr>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen stock forecast and price target" href="/stocks/NASDAQ/BIIB/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td data-sort-value="2.45" data-clean="2.45">
<div class="text-center" style="max-width:50px;">
<div style="aspect-ratio: 127 / 73; margin:0 auto;">
<svg style="width:100%;height:100%;" width="127" height="73" viewBox="0 0 127 73" fill="none" xmlns="http://www.w3.org/2000/svg">
<path class="speedometer-pointer" fill-rule="evenodd" clip-rule="evenodd"
d="M62.8053 22.5363C63.2746 22.5335 63.66 22.9063 63.6728 23.3755L64.8044 64.9676C65.2233 65.1826 65.6047 65.4872 65.9183 65.8782C67.1107 67.3649 66.8722 69.5366 65.3856 70.729C63.899 71.9214 61.7272 71.6829 60.5348 70.1963C59.3424 68.7097 59.5809 66.5379 61.0676 65.3455C61.1458 65.2828 61.2259 65.224 61.3076 65.1692L61.9479 23.3857C61.9551 22.9165 62.336 22.5391 62.8053 22.5363Z"
fill="#4F545A" style=" transform: rotate(-1.86206896551724deg); transform-origin:bottom center;"></path>
<path d="M4 63.6605C4 30.7109 30.7941 4 63.8463 4C84.1833 4 101.779 14.1126 112.594 29.5688C119.356 39.2324 123.321 50.9848 123.321 63.6605" stroke="url(#gradient0_top)" stroke-width="7"></path>
<path d="M112.594 29.5688C119.355 39.2324 123.321 50.9848 123.321 63.6606" stroke="#C3CACD" stroke-width="7"></path>
<path opacity="0.5" d="M11.0186 63.6604C11.0186 34.5872 34.6194 11.0188 63.7326 11.0188C81.6116 11.0188 97.4117 19.9075 106.943 33.5012" stroke="url(#gradient1_top)" stroke-width="7"></path>
<defs>
<linearGradient id="gradient0_top" x1="123.693" y1="63.6605" x2="4" y2="63.6605" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
<linearGradient id="gradient1_top" x1="107.242" y1="63.6604" x2="11.0186" y2="63.6604" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
</defs>
</svg>
</div><strong>2.45</strong>
</div>
</td>
<td><strong><span class="c-dark-gray ">Hold</span></strong></td>
<td data-sort-value="242.68">$242.68</td>
<td class="c-green" data-sort-clean="0.6246"><span class="fa-regular fa-arrow-up mr-2" aria-hidden="true"></span>62.46% Upside</td>
</tr>
<tr>
<td data-clean="BMRN|BioMarin Pharmaceutical">
<a class="profile-link" title="BioMarin Pharmaceutical stock forecast and price target" href="/stocks/NASDAQ/BMRN/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="60" width="80" src="https://www.marketbeat.com/logos/thumbnail/biomarin-pharm-logo.png" alt="BioMarin Pharmaceutical Inc. stock logo"></div><div class="ticker-area">BMRN</div><div class="title-area">BioMarin Pharmaceutical</div></a>
</td>
<td data-sort-value="2.74" data-clean="2.74">
<div class="text-center" style="max-width:50px;">
<div style="aspect-ratio: 127 / 73; margin:0 auto;">
<svg style="width:100%;height:100%;" width="127" height="73" viewBox="0 0 127 73" fill="none" xmlns="http://www.w3.org/2000/svg">
<path class="speedometer-pointer" fill-rule="evenodd" clip-rule="evenodd"
d="M62.8053 22.5363C63.2746 22.5335 63.66 22.9063 63.6728 23.3755L64.8044 64.9676C65.2233 65.1826 65.6047 65.4872 65.9183 65.8782C67.1107 67.3649 66.8722 69.5366 65.3856 70.729C63.899 71.9214 61.7272 71.6829 60.5348 70.1963C59.3424 68.7097 59.5809 66.5379 61.0676 65.3455C61.1458 65.2828 61.2259 65.224 61.3076 65.1692L61.9479 23.3857C61.9551 22.9165 62.336 22.5391 62.8053 22.5363Z"
fill="#4F545A" style=" transform: rotate(8.60869565217392deg); transform-origin:bottom center;"></path>
<path d="M4 63.6605C4 30.7109 30.7941 4 63.8463 4C84.1833 4 101.779 14.1126 112.594 29.5688C119.356 39.2324 123.321 50.9848 123.321 63.6605" stroke="url(#gradient0_top)" stroke-width="7"></path>
<path d="M112.594 29.5688C119.355 39.2324 123.321 50.9848 123.321 63.6606" stroke="#C3CACD" stroke-width="7"></path>
<path opacity="0.5" d="M11.0186 63.6604C11.0186 34.5872 34.6194 11.0188 63.7326 11.0188C81.6116 11.0188 97.4117 19.9075 106.943 33.5012" stroke="url(#gradient1_top)" stroke-width="7"></path>
<defs>
<linearGradient id="gradient0_top" x1="123.693" y1="63.6605" x2="4" y2="63.6605" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
<linearGradient id="gradient1_top" x1="107.242" y1="63.6604" x2="11.0186" y2="63.6604" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
</defs>
</svg>
</div><strong>2.74</strong>
</div>
</td>
<td><strong><span class="c-green ">Moderate Buy</span></strong></td>
<td data-sort-value="94.2">$94.20</td>
<td class="c-green" data-sort-clean="0.4215"><span class="fa-regular fa-arrow-up mr-2" aria-hidden="true"></span>42.15% Upside</td>
</tr>
<tr>
<td data-clean="BNTX|BioNTech">
<a class="profile-link" title="BioNTech stock forecast and price target" href="/stocks/NASDAQ/BNTX/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/biontech-se-logo.png?v=20231226132334" alt="BioNTech SE stock logo"></div><div class="ticker-area">BNTX</div><div class="title-area">BioNTech</div></a>
</td>
<td data-sort-value="2.82" data-clean="2.82">
<div class="text-center" style="max-width:50px;">
<div style="aspect-ratio: 127 / 73; margin:0 auto;">
<svg style="width:100%;height:100%;" width="127" height="73" viewBox="0 0 127 73" fill="none" xmlns="http://www.w3.org/2000/svg">
<path class="speedometer-pointer" fill-rule="evenodd" clip-rule="evenodd"
d="M62.8053 22.5363C63.2746 22.5335 63.66 22.9063 63.6728 23.3755L64.8044 64.9676C65.2233 65.1826 65.6047 65.4872 65.9183 65.8782C67.1107 67.3649 66.8722 69.5366 65.3856 70.729C63.899 71.9214 61.7272 71.6829 60.5348 70.1963C59.3424 68.7097 59.5809 66.5379 61.0676 65.3455C61.1458 65.2828 61.2259 65.224 61.3076 65.1692L61.9479 23.3857C61.9551 22.9165 62.336 22.5391 62.8053 22.5363Z"
fill="#4F545A" style=" transform: rotate(11.6470588235294deg); transform-origin:bottom center;"></path>
<path d="M4 63.6605C4 30.7109 30.7941 4 63.8463 4C84.1833 4 101.779 14.1126 112.594 29.5688C119.356 39.2324 123.321 50.9848 123.321 63.6605" stroke="url(#gradient0_top)" stroke-width="7"></path>
<path d="M112.594 29.5688C119.355 39.2324 123.321 50.9848 123.321 63.6606" stroke="#C3CACD" stroke-width="7"></path>
<path opacity="0.5" d="M11.0186 63.6604C11.0186 34.5872 34.6194 11.0188 63.7326 11.0188C81.6116 11.0188 97.4117 19.9075 106.943 33.5012" stroke="url(#gradient1_top)" stroke-width="7"></path>
<defs>
<linearGradient id="gradient0_top" x1="123.693" y1="63.6605" x2="4" y2="63.6605" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
<linearGradient id="gradient1_top" x1="107.242" y1="63.6604" x2="11.0186" y2="63.6604" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
</defs>
</svg>
</div><strong>2.82</strong>
</div>
</td>
<td><strong><span class="c-green ">Moderate Buy</span></strong></td>
<td data-sort-value="140.762666666667">$140.76</td>
<td class="c-green" data-sort-clean="0.2401"><span class="fa-regular fa-arrow-up mr-2" aria-hidden="true"></span>24.01% Upside</td>
</tr>
<tr>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences stock forecast and price target" href="/stocks/NASDAQ/GILD/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td data-sort-value="2.67" data-clean="2.67">
<div class="text-center" style="max-width:50px;">
<div style="aspect-ratio: 127 / 73; margin:0 auto;">
<svg style="width:100%;height:100%;" width="127" height="73" viewBox="0 0 127 73" fill="none" xmlns="http://www.w3.org/2000/svg">
<path class="speedometer-pointer" fill-rule="evenodd" clip-rule="evenodd"
d="M62.8053 22.5363C63.2746 22.5335 63.66 22.9063 63.6728 23.3755L64.8044 64.9676C65.2233 65.1826 65.6047 65.4872 65.9183 65.8782C67.1107 67.3649 66.8722 69.5366 65.3856 70.729C63.899 71.9214 61.7272 71.6829 60.5348 70.1963C59.3424 68.7097 59.5809 66.5379 61.0676 65.3455C61.1458 65.2828 61.2259 65.224 61.3076 65.1692L61.9479 23.3857C61.9551 22.9165 62.336 22.5391 62.8053 22.5363Z"
fill="#4F545A" style=" transform: rotate(6deg); transform-origin:bottom center;"></path>
<path d="M4 63.6605C4 30.7109 30.7941 4 63.8463 4C84.1833 4 101.779 14.1126 112.594 29.5688C119.356 39.2324 123.321 50.9848 123.321 63.6605" stroke="url(#gradient0_top)" stroke-width="7"></path>
<path d="M112.594 29.5688C119.355 39.2324 123.321 50.9848 123.321 63.6606" stroke="#C3CACD" stroke-width="7"></path>
<path opacity="0.5" d="M11.0186 63.6604C11.0186 34.5872 34.6194 11.0188 63.7326 11.0188C81.6116 11.0188 97.4117 19.9075 106.943 33.5012" stroke="url(#gradient1_top)" stroke-width="7"></path>
<defs>
<linearGradient id="gradient0_top" x1="123.693" y1="63.6605" x2="4" y2="63.6605" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
<linearGradient id="gradient1_top" x1="107.242" y1="63.6604" x2="11.0186" y2="63.6604" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
</defs>
</svg>
</div><strong>2.67</strong>
</div>
</td>
<td><strong><span class="c-green ">Moderate Buy</span></strong></td>
<td data-sort-value="96.4347826086957">$96.43</td>
<td class="c-green" data-sort-clean="0.0325"><span class="fa-regular fa-arrow-up mr-2" aria-hidden="true"></span>3.25% Upside</td>
</tr>
<tr>
<td data-clean="GMAB|Genmab A/S">
<a class="profile-link" title="Genmab A/S stock forecast and price target" href="/stocks/NASDAQ/GMAB/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="59" width="80" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div><div class="ticker-area">GMAB</div><div class="title-area">Genmab A/S</div></a>
</td>
<td data-sort-value="2.56" data-clean="2.56">
<div class="text-center" style="max-width:50px;">
<div style="aspect-ratio: 127 / 73; margin:0 auto;">
<svg style="width:100%;height:100%;" width="127" height="73" viewBox="0 0 127 73" fill="none" xmlns="http://www.w3.org/2000/svg">
<path class="speedometer-pointer" fill-rule="evenodd" clip-rule="evenodd"
d="M62.8053 22.5363C63.2746 22.5335 63.66 22.9063 63.6728 23.3755L64.8044 64.9676C65.2233 65.1826 65.6047 65.4872 65.9183 65.8782C67.1107 67.3649 66.8722 69.5366 65.3856 70.729C63.899 71.9214 61.7272 71.6829 60.5348 70.1963C59.3424 68.7097 59.5809 66.5379 61.0676 65.3455C61.1458 65.2828 61.2259 65.224 61.3076 65.1692L61.9479 23.3857C61.9551 22.9165 62.336 22.5391 62.8053 22.5363Z"
fill="#4F545A" style=" transform: rotate(2deg); transform-origin:bottom center;"></path>
<path d="M4 63.6605C4 30.7109 30.7941 4 63.8463 4C84.1833 4 101.779 14.1126 112.594 29.5688C119.356 39.2324 123.321 50.9848 123.321 63.6605" stroke="url(#gradient0_top)" stroke-width="7"></path>
<path d="M112.594 29.5688C119.355 39.2324 123.321 50.9848 123.321 63.6606" stroke="#C3CACD" stroke-width="7"></path>
<path opacity="0.5" d="M11.0186 63.6604C11.0186 34.5872 34.6194 11.0188 63.7326 11.0188C81.6116 11.0188 97.4117 19.9075 106.943 33.5012" stroke="url(#gradient1_top)" stroke-width="7"></path>
<defs>
<linearGradient id="gradient0_top" x1="123.693" y1="63.6605" x2="4" y2="63.6605" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
<linearGradient id="gradient1_top" x1="107.242" y1="63.6604" x2="11.0186" y2="63.6604" gradientUnits="userSpaceOnUse">
<stop offset="0%" stop-color="#11A65A"></stop>
<stop offset="16.67%" stop-color="#70C599"></stop>
<stop offset="50%" stop-color="#FEE29C"></stop>
<stop offset="83.33%" stop-color="#F1656A"></stop>
<stop offset="100%" stop-color="#D2333D"></stop>
</linearGradient>
</defs>
</svg>
</div><strong>2.56</strong>
</div>
</td>
<td><strong><span class="c-green ">Moderate Buy</span></strong></td>
<td data-sort-value="45.2">$45.20</td>
<td class="c-green" data-sort-clean="1.1773"><span class="fa-regular fa-arrow-up mr-2" aria-hidden="true"></span>117.73% Upside</td>
</tr>
</tbody>
</table>
</div>
</div>
</div>
<div class="col-12 col-md-5 mb-3">
<div class="border rounded p-3 mt-2">
<div class="section-heading">
<h2 class="m-0 h3 d-inline-block">Current Analyst Ratings</h2>
</div>
<div class="dv-chart-wrapper px-3">
<div id="comparisonRatingChart" class="dv-chart" style="height:850px;"><svg id="svgcomparisonRatingChart" width="503" height="850" aria-label="This chart shows a comparison each company's current ratings by analysts."
data-pastpercentage="1" data-margintop="20" data-marginleft="53">
<g class="underGroup">
<g class="y axis" transform="translate(53,5)" fill="none" font-size="10" font-family="sans-serif" text-anchor="middle">
<path class="domain" stroke="#000" d="M0.5,740V0.5H410.5V740"></path>
<g class="tick" opacity="1" transform="translate(0.5,0)">
<line stroke="#000" y2="740"></line><text fill="#000" y="743" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(41.5,0)">
<line stroke="#000" y2="740"></line><text fill="#000" y="743" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(82.5,0)">
<line stroke="#000" y2="740"></line><text fill="#000" y="743" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(123.5,0)">
<line stroke="#000" y2="740"></line><text fill="#000" y="743" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(164.5,0)">
<line stroke="#000" y2="740"></line><text fill="#000" y="743" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(205.5,0)">
<line stroke="#000" y2="740"></line><text fill="#000" y="743" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(246.5,0)">
<line stroke="#000" y2="740"></line><text fill="#000" y="743" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(287.5,0)">
<line stroke="#000" y2="740"></line><text fill="#000" y="743" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(328.5,0)">
<line stroke="#000" y2="740"></line><text fill="#000" y="743" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(369.5,0)">
<line stroke="#000" y2="740"></line><text fill="#000" y="743" dy="0.71em"></text>
</g>
<g class="tick" opacity="1" transform="translate(410.5,0)">
<line stroke="#000" y2="740"></line><text fill="#000" y="743" dy="0.71em"></text>
</g>
</g>
</g>
<g class="shadowGroup" transform="translate(53,20)" width="410" height="760" clip-path="url(#comparisonRatingChartclip)"></g>
<g class="mainGroup" transform="translate(53,20)" width="410" height="0" clip-path="url(#comparisonRatingChartclip)">
<clipPath class="clip" id="comparisonRatingChartclip">
<rect transform="translate(-15,-20)" width="440" height="850"></rect>
</clipPath>
<g class="bars">
<g fill="var(--dv-hc-6)">
<rect x="0" y="2.980392156862752" height="59.607843137254896" width="10.852664576802507"></rect>
<rect x="0" y="77.49019607843137" height="59.607843137254896" width="23.705329153605014"></rect>
<rect x="0" y="152" height="59.607843137254896" width="-2"></rect>
<rect x="0" y="226.50980392156862" height="59.607843137254896" width="-2"></rect>
<rect x="0" y="301.01960784313724" height="59.607843137254896" width="-2"></rect>
<rect x="0" y="375.52941176470586" height="59.607843137254896" width="-2"></rect>
<rect x="0" y="450.0392156862745" height="59.607843137254896" width="-2"></rect>
<rect x="0" y="524.5490196078431" height="59.607843137254896" width="-2"></rect>
<rect x="0" y="599.0588235294117" height="59.607843137254896" width="-2"></rect>
<rect x="0" y="673.5686274509803" height="59.607843137254896" width="10.852664576802507"></rect>
</g>
<g fill="var(--dv-hc-4)">
<rect x="12.852664576802507" y="2.980392156862752" height="59.607843137254896" width="62.263322884012524"></rect>
<rect x="25.705329153605014" y="77.49019607843137" height="59.607843137254896" width="152.23197492163007"></rect>
<rect x="0" y="152" height="59.607843137254896" width="36.55799373040752"></rect>
<rect x="0" y="226.50980392156862" height="59.607843137254896" width="36.55799373040752"></rect>
<rect x="0" y="301.01960784313724" height="59.607843137254896" width="23.705329153605014"></rect>
<rect x="0" y="375.52941176470586" height="59.607843137254896" width="203.6426332288401"></rect>
<rect x="0" y="450.0392156862745" height="59.607843137254896" width="87.96865203761755"></rect>
<rect x="0" y="524.5490196078431" height="59.607843137254896" width="49.41065830721003"></rect>
<rect x="0" y="599.0588235294117" height="59.607843137254896" width="152.23197492163007"></rect>
<rect x="12.852664576802507" y="673.5686274509803" height="59.607843137254896" width="23.70532915360501"></rect>
</g>
<g fill="var(--dv-hc-2)">
<rect x="77.11598746081503" y="2.980392156862752" height="59.607843137254896" width="229.3479623824451"></rect>
<rect x="179.9373040752351" y="77.49019607843137" height="59.607843137254896" width="126.52664576802505"></rect>
<rect x="38.55799373040752" y="152" height="59.607843137254896" width="229.34796238244513"></rect>
<rect x="38.55799373040752" y="226.50980392156862" height="59.607843137254896" width="75.11598746081505"></rect>
<rect x="25.705329153605014" y="301.01960784313724" height="59.607843137254896" width="75.11598746081503"></rect>
<rect x="205.6426332288401" y="375.52941176470586" height="59.607843137254896" width="165.08463949843258"></rect>
<rect x="89.96865203761755" y="450.0392156862745" height="59.607843137254896" width="190.78996865203757"></rect>
<rect x="51.41065830721003" y="524.5490196078431" height="59.607843137254896" width="152.23197492163007"></rect>
<rect x="154.23197492163007" y="599.0588235294117" height="59.607843137254896" width="152.23197492163007"></rect>
<rect x="38.55799373040752" y="673.5686274509803" height="59.607843137254896" width="75.11598746081505"></rect>
</g>
<g fill="var(--dv-hc-1)">
<rect x="308.46394984326014" y="2.980392156862752" height="59.607843137254896" width="-2"></rect>
<rect x="308.46394984326014" y="77.49019607843137" height="59.607843137254896" width="10.852664576802567"></rect>
<rect x="269.90595611285266" y="152" height="59.607843137254896" width="10.852664576802454"></rect>
<rect x="115.67398119122257" y="226.50980392156862" height="59.607843137254896" width="23.705329153604993"></rect>
<rect x="102.82131661442006" y="301.01960784313724" height="59.607843137254896" width="-2"></rect>
<rect x="372.7272727272727" y="375.52941176470586" height="59.607843137254896" width="-2"></rect>
<rect x="282.7586206896551" y="450.0392156862745" height="59.607843137254896" width="10.852664576802567"></rect>
<rect x="205.6426332288401" y="524.5490196078431" height="59.607843137254896" width="10.85266457680251"></rect>
<rect x="308.46394984326014" y="599.0588235294117" height="59.607843137254896" width="36.55799373040759"></rect>
<rect x="115.67398119122257" y="673.5686274509803" height="59.607843137254896" width="-2"></rect>
</g>
</g>
<g transform="translate(0,740)" class="x axis" fill="none" font-size="10" font-family="sans-serif" text-anchor="middle">
<path class="domain" stroke="#000" d="M0.5,6V0.5H410.5V6"></path>
<g class="tick" opacity="1" transform="translate(0.5,0)">
<line stroke="#000" y2="6"></line><text fill="#000" y="9" dy="0.71em">0</text>
</g>
<g class="tick" opacity="1" transform="translate(64.76332288401254,0)">
<line stroke="#000" y2="6"></line><text fill="#000" y="9" dy="0.71em">5</text>
</g>
<g class="tick" opacity="1" transform="translate(129.02664576802508,0)">
<line stroke="#000" y2="6"></line><text fill="#000" y="9" dy="0.71em">10</text>
</g>
<g class="tick" opacity="1" transform="translate(193.2899686520376,0)">
<line stroke="#000" y2="6"></line><text fill="#000" y="9" dy="0.71em">15</text>
</g>
<g class="tick" opacity="1" transform="translate(257.55329153605015,0)">
<line stroke="#000" y2="6"></line><text fill="#000" y="9" dy="0.71em">20</text>
</g>
<g class="tick" opacity="1" transform="translate(321.8166144200627,0)">
<line stroke="#000" y2="6"></line><text fill="#000" y="9" dy="0.71em">25</text>
</g>
<g class="tick" opacity="1" transform="translate(386.0799373040752,0)">
<line stroke="#000" y2="6"></line><text fill="#000" y="9" dy="0.71em">30</text>
</g><text y="2" x="386.0799373040752" dy="0.32em" fill="#A6B1B7" font-weight="600" text-anchor="start"></text>
</g>
</g>
<g class="bottomGroup" transform="translate(53,20)" width="410" height="0" clip-path="url(#comparisonRatingChartclip)"></g>
<g class="yTextGroup">
<g class="y axis top" transform="translate(53,20)" fill="none" font-size="10" font-family="sans-serif" text-anchor="end">
<path class="domain" stroke="#000" d="M-6,0.5H0.5V760.5H-6"></path>
<g class="tick" opacity="1" transform="translate(0,32.7843137254902)">
<line stroke="#000" x2="-6"></line><text fill="#000" x="-9" dy="0.32em">ALNY</text>
</g>
<g class="tick" opacity="1" transform="translate(0,107.29411764705881)">
<line stroke="#000" x2="-6"></line><text fill="#000" x="-9" dy="0.32em">AMGN</text>
</g>
<g class="tick" opacity="1" transform="translate(0,181.80392156862746)">
<line stroke="#000" x2="-6"></line><text fill="#000" x="-9" dy="0.32em">ARGX</text>
</g>
<g class="tick" opacity="1" transform="translate(0,256.3137254901961)">
<line stroke="#000" x2="-6"></line><text fill="#000" x="-9" dy="0.32em">AZN</text>
</g>
<g class="tick" opacity="1" transform="translate(0,330.8235294117647)">
<line stroke="#000" x2="-6"></line><text fill="#000" x="-9" dy="0.32em">BGNE</text>
</g>
<g class="tick" opacity="1" transform="translate(0,405.3333333333333)">
<line stroke="#000" x2="-6"></line><text fill="#000" x="-9" dy="0.32em">BIIB</text>
</g>
<g class="tick" opacity="1" transform="translate(0,479.84313725490193)">
<line stroke="#000" x2="-6"></line><text fill="#000" x="-9" dy="0.32em">BMRN</text>
</g>
<g class="tick" opacity="1" transform="translate(0,554.3529411764705)">
<line stroke="#000" x2="-6"></line><text fill="#000" x="-9" dy="0.32em">BNTX</text>
</g>
<g class="tick" opacity="1" transform="translate(0,628.8627450980391)">
<line stroke="#000" x2="-6"></line><text fill="#000" x="-9" dy="0.32em">GILD</text>
</g>
<g class="tick" opacity="1" transform="translate(0,703.3725490196077)">
<line stroke="#000" x2="-6"></line><text fill="#000" x="-9" dy="0.32em">GMAB</text>
</g>
</g>
<g class="footnote" text-anchor="end" transform="translate(53,0)">
<g transform="translate(20,795)">
<rect x="391" width="19" height="19" fill="var(--dv-hc-6)"></rect><text x="386" y="9.5" dy="0.32em" style="font-size: 15px;">Sell</text>
</g>
<g transform="translate(-40,795)">
<rect x="391" width="19" height="19" fill="var(--dv-hc-4)"></rect><text x="386" y="9.5" dy="0.32em" style="font-size: 15px;">Hold</text>
</g>
<g transform="translate(-100,795)">
<rect x="391" width="19" height="19" fill="var(--dv-hc-2)"></rect><text x="386" y="9.5" dy="0.32em" style="font-size: 15px;">Buy</text>
</g>
<g transform="translate(-160,795)">
<rect x="391" width="19" height="19" fill="var(--dv-hc-1)"></rect><text x="386" y="9.5" dy="0.32em" style="font-size: 15px;">Strong Buy</text>
</g>
</g>
</g>
<g class="overGroup" transform="translate(53,20)" width="410" height="760" clip-path="url(#comparisonRatingChartclip)"></g>
<defs>
<linearGradient id="comparisonRatingChartpastFutureGradient" x1="0%" x2="100%" y1="100%" y2="100%">
<stop class="start" offset="0%" stop-color="var(--blue-8)" stop-opacity="1"></stop>
<stop class="middle" offset="100%" stop-color="var(--blue-8)"></stop>
<stop class="othermiddle" offset="100%" stop-color="#ccc" stop-opacity="0"></stop>
<stop class="end" offset="100%" stop-color="#ccc" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonRatingChartfutureBarGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="#888888" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="#888888" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#888888" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonRatingChartpastBarGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="var(--blue-8)" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="var(--blue-8)" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="var(--blue-8)" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="boughtGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="#0B824D" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="#0B824D" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#0B824D" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonRatingChartsoldGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="#E84B56" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="#E84B56" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#E84B56" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonRatingChartLightBlueGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="var(--blue-2)" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="var(--blue-2)" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="var(--blue-2)" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonRatingChartfadeGradient" x1="0%" x2="100%" y1="100%" y2="100%">
<stop class="start" offset="0%" stop-color="#fff" stop-opacity="1"></stop>
<stop class="middle" offset="3.6585365853658534%" stop-color="#000" stop-opacity="1"></stop>
<stop class="othermiddle" offset="96.34146341463415%" stop-color="#000" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#fff" stop-opacity="1"></stop>
</linearGradient>
<mask id="comparisonRatingChartmask">
<rect x="0" y="0" width="463" height="850" style="fill: url("#comparisonRatingChartfadeGradient"); opacity: 1;"></rect>
</mask>
<filter id="comparisonRatingChartinnerShadow" x0="-50%" y0="-50%" width="200%" height="200%">
<feGaussianBlur in="SourceAlpha" stdDeviation="5" result="blur"></feGaussianBlur>
<feOffset dy="10" dx="3"></feOffset>
<feComposite in2="SourceAlpha" operator="arithmetic" k2="-1" k3="1" result="shadowDiff"></feComposite>
<feFlood flood-color="#75a0bb" flood-opacity="0.3"></feFlood>
<feComposite in2="shadowDiff" operator="in"></feComposite>
<feComposite in2="SourceGraphic" operator="over" result="firstfilter"></feComposite>
<feGaussianBlur in="firstfilter" stdDeviation="3" result="blur2"></feGaussianBlur>
<feOffset dy="-10" dx="-3"></feOffset>
<feComposite in2="firstfilter" operator="arithmetic" k2="-1" k3="1" result="shadowDiff"></feComposite>
<feFlood flood-color="#75a0bb" flood-opacity="0.3"></feFlood>
<feComposite in2="shadowDiff" operator="in"></feComposite>
<feComposite in2="firstfilter" operator="over"></feComposite>
</filter>
</defs>
</svg>
<div class="tooltip" style="opacity: 0; background-color: white; border: 1px solid; border-radius: 0px; padding: 10px;"></div>
</div>
</div>
</div>
</div>
</div>
<h3 class="mt-2">Latest Pharmaceutical Stocks Analyst Ratings</h3>
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper" style="padding-top: 33.2812px;">
<table class="scroll-table sort-table analystratings-table fixed-header">
<thead class="hide-scrollbar" style="width: 1448px; position: absolute; top: 0px;">
<tr>
<th data-sort="int" style="min-width: 130.859px; max-width: 130.859px;">Date</th>
<th data-sort="string" data-clean="Symbol|Company" style="min-width: 254.812px; max-width: 254.812px;">Company</th>
<th data-sort="string" style="min-width: 241.922px; max-width: 241.922px;">Brokerage</th>
<th data-sort="string" style="min-width: 195.938px; max-width: 195.938px;">Action</th>
<th data-sort="int" style="min-width: 335.047px; max-width: 335.047px;">Rating</th>
<th data-sort="float" style="min-width: 200.391px; max-width: 200.391px;">Price Target</th>
<th data-sort="string" style="min-width: 89.0312px; max-width: 89.0312px;">Details</th>
</tr>
</thead>
<tbody>
<tr>
<td data-sort-value="20241220000000">12/20/2024</td>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen stock forecast and price target" href="/stocks/NASDAQ/BIIB/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td>
<a href="/ratings/by-issuer/bmo-capital-markets-stock-recommendations/">BMO Capital Markets</a><br><a class="d-block d-sm-inline-block text-decoration-none" style="font-size:0.6em;" rel="nofollow" href="/subscribe/all-access/?ReferralType=StarRating" title="Upgrade to MarketBeat All Access to see this firm's recommendation accuracy ranking."><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-lock-keyhole c-blue ml-2" aria-hidden="true" style="line-height:0.6em;"></span><span class="sr-only">Subscribe to MarketBeat All Access for the recommendation accuracy rating</span></a>
</td>
<td>Downgrade</td>
<td data-sort-value="2">Outperform ➝ Market Perform</td>
<td data-sort-value="164">$230.00 ➝ $164.00</td>
<td data-clean="https://www.marketbeat.com/all-access/ratings-screener/details/2152533/" style="min-width:75px;text-align:center;">
<a title="View Ratings Details" rel="nofollow" href="/all-access/ratings-screener/details/2152533/" class="btn btn-secondary p-2"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241219000000">12/19/2024</td>
<td data-clean="ARGX|argenx">
<a class="profile-link" title="argenx stock forecast and price target" href="/stocks/NASDAQ/ARGX/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/argenx-se---american-depositary-shares-logo.jpg" alt="argenx SE stock logo"></div><div class="ticker-area">ARGX</div><div class="title-area">argenx</div></a>
</td>
<td>
<a href="/ratings/by-issuer/wells-fargo-co-stock-recommendations/">Wells Fargo & Company</a><br><a class="d-block d-sm-inline-block text-decoration-none" style="font-size:0.6em;" rel="nofollow" href="/subscribe/all-access/?ReferralType=StarRating" title="Upgrade to MarketBeat All Access to see this firm's recommendation accuracy ranking."><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-lock-keyhole c-blue ml-2" aria-hidden="true" style="line-height:0.6em;"></span><span class="sr-only">Subscribe to MarketBeat All Access for the recommendation accuracy rating</span></a>
</td>
<td>Boost Price Target</td>
<td data-sort-value="3">Overweight ➝ Overweight</td>
<td data-sort-value="723">$639.00 ➝ $723.00</td>
<td data-clean="https://www.marketbeat.com/all-access/ratings-screener/details/2151950/" style="min-width:75px;text-align:center;">
<a title="View Ratings Details" rel="nofollow" href="/all-access/ratings-screener/details/2151950/" class="btn btn-secondary p-2"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241216000000">12/16/2024</td>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen stock forecast and price target" href="/stocks/NASDAQ/BIIB/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td>
<a href="/ratings/by-issuer/stifel-nicolaus-stock-recommendations/">Stifel Nicolaus</a><br><a class="d-block d-sm-inline-block text-decoration-none" style="font-size:0.6em;" rel="nofollow" href="/subscribe/all-access/?ReferralType=StarRating" title="Upgrade to MarketBeat All Access to see this firm's recommendation accuracy ranking."><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-lock-keyhole c-blue ml-2" aria-hidden="true" style="line-height:0.6em;"></span><span class="sr-only">Subscribe to MarketBeat All Access for the recommendation accuracy rating</span></a>
</td>
<td>Downgrade</td>
<td data-sort-value="2">Buy ➝ Hold</td>
<td data-sort-value="175">$175.00</td>
<td data-clean="https://www.marketbeat.com/all-access/ratings-screener/details/2150436/" style="min-width:75px;text-align:center;">
<a title="View Ratings Details" rel="nofollow" href="/all-access/ratings-screener/details/2150436/" class="btn btn-secondary p-2"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241212000000">12/12/2024</td>
<td data-clean="BMRN|BioMarin Pharmaceutical">
<a class="profile-link" title="BioMarin Pharmaceutical stock forecast and price target" href="/stocks/NASDAQ/BMRN/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="60" width="80" src="https://www.marketbeat.com/logos/thumbnail/biomarin-pharm-logo.png" alt="BioMarin Pharmaceutical Inc. stock logo"></div><div class="ticker-area">BMRN</div><div class="title-area">BioMarin Pharmaceutical</div></a>
</td>
<td>
<a href="/ratings/by-issuer/cantor-fitzgerald-stock-recommendations/">Cantor Fitzgerald</a><br><a class="d-block d-sm-inline-block text-decoration-none" style="font-size:0.6em;" rel="nofollow" href="/subscribe/all-access/?ReferralType=StarRating" title="Upgrade to MarketBeat All Access to see this firm's recommendation accuracy ranking."><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-lock-keyhole c-blue ml-2" aria-hidden="true" style="line-height:0.6em;"></span><span class="sr-only">Subscribe to MarketBeat All Access for the recommendation accuracy rating</span></a>
</td>
<td>Reiterated Rating</td>
<td data-sort-value="3">Overweight ➝ Overweight</td>
<td data-sort-value="90">$90.00 ➝ $90.00</td>
<td data-clean="https://www.marketbeat.com/all-access/ratings-screener/details/2149549/" style="min-width:75px;text-align:center;">
<a title="View Ratings Details" rel="nofollow" href="/all-access/ratings-screener/details/2149549/" class="btn btn-secondary p-2"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241211000000">12/11/2024</td>
<td data-clean="BNTX|BioNTech">
<a class="profile-link" title="BioNTech stock forecast and price target" href="/stocks/NASDAQ/BNTX/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/biontech-se-logo.png?v=20231226132334" alt="BioNTech SE stock logo"></div><div class="ticker-area">BNTX</div><div class="title-area">BioNTech</div></a>
</td>
<td>
<a href="/ratings/by-issuer/wells-fargo-co-stock-recommendations/">Wells Fargo & Company</a><br><a class="d-block d-sm-inline-block text-decoration-none" style="font-size:0.6em;" rel="nofollow" href="/subscribe/all-access/?ReferralType=StarRating" title="Upgrade to MarketBeat All Access to see this firm's recommendation accuracy ranking."><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-lock-keyhole c-blue ml-2" aria-hidden="true" style="line-height:0.6em;"></span><span class="sr-only">Subscribe to MarketBeat All Access for the recommendation accuracy rating</span></a>
</td>
<td>Initiated Coverage</td>
<td data-sort-value="3">Overweight</td>
<td data-sort-value="170">$170.00</td>
<td data-clean="https://www.marketbeat.com/all-access/ratings-screener/details/2148506/" style="min-width:75px;text-align:center;">
<a title="View Ratings Details" rel="nofollow" href="/all-access/ratings-screener/details/2148506/" class="btn btn-secondary p-2"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241211000000">12/11/2024</td>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences stock forecast and price target" href="/stocks/NASDAQ/GILD/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td>
<a href="/ratings/by-issuer/cantor-fitzgerald-stock-recommendations/">Cantor Fitzgerald</a><br><a class="d-block d-sm-inline-block text-decoration-none" style="font-size:0.6em;" rel="nofollow" href="/subscribe/all-access/?ReferralType=StarRating" title="Upgrade to MarketBeat All Access to see this firm's recommendation accuracy ranking."><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-lock-keyhole c-blue ml-2" aria-hidden="true" style="line-height:0.6em;"></span><span class="sr-only">Subscribe to MarketBeat All Access for the recommendation accuracy rating</span></a>
</td>
<td>Reiterated Rating</td>
<td data-sort-value="2">Neutral ➝ Neutral</td>
<td data-sort-value="80">$80.00 ➝ $80.00</td>
<td data-clean="https://www.marketbeat.com/all-access/ratings-screener/details/2148765/" style="min-width:75px;text-align:center;">
<a title="View Ratings Details" rel="nofollow" href="/all-access/ratings-screener/details/2148765/" class="btn btn-secondary p-2"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241211000000">12/11/2024</td>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences stock forecast and price target" href="/stocks/NASDAQ/GILD/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td>
<a href="/ratings/by-issuer/royal-bank-of-canada-stock-recommendations/">Royal Bank of Canada</a><br><a class="d-block d-sm-inline-block text-decoration-none" style="font-size:0.6em;" rel="nofollow" href="/subscribe/all-access/?ReferralType=StarRating" title="Upgrade to MarketBeat All Access to see this firm's recommendation accuracy ranking."><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-lock-keyhole c-blue ml-2" aria-hidden="true" style="line-height:0.6em;"></span><span class="sr-only">Subscribe to MarketBeat All Access for the recommendation accuracy rating</span></a>
</td>
<td>Reiterated Rating</td>
<td data-sort-value="2">Sector Perform ➝ Sector Perform</td>
<td data-sort-value="84">$84.00 ➝ $84.00</td>
<td data-clean="https://www.marketbeat.com/all-access/ratings-screener/details/2148698/" style="min-width:75px;text-align:center;">
<a title="View Ratings Details" rel="nofollow" href="/all-access/ratings-screener/details/2148698/" class="btn btn-secondary p-2"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241210000000">12/10/2024</td>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen stock forecast and price target" href="/stocks/NASDAQ/AMGN/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td>
<a href="/ratings/by-issuer/bank-of-america-stock-recommendations/">Bank of America</a><br><a class="d-block d-sm-inline-block text-decoration-none" style="font-size:0.6em;" rel="nofollow" href="/subscribe/all-access/?ReferralType=StarRating" title="Upgrade to MarketBeat All Access to see this firm's recommendation accuracy ranking."><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-lock-keyhole c-blue ml-2" aria-hidden="true" style="line-height:0.6em;"></span><span class="sr-only">Subscribe to MarketBeat All Access for the recommendation accuracy rating</span></a>
</td>
<td>Reiterated Rating</td>
<td data-sort-value="1">Underperform</td>
<td data-sort-value="256">$256.00</td>
<td data-clean="https://www.marketbeat.com/all-access/ratings-screener/details/2148038/" style="min-width:75px;text-align:center;">
<a title="View Ratings Details" rel="nofollow" href="/all-access/ratings-screener/details/2148038/" class="btn btn-secondary p-2"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241210000000">12/10/2024</td>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen stock forecast and price target" href="/stocks/NASDAQ/BIIB/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td>
<a href="/ratings/by-issuer/bank-of-america-stock-recommendations/">Bank of America</a><br><a class="d-block d-sm-inline-block text-decoration-none" style="font-size:0.6em;" rel="nofollow" href="/subscribe/all-access/?ReferralType=StarRating" title="Upgrade to MarketBeat All Access to see this firm's recommendation accuracy ranking."><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-lock-keyhole c-blue ml-2" aria-hidden="true" style="line-height:0.6em;"></span><span class="sr-only">Subscribe to MarketBeat All Access for the recommendation accuracy rating</span></a>
</td>
<td>Reiterated Rating</td>
<td data-sort-value="2">Neutral</td>
<td data-sort-value="178">$178.00</td>
<td data-clean="https://www.marketbeat.com/all-access/ratings-screener/details/2148032/" style="min-width:75px;text-align:center;">
<a title="View Ratings Details" rel="nofollow" href="/all-access/ratings-screener/details/2148032/" class="btn btn-secondary p-2"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241210000000">12/10/2024</td>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences stock forecast and price target" href="/stocks/NASDAQ/GILD/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td>
<a href="/ratings/by-issuer/oppenheimer-stock-recommendations/">Oppenheimer</a><br><a class="d-block d-sm-inline-block text-decoration-none" style="font-size:0.6em;" rel="nofollow" href="/subscribe/all-access/?ReferralType=StarRating" title="Upgrade to MarketBeat All Access to see this firm's recommendation accuracy ranking."><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-lock-keyhole c-blue ml-2" aria-hidden="true" style="line-height:0.6em;"></span><span class="sr-only">Subscribe to MarketBeat All Access for the recommendation accuracy rating</span></a>
</td>
<td>Boost Price Target</td>
<td data-sort-value="3">Outperform ➝ Outperform</td>
<td data-sort-value="115">$105.00 ➝ $115.00</td>
<td data-clean="https://www.marketbeat.com/all-access/ratings-screener/details/2148100/" style="min-width:75px;text-align:center;">
<a title="View Ratings Details" rel="nofollow" href="/all-access/ratings-screener/details/2148100/" class="btn btn-secondary p-2"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241210000000">12/10/2024</td>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences stock forecast and price target" href="/stocks/NASDAQ/GILD/forecast/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td>
<a href="/ratings/by-issuer/bank-of-america-stock-recommendations/">Bank of America</a><br><a class="d-block d-sm-inline-block text-decoration-none" style="font-size:0.6em;" rel="nofollow" href="/subscribe/all-access/?ReferralType=StarRating" title="Upgrade to MarketBeat All Access to see this firm's recommendation accuracy ranking."><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-star c-gray-3" aria-hidden="true"></span><span class="fa-solid fa-lock-keyhole c-blue ml-2" aria-hidden="true" style="line-height:0.6em;"></span><span class="sr-only">Subscribe to MarketBeat All Access for the recommendation accuracy rating</span></a>
</td>
<td>Reiterated Rating</td>
<td data-sort-value="3">Buy</td>
<td data-sort-value="109">$109.00</td>
<td data-clean="https://www.marketbeat.com/all-access/ratings-screener/details/2148040/" style="min-width:75px;text-align:center;">
<a title="View Ratings Details" rel="nofollow" href="/all-access/ratings-screener/details/2148040/" class="btn btn-secondary p-2"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
</tbody>
</table>
</div>
</div><em>(Data available from 12/23/2021 forward. View 10+ years of historical ratings with our <a href="https://www.marketbeat.com/all-access/ratings-screener/">analyst ratings screener</a>.)</em><br>
<h2 class="mt-5">Sales & Book Value</h2>
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper" style="padding-top: 33.2812px;">
<table class="scroll-table sort-table sales-table fixed-header">
<thead class="hide-scrollbar" style="width: 1448px; position: absolute; top: 0px;">
<tr>
<th data-sort="string" data-clean="Symbol|Company" style="min-width: 335.188px; max-width: 335.188px;">Company</th>
<th data-sort="int" style="min-width: 158.297px; max-width: 158.297px;">Annual Revenue</th>
<th data-sort="float" style="min-width: 158.297px; max-width: 158.297px;">Price/Sales</th>
<th data-sort="float" data-clean="Cashflow (per share)" style="min-width: 232.438px; max-width: 232.438px;">Cashflow</th>
<th data-sort="float" style="min-width: 158.297px; max-width: 158.297px;">Price/Cash</th>
<th data-sort="float" data-clean="Book Value (per share)" style="min-width: 247.156px; max-width: 247.156px;">Book Value</th>
<th data-sort="float" style="min-width: 158.328px; max-width: 158.328px;">Price/Book</th>
</tr>
</thead>
<tbody>
<tr>
<td data-clean="ALNY|Alnylam Pharmaceuticals">
<a class="profile-link" title="Alnylam Pharmaceuticals stock price and analysis" href="/stocks/NASDAQ/ALNY/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="22" width="80" src="https://www.marketbeat.com/logos/thumbnail/alnylam-pharma-logo.png" alt="Alnylam Pharmaceuticals, Inc. stock logo"></div><div class="ticker-area">ALNY</div><div class="title-area">Alnylam Pharmaceuticals</div></a>
</td>
<td data-clean="$2,094,795,000.00" data-sort-value="2094795000">$2.09B</td>
<td>14.92</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-clean="($1.76)" data-sort-value="-1.76">($1.76) per share</td>
<td>-137.65</td>
</tr>
<tr>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen stock price and analysis" href="/stocks/NASDAQ/AMGN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td data-clean="$32,534,000,000.00" data-sort-value="32534000000">$32.53B</td>
<td>4.36</td>
<td data-clean="$25.46" data-sort-value="25.4580520732883">$25.46 per share</td>
<td>10.37</td>
<td data-clean="$11.65" data-sort-value="11.65">$11.65 per share</td>
<td>22.66</td>
</tr>
<tr>
<td data-clean="ARGX|argenx">
<a class="profile-link" title="argenx stock price and analysis" href="/stocks/NASDAQ/ARGX/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/argenx-se---american-depositary-shares-logo.jpg" alt="argenx SE stock logo"></div><div class="ticker-area">ARGX</div><div class="title-area">argenx</div></a>
</td>
<td data-clean="$1,858,657,000.00" data-sort-value="1858657000">$1.86B</td>
<td>20.41</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-clean="$69.22" data-sort-value="69.22">$69.22 per share</td>
<td>9.08</td>
</tr>
<tr>
<td data-clean="AZN|AstraZeneca">
<a class="profile-link" title="AstraZeneca stock price and analysis" href="/stocks/NASDAQ/AZN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/astrazeneca-plc-logo.png?v=20231213131257" alt="AstraZeneca PLC stock logo"></div><div class="ticker-area">AZN</div><div class="title-area">AstraZeneca</div></a>
</td>
<td data-clean="$51,206,000,000.00" data-sort-value="51206000000">$51.21B</td>
<td>4.03</td>
<td data-clean="$5.40" data-sort-value="5.39951377633711">$5.40 per share</td>
<td>12.34</td>
<td data-clean="$12.63" data-sort-value="12.63">$12.63 per share</td>
<td>5.28</td>
</tr>
<tr>
<td data-clean="BGNE|BeiGene">
<a class="profile-link" title="BeiGene stock price and analysis" href="/stocks/NASDAQ/BGNE/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="14" width="80" src="https://www.marketbeat.com/logos/thumbnail/beigene-ltd-logo.png?v=20221103144100" alt="BeiGene, Ltd. stock logo"></div><div class="ticker-area">BGNE</div><div class="title-area">BeiGene</div></a>
</td>
<td data-clean="$3,316,826,000.00" data-sort-value="3316826000">$3.32B</td>
<td>5.22</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-clean="$37.10" data-sort-value="37.1">$37.10 per share</td>
<td>4.79</td>
</tr>
<tr>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen stock price and analysis" href="/stocks/NASDAQ/BIIB/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td data-clean="$9,607,500,000.00" data-sort-value="9607500000">$9.61B</td>
<td>2.27</td>
<td data-clean="$17.49" data-sort-value="17.4918032786885">$17.49 per share</td>
<td>8.54</td>
<td data-clean="$102.14" data-sort-value="102.14">$102.14 per share</td>
<td>1.46</td>
</tr>
<tr>
<td data-clean="BMRN|BioMarin Pharmaceutical">
<a class="profile-link" title="BioMarin Pharmaceutical stock price and analysis" href="/stocks/NASDAQ/BMRN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="60" width="80" src="https://www.marketbeat.com/logos/thumbnail/biomarin-pharm-logo.png" alt="BioMarin Pharmaceutical Inc. stock logo"></div><div class="ticker-area">BMRN</div><div class="title-area">BioMarin Pharmaceutical</div></a>
</td>
<td data-clean="$2,752,809,000.00" data-sort-value="2752809000">$2.75B</td>
<td>4.59</td>
<td data-clean="$1.80" data-sort-value="1.79690889370933">$1.80 per share</td>
<td>36.88</td>
<td data-clean="$26.29" data-sort-value="26.29">$26.29 per share</td>
<td>2.52</td>
</tr>
<tr>
<td data-clean="BNTX|BioNTech">
<a class="profile-link" title="BioNTech stock price and analysis" href="/stocks/NASDAQ/BNTX/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/biontech-se-logo.png?v=20231226132334" alt="BioNTech SE stock logo"></div><div class="ticker-area">BNTX</div><div class="title-area">BioNTech</div></a>
</td>
<td data-clean="$3,040,100,000.00" data-sort-value="3040100000">$3.04B</td>
<td>8.88</td>
<td data-clean="$4.82" data-sort-value="4.82200509770603">$4.82 per share</td>
<td>23.54</td>
<td data-clean="$92.17" data-sort-value="92.17">$92.17 per share</td>
<td>1.23</td>
</tr>
<tr>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences stock price and analysis" href="/stocks/NASDAQ/GILD/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td data-clean="$28,299,000,000.00" data-sort-value="28299000000">$28.30B</td>
<td>4.11</td>
<td data-clean="$9.04" data-sort-value="9.04162633107454">$9.04 per share</td>
<td>10.33</td>
<td data-clean="$18.26" data-sort-value="18.26">$18.26 per share</td>
<td>5.12</td>
</tr>
<tr>
<td data-clean="GMAB|Genmab A/S">
<a class="profile-link" title="Genmab A/S stock price and analysis" href="/stocks/NASDAQ/GMAB/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="59" width="80" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div><div class="ticker-area">GMAB</div><div class="title-area">Genmab A/S</div></a>
</td>
<td data-clean="$19,844,000,000.00" data-sort-value="19844000000">$19.84B</td>
<td>0.69</td>
<td data-clean="$1.19" data-sort-value="1.19447640966628">$1.19 per share</td>
<td>17.38</td>
<td data-clean="$6.95" data-sort-value="6.95">$6.95 per share</td>
<td>2.99</td>
</tr>
</tbody>
</table>
</div>
</div>
<h2 class="mt-5">Profitability & Earnings</h2>
<div class="row">
<div class="col-12">
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper" style="padding-top: 50.5625px;">
<table class="scroll-table sort-table profitability-table fixed-header">
<thead class="hide-scrollbar" style="width: 1448px; position: absolute; top: 0px;">
<tr>
<th data-sort="string" data-clean="Symbol|Company" style="min-width: 275.672px; max-width: 275.672px;">Company</th>
<th data-sort="int" style="min-width: 130.781px; max-width: 130.781px;">Net Income</th>
<th data-sort="float" style="min-width: 130.188px; max-width: 130.188px;">EPS</th>
<th data-sort="float" style="min-width: 130.188px; max-width: 130.188px;">Trailing P/E Ratio</th>
<th data-sort="float" style="min-width: 130.188px; max-width: 130.188px;">Forward P/E Ratio</th>
<th data-sort="float" style="min-width: 130.188px; max-width: 130.188px;">P/E Growth</th>
<th data-sort="float" style="min-width: 130.188px; max-width: 130.188px;">Net Margins</th>
<th data-sort="float" style="min-width: 130.188px; max-width: 130.188px;">Return on Equity (ROE)</th>
<th data-sort="float" style="min-width: 130.188px; max-width: 130.188px;">Return on Assets (ROA)</th>
<th data-sort="int" style="min-width: 130.234px; max-width: 130.234px;">Next Earnings Date</th>
</tr>
</thead>
<tbody>
<tr>
<td data-clean="ALNY|Alnylam Pharmaceuticals">
<a class="profile-link" title="Alnylam Pharmaceuticals earnings report, date, and call information" href="/stocks/NASDAQ/ALNY/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="22" width="80" src="https://www.marketbeat.com/logos/thumbnail/alnylam-pharma-logo.png" alt="Alnylam Pharmaceuticals, Inc. stock logo"></div><div class="ticker-area">ALNY</div><div class="title-area">Alnylam Pharmaceuticals</div></a>
</td>
<td data-sort-value="-440240000" data-clean="($440,240,000.00)">-$440.24M</td>
<td data-clean="($2.62)" data-sort-value="-2.62">-$2.62</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="-15.86">-15.86%</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="-8.38">-8.38%</td>
<td data-sort-value="0" data-clean="0">N/A</td>
</tr>
<tr>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen earnings report, date, and call information" href="/stocks/NASDAQ/AMGN/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td data-sort-value="6717000000" data-clean="$6,717,000,000.00">$6.72B</td>
<td data-clean="$7.81" data-sort-value="7.81">$7.81</td>
<td>33.80</td>
<td>12.97</td>
<td>2.91</td>
<td data-sort-value="13">13.00%</td>
<td data-sort-value="168.35">168.35%</td>
<td data-sort-value="11.18">11.18%</td>
<td data-sort-value="0" data-clean="0">N/A</td>
</tr>
<tr>
<td data-clean="ARGX|argenx">
<a class="profile-link" title="argenx earnings report, date, and call information" href="/stocks/NASDAQ/ARGX/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/argenx-se---american-depositary-shares-logo.jpg" alt="argenx SE stock logo"></div><div class="ticker-area">ARGX</div><div class="title-area">argenx</div></a>
</td>
<td data-sort-value="-295050000" data-clean="($295,050,000.00)">-$295.05M</td>
<td data-clean="($0.88)" data-sort-value="-0.88">-$0.88</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td>72.47</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="-2.11">-2.11%</td>
<td data-sort-value="-1.45">-1.45%</td>
<td data-sort-value="-1.29">-1.29%</td>
<td data-sort-value="0" data-clean="0">N/A</td>
</tr>
<tr>
<td data-clean="AZN|AstraZeneca">
<a class="profile-link" title="AstraZeneca earnings report, date, and call information" href="/stocks/NASDAQ/AZN/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/astrazeneca-plc-logo.png?v=20231213131257" alt="AstraZeneca PLC stock logo"></div><div class="ticker-area">AZN</div><div class="title-area">AstraZeneca</div></a>
</td>
<td data-sort-value="5955000000" data-clean="$5,955,000,000.00">$5.96B</td>
<td data-clean="$2.09" data-sort-value="2.09">$2.09</td>
<td>31.88</td>
<td>14.12</td>
<td>1.19</td>
<td data-sort-value="12.68">12.68%</td>
<td data-sort-value="30.01">30.01%</td>
<td data-sort-value="11.42">11.42%</td>
<td data-sort-value="0" data-clean="0">N/A</td>
</tr>
<tr>
<td data-clean="BGNE|BeiGene">
<a class="profile-link" title="BeiGene earnings report, date, and call information" href="/stocks/NASDAQ/BGNE/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="14" width="80" src="https://www.marketbeat.com/logos/thumbnail/beigene-ltd-logo.png?v=20221103144100" alt="BeiGene, Ltd. stock logo"></div><div class="ticker-area">BGNE</div><div class="title-area">BeiGene</div></a>
</td>
<td data-sort-value="-881710000" data-clean="($881,710,000.00)">-$881.71M</td>
<td data-clean="($8.24)" data-sort-value="-8.24">-$8.24</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="-25.94">-25.94%</td>
<td data-sort-value="-25.12">-25.12%</td>
<td data-sort-value="-14.95">-14.95%</td>
<td data-sort-value="0" data-clean="0">N/A</td>
</tr>
<tr>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen earnings report, date, and call information" href="/stocks/NASDAQ/BIIB/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td data-sort-value="1161100000" data-clean="$1,161,100,000.00">$1.16B</td>
<td data-clean="$11.07" data-sort-value="11.07">$11.07</td>
<td>13.49</td>
<td>8.87</td>
<td>1.83</td>
<td data-sort-value="16.81">16.81%</td>
<td data-sort-value="14.98">14.98%</td>
<td data-sort-value="8.59">8.59%</td>
<td data-sort-value="0" data-clean="0">N/A</td>
</tr>
<tr>
<td data-clean="BMRN|BioMarin Pharmaceutical">
<a class="profile-link" title="BioMarin Pharmaceutical earnings report, date, and call information" href="/stocks/NASDAQ/BMRN/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="60" width="80" src="https://www.marketbeat.com/logos/thumbnail/biomarin-pharm-logo.png" alt="BioMarin Pharmaceutical Inc. stock logo"></div><div class="ticker-area">BMRN</div><div class="title-area">BioMarin Pharmaceutical</div></a>
</td>
<td data-sort-value="167650000" data-clean="$167,650,000.00">$167.65M</td>
<td data-clean="$1.67" data-sort-value="1.67">$1.67</td>
<td>39.68</td>
<td>21.94</td>
<td>0.65</td>
<td data-sort-value="11.71">11.71%</td>
<td data-sort-value="8.53">8.53%</td>
<td data-sort-value="6.4">6.40%</td>
<td data-sort-value="0" data-clean="0">N/A</td>
</tr>
<tr>
<td data-clean="BNTX|BioNTech">
<a class="profile-link" title="BioNTech earnings report, date, and call information" href="/stocks/NASDAQ/BNTX/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/biontech-se-logo.png?v=20231226132334" alt="BioNTech SE stock logo"></div><div class="ticker-area">BNTX</div><div class="title-area">BioNTech</div></a>
</td>
<td data-sort-value="1006860000" data-clean="$1,006,860,000.00">$1.01B</td>
<td data-clean="($2.10)" data-sort-value="-2.1">-$2.10</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="0" data-clean="0">N/A</td>
<td data-sort-value="-15.16">-15.16%</td>
<td data-sort-value="-2.35">-2.35%</td>
<td data-sort-value="-2.05">-2.05%</td>
<td data-sort-value="0" data-clean="0">N/A</td>
</tr>
<tr>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences earnings report, date, and call information" href="/stocks/NASDAQ/GILD/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td data-sort-value="5665000000" data-clean="$5,665,000,000.00">$5.67B</td>
<td data-clean="$0.09" data-sort-value="0.09">$0.09</td>
<td>1,037.78</td>
<td>12.50</td>
<td>2.38</td>
<td data-sort-value="0.45">0.45%</td>
<td data-sort-value="29">29.00%</td>
<td data-sort-value="9.83">9.83%</td>
<td data-sort-value="0" data-clean="0">N/A</td>
</tr>
<tr>
<td data-clean="GMAB|Genmab A/S">
<a class="profile-link" title="Genmab A/S earnings report, date, and call information" href="/stocks/NASDAQ/GMAB/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="59" width="80" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div><div class="ticker-area">GMAB</div><div class="title-area">Genmab A/S</div></a>
</td>
<td data-sort-value="631910000" data-clean="$631,910,000.00">$631.91M</td>
<td data-clean="$1.03" data-sort-value="1.03">$1.03</td>
<td>20.16</td>
<td>14.03</td>
<td>0.67</td>
<td data-sort-value="23.49">23.49%</td>
<td data-sort-value="14.64">14.64%</td>
<td data-sort-value="12.37">12.37%</td>
<td data-sort-value="0" data-clean="0">N/A</td>
</tr>
</tbody>
</table>
</div>
</div>
</div>
</div>
<h3 class="mt-2">Latest Pharmaceutical Stocks Earnings</h3>
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper" style="padding-top: 50.5625px;">
<table class="scroll-table sort-table profitability-table fixed-header">
<thead class="hide-scrollbar" style="width: 1448px; position: absolute; top: 0px;">
<tr>
<th data-sort="int" style="min-width: 131.531px; max-width: 131.531px;">Date</th>
<th style="min-width: 121.625px; max-width: 121.625px;">Quarter</th>
<th data-sort="string" data-clean="Symbol|Company" style="min-width: 257.562px; max-width: 257.562px;">Company</th>
<th data-sort="float" style="min-width: 121.625px; max-width: 121.625px;">Consensus Estimate</th>
<th data-sort="float" style="min-width: 121.625px; max-width: 121.625px;">Reported EPS</th>
<th data-sort="float" style="min-width: 121.625px; max-width: 121.625px;">Beat/Miss</th>
<th data-sort="float" style="min-width: 121.625px; max-width: 121.625px;">Gap EPS</th>
<th data-sort="float" style="min-width: 164.531px; max-width: 164.531px;">Revenue Estimate</th>
<th data-sort="float" style="min-width: 164.531px; max-width: 164.531px;">Actual Revenue</th>
<th data-sort="float" style="min-width: 121.719px; max-width: 121.719px;">Details</th>
</tr>
</thead>
<tbody>
<tr>
<td data-sort-value="20241112000000">11/12/2024</td>
<td>Q3 2024</td>
<td data-clean="AZN|AstraZeneca">
<a class="profile-link" title="AstraZeneca earnings report, date, and call information" href="/stocks/NASDAQ/AZN/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/astrazeneca-plc-logo.png?v=20231213131257" alt="AstraZeneca PLC stock logo"></div><div class="ticker-area">AZN</div><div class="title-area">AstraZeneca</div></a>
</td>
<td data-clean="$1.01" data-sort-value="1.01">$1.01</td>
<td data-clean="$1.04" data-sort-value="1.04">$1.04</td>
<td class="c-green" data-clean="$0.03" data-sort-value="0.03">+$0.03</td>
<td data-clean="$1.62" data-sort-value="1.62">$1.62</td>
<td data-clean="$13,075.90" data-sort-value="13075.9">$13.08 billion</td>
<td data-clean="$13,565.00" data-sort-value="13565">$13.57 billion</td>
<td data-clean="https://www.marketbeat.com/earnings/reports/2024-11-12-astrazeneca-plc-stock/">
<a href="/earnings/reports/2024-11-12-astrazeneca-plc-stock/" class="btn btn-secondary p-2" title="View AstraZeneca Earnings Report for 11/12/2024"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241112000000">11/12/2024</td>
<td>Q3 2024</td>
<td data-clean="BGNE|BeiGene">
<a class="profile-link" title="BeiGene earnings report, date, and call information" href="/stocks/NASDAQ/BGNE/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="14" width="80" src="https://www.marketbeat.com/logos/thumbnail/beigene-ltd-logo.png?v=20221103144100" alt="BeiGene, Ltd. stock logo"></div><div class="ticker-area">BGNE</div><div class="title-area">BeiGene</div></a>
</td>
<td data-clean="($1.11)" data-sort-value="-1.11">-$1.11</td>
<td data-clean="($1.15)" data-sort-value="-1.15">-$1.15</td>
<td class="c-red" data-clean="($0.04)" data-sort-value="-0.0399999999999998">-$0.04</td>
<td data-clean="($1.15)" data-sort-value="-1.15">-$1.15</td>
<td data-clean="$983.26" data-sort-value="983.26">$983.26 million</td>
<td data-clean="$1,001.60" data-sort-value="1001.6">$1.00 billion</td>
<td data-clean="https://www.marketbeat.com/earnings/reports/2024-11-12-beigene-ltd-stock/">
<a href="/earnings/reports/2024-11-12-beigene-ltd-stock/" class="btn btn-secondary p-2" title="View BeiGene Earnings Report for 11/12/2024"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241106000000">11/6/2024</td>
<td>Q3 2024</td>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences earnings report, date, and call information" href="/stocks/NASDAQ/GILD/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td data-clean="$1.58" data-sort-value="1.58">$1.58</td>
<td data-clean="$2.02" data-sort-value="2.02">$2.02</td>
<td class="c-green" data-clean="$0.44" data-sort-value="0.44">+$0.44</td>
<td data-clean="$3.04" data-sort-value="3.04">$3.04</td>
<td data-clean="$7,009.17" data-sort-value="7009.17">$7.01 billion</td>
<td data-clean="$7,545.00" data-sort-value="7545">$7.55 billion</td>
<td data-clean="https://www.marketbeat.com/earnings/reports/2024-11-6-gilead-sciences-inc-stock/">
<a href="/earnings/reports/2024-11-6-gilead-sciences-inc-stock/" class="btn btn-secondary p-2" title="View Gilead Sciences Earnings Report for 11/6/2024"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241106000000">11/6/2024</td>
<td>Q3 2024</td>
<td data-clean="GMAB|Genmab A/S">
<a class="profile-link" title="Genmab A/S earnings report, date, and call information" href="/stocks/NASDAQ/GMAB/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="59" width="80" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div><div class="ticker-area">GMAB</div><div class="title-area">Genmab A/S</div></a>
</td>
<td data-clean="$0.32" data-sort-value="0.32">$0.32</td>
<td data-clean="$0.29" data-sort-value="0.29">$0.29</td>
<td class="c-red" data-clean="($0.03)" data-sort-value="-0.03">-$0.03</td>
<td data-clean="$0.29" data-sort-value="0.29">$0.29</td>
<td data-clean="$838.20" data-sort-value="838.2">$838.20 million</td>
<td data-clean="$816.10" data-sort-value="816.1">$816.10 million</td>
<td data-clean="https://www.marketbeat.com/earnings/reports/2024-11-6-genmab-as-stock/">
<a href="/earnings/reports/2024-11-6-genmab-as-stock/" class="btn btn-secondary p-2" title="View Genmab A/S Earnings Report for 11/6/2024"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241104000000">11/4/2024</td>
<td>Q3 2024</td>
<td data-clean="BNTX|BioNTech">
<a class="profile-link" title="BioNTech earnings report, date, and call information" href="/stocks/NASDAQ/BNTX/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/biontech-se-logo.png?v=20231226132334" alt="BioNTech SE stock logo"></div><div class="ticker-area">BNTX</div><div class="title-area">BioNTech</div></a>
</td>
<td data-clean="($1.26)" data-sort-value="-1.26">-$1.26</td>
<td data-clean="$0.81" data-sort-value="0.81">$0.81</td>
<td class="c-green" data-clean="$2.07" data-sort-value="2.07">+$2.07</td>
<td data-clean="$0.89" data-sort-value="0.89">$0.89</td>
<td data-clean="$514.08" data-sort-value="514.08">$514.08 million</td>
<td data-clean="$1,244.00" data-sort-value="1244">$1.24 billion</td>
<td data-clean="https://www.marketbeat.com/earnings/reports/2024-11-4-biontech-se-stock/">
<a href="/earnings/reports/2024-11-4-biontech-se-stock/" class="btn btn-secondary p-2" title="View BioNTech Earnings Report for 11/4/2024"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241031000000">10/31/2024</td>
<td>Q3 2024</td>
<td data-clean="ALNY|Alnylam Pharmaceuticals">
<a class="profile-link" title="Alnylam Pharmaceuticals earnings report, date, and call information" href="/stocks/NASDAQ/ALNY/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="22" width="80" src="https://www.marketbeat.com/logos/thumbnail/alnylam-pharma-logo.png" alt="Alnylam Pharmaceuticals, Inc. stock logo"></div><div class="ticker-area">ALNY</div><div class="title-area">Alnylam Pharmaceuticals</div></a>
</td>
<td data-clean="($0.51)" data-sort-value="-0.51">-$0.51</td>
<td data-clean="($0.87)" data-sort-value="-0.87">-$0.87</td>
<td class="c-red" data-clean="($0.36)" data-sort-value="-0.36">-$0.36</td>
<td data-clean="($0.87)" data-sort-value="-0.87">-$0.87</td>
<td data-clean="$532.91" data-sort-value="532.91">$532.91 million</td>
<td data-clean="$500.90" data-sort-value="500.9">$500.90 million</td>
<td data-clean="https://www.marketbeat.com/earnings/reports/2024-10-31-alnylam-pharmaceuticals-inc-stock/">
<a href="/earnings/reports/2024-10-31-alnylam-pharmaceuticals-inc-stock/" class="btn btn-secondary p-2" title="View Alnylam Pharmaceuticals Earnings Report for 10/31/2024"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241031000000">10/31/2024</td>
<td>Q3 2024</td>
<td data-clean="ARGX|argenx">
<a class="profile-link" title="argenx earnings report, date, and call information" href="/stocks/NASDAQ/ARGX/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/argenx-se---american-depositary-shares-logo.jpg" alt="argenx SE stock logo"></div><div class="ticker-area">ARGX</div><div class="title-area">argenx</div></a>
</td>
<td data-clean="$0.10" data-sort-value="0.1">$0.10</td>
<td data-clean="$1.39" data-sort-value="1.39">$1.39</td>
<td class="c-green" data-clean="$1.29" data-sort-value="1.29">+$1.29</td>
<td data-clean="$1.39" data-sort-value="1.39">$1.39</td>
<td data-clean="$543.29" data-sort-value="543.29">$543.29 million</td>
<td data-clean="$588.88" data-sort-value="588.88">$588.88 million</td>
<td data-clean="https://www.marketbeat.com/earnings/reports/2024-10-31-argenx-se-stock/">
<a href="/earnings/reports/2024-10-31-argenx-se-stock/" class="btn btn-secondary p-2" title="View argenx Earnings Report for 10/31/2024"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241030000000">10/30/2024</td>
<td>Q3 2024</td>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen earnings report, date, and call information" href="/stocks/NASDAQ/AMGN/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td data-clean="$5.11" data-sort-value="5.11">$5.11</td>
<td data-clean="$5.58" data-sort-value="5.58">$5.58</td>
<td class="c-green" data-clean="$0.47" data-sort-value="0.47">+$0.47</td>
<td data-clean="$5.94" data-sort-value="5.94">$5.94</td>
<td data-clean="$8,502.67" data-sort-value="8502.67">$8.50 billion</td>
<td data-clean="$8,503.00" data-sort-value="8503">$8.50 billion</td>
<td data-clean="https://www.marketbeat.com/earnings/reports/2024-10-30-amgen-inc-stock/">
<a href="/earnings/reports/2024-10-30-amgen-inc-stock/" class="btn btn-secondary p-2" title="View Amgen Earnings Report for 10/30/2024"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241030000000">10/30/2024</td>
<td>Q3 2024</td>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen earnings report, date, and call information" href="/stocks/NASDAQ/BIIB/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td data-clean="$3.77" data-sort-value="3.77">$3.77</td>
<td data-clean="$4.08" data-sort-value="4.08">$4.08</td>
<td class="c-green" data-clean="$0.31" data-sort-value="0.31">+$0.31</td>
<td data-clean="$5.50" data-sort-value="5.5">$5.50</td>
<td data-clean="$2,434.52" data-sort-value="2434.52">$2.43 billion</td>
<td data-clean="$2,466.00" data-sort-value="2466">$2.47 billion</td>
<td data-clean="https://www.marketbeat.com/earnings/reports/2024-10-30-biogen-inc-stock/">
<a href="/earnings/reports/2024-10-30-biogen-inc-stock/" class="btn btn-secondary p-2" title="View Biogen Earnings Report for 10/30/2024"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
<tr>
<td data-sort-value="20241029000000">10/29/2024</td>
<td>Q3 2024</td>
<td data-clean="BMRN|BioMarin Pharmaceutical">
<a class="profile-link" title="BioMarin Pharmaceutical earnings report, date, and call information" href="/stocks/NASDAQ/BMRN/earnings/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="60" width="80" src="https://www.marketbeat.com/logos/thumbnail/biomarin-pharm-logo.png" alt="BioMarin Pharmaceutical Inc. stock logo"></div><div class="ticker-area">BMRN</div><div class="title-area">BioMarin Pharmaceutical</div></a>
</td>
<td data-clean="$0.78" data-sort-value="0.78">$0.78</td>
<td data-clean="$0.55" data-sort-value="0.55">$0.55</td>
<td class="c-red" data-clean="($0.23)" data-sort-value="-0.23">-$0.23</td>
<td data-clean="$0.93" data-sort-value="0.93">$0.93</td>
<td data-clean="$703.37" data-sort-value="703.37">$703.37 million</td>
<td data-clean="$746.00" data-sort-value="746">$746.00 million</td>
<td data-clean="https://www.marketbeat.com/earnings/reports/2024-10-29-biomarin-pharmaceutical-inc-stock/">
<a href="/earnings/reports/2024-10-29-biomarin-pharmaceutical-inc-stock/" class="btn btn-secondary p-2" title="View BioMarin Pharmaceutical Earnings Report for 10/29/2024"><span class="fa-regular fa-square-list"></span></a></td>
</tr>
</tbody>
</table>
</div>
</div>
<h2 class="mt-5">Dividends</h2>
<div class="row">
<div class="col-12">
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper" style="padding-top: 50.5625px;">
<table class="scroll-table sort-table dividend-table fixed-header">
<thead class="hide-scrollbar" style="width: 1448px; position: absolute; top: 0px;">
<tr>
<th data-sort="string" data-clean="Symbol|Company" style="min-width: 430.781px; max-width: 430.781px;">Company</th>
<th data-sort="float" style="min-width: 203.438px; max-width: 203.438px;">Annual Payout</th>
<th data-sort="float" style="min-width: 203.438px; max-width: 203.438px;">Dividend Yield</th>
<th data-sort="float" style="min-width: 203.438px; max-width: 203.438px;">3-Year Dividend Growth</th>
<th data-sort="float" style="min-width: 203.438px; max-width: 203.438px;">Payout Ratio</th>
<th data-sort="int" style="min-width: 203.469px; max-width: 203.469px;">Years of Consecutive Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td data-clean="ALNY|Alnylam Pharmaceuticals">
<a class="profile-link" title="Alnylam Pharmaceuticals dividend" href="/stocks/NASDAQ/ALNY/dividend/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="22" width="80" src="https://www.marketbeat.com/logos/thumbnail/alnylam-pharma-logo.png" alt="Alnylam Pharmaceuticals, Inc. stock logo"></div><div class="ticker-area">ALNY</div><div class="title-area">Alnylam Pharmaceuticals</div></a>
</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
</tr>
<tr>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen dividend" href="/stocks/NASDAQ/AMGN/dividend/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td data-clean="$9.52" data-sort-value="9.52000046">$9.52</td>
<td data-sort-value="0.04">3.61%</td>
<td class="c-green" data-sort-value="10.01">+10.01%</td>
<td data-sort-value="1.22">121.90%</td>
<td data-clean="0" data-sort-value="0">N/A</td>
</tr>
<tr>
<td data-clean="ARGX|argenx">
<a class="profile-link" title="argenx dividend" href="/stocks/NASDAQ/ARGX/dividend/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/argenx-se---american-depositary-shares-logo.jpg" alt="argenx SE stock logo"></div><div class="ticker-area">ARGX</div><div class="title-area">argenx</div></a>
</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
</tr>
<tr>
<td data-clean="AZN|AstraZeneca">
<a class="profile-link" title="AstraZeneca dividend" href="/stocks/NASDAQ/AZN/dividend/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/astrazeneca-plc-logo.png?v=20231213131257" alt="AstraZeneca PLC stock logo"></div><div class="ticker-area">AZN</div><div class="title-area">AstraZeneca</div></a>
</td>
<td data-clean="$0.98" data-sort-value="0.98000002">$0.98</td>
<td data-sort-value="0.01">1.47%</td>
<td class="c-green" data-sort-value="1.18">+1.18%</td>
<td data-sort-value="0.47">46.89%</td>
<td data-clean="0" data-sort-value="0">N/A</td>
</tr>
<tr>
<td data-clean="BGNE|BeiGene">
<a class="profile-link" title="BeiGene dividend" href="/stocks/NASDAQ/BGNE/dividend/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="14" width="80" src="https://www.marketbeat.com/logos/thumbnail/beigene-ltd-logo.png?v=20221103144100" alt="BeiGene, Ltd. stock logo"></div><div class="ticker-area">BGNE</div><div class="title-area">BeiGene</div></a>
</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
</tr>
<tr>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen dividend" href="/stocks/NASDAQ/BIIB/dividend/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
</tr>
<tr>
<td data-clean="BMRN|BioMarin Pharmaceutical">
<a class="profile-link" title="BioMarin Pharmaceutical dividend" href="/stocks/NASDAQ/BMRN/dividend/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="60" width="80" src="https://www.marketbeat.com/logos/thumbnail/biomarin-pharm-logo.png" alt="BioMarin Pharmaceutical Inc. stock logo"></div><div class="ticker-area">BMRN</div><div class="title-area">BioMarin Pharmaceutical</div></a>
</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
</tr>
<tr>
<td data-clean="BNTX|BioNTech">
<a class="profile-link" title="BioNTech dividend" href="/stocks/NASDAQ/BNTX/dividend/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/biontech-se-logo.png?v=20231226132334" alt="BioNTech SE stock logo"></div><div class="ticker-area">BNTX</div><div class="title-area">BioNTech</div></a>
</td>
<td data-clean="$1.53" data-sort-value="1.52999997">$1.53</td>
<td data-sort-value="0.01">1.35%</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-sort-value="-0.73">N/A </td>
<td data-clean="0" data-sort-value="0">N/A</td>
</tr>
<tr>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences dividend" href="/stocks/NASDAQ/GILD/dividend/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td data-clean="$3.08" data-sort-value="3.07999992">$3.08</td>
<td data-sort-value="0.03">3.30%</td>
<td class="c-green" data-sort-value="3.32">+3.32%</td>
<td data-sort-value="34.22">3,422.22%</td>
<td data-clean="0" data-sort-value="0">N/A</td>
</tr>
<tr>
<td data-clean="GMAB|Genmab A/S">
<a class="profile-link" title="Genmab A/S dividend" href="/stocks/NASDAQ/GMAB/dividend/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="59" width="80" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div><div class="ticker-area">GMAB</div><div class="title-area">Genmab A/S</div></a>
</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
<td data-clean="0" data-sort-value="0">N/A</td>
</tr>
</tbody>
</table>
</div>
</div>
</div>
</div>
<h3 class="mt-2">Latest Pharmaceutical Stocks Dividends</h3>
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper">
<table class="scroll-table sort-table dividend-table">
<thead>
<tr>
<th data-sort="int">Announcement</th>
<th data-sort="string" data-clean="Symbol|Company">Company</th>
<th data-sort="string">Period</th>
<th data-sort="float">Amount</th>
<th data-sort="float">Yield</th>
<th data-sort="int">Ex-Dividend Date</th>
<th data-sort="int">Record Date</th>
<th data-sort="int">Payable Date</th>
</tr>
</thead>
<tbody>
<tr>
<td data-sort-value="20241210000000">12/10/2024</td>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen dividend" href="/stocks/NASDAQ/AMGN/dividend/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td>quarterly</td>
<td data-sort-value="2.38">$2.38</td>
<td>3.45%</td>
<td data-sort-value="20250214000000">2/14/2025</td>
<td data-sort-value="20250214000000">2/14/2025</td>
<td data-sort-value="20250307000000">3/7/2025</td>
</tr>
<tr>
<td data-sort-value="20241030000000">10/30/2024</td>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences dividend" href="/stocks/NASDAQ/GILD/dividend/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td>Quarterly</td>
<td data-sort-value="0.77">$0.77</td>
<td>3.15%</td>
<td data-sort-value="20241213000000">12/13/2024</td>
<td data-sort-value="20241213000000">12/13/2024</td>
<td data-sort-value="20241230000000">12/30/2024</td>
</tr>
<tr>
<td data-sort-value="20241025000000">10/25/2024</td>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen dividend" href="/stocks/NASDAQ/AMGN/dividend/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td>quarterly</td>
<td data-sort-value="2.25">$2.25</td>
<td>2.84%</td>
<td data-sort-value="20241118000000">11/18/2024</td>
<td data-sort-value="20241118000000">11/18/2024</td>
<td data-sort-value="20241209000000">12/9/2024</td>
</tr>
</tbody>
</table>
</div>
</div><em>(Data available from 1/1/2013 forward)</em><br>
<h2 class="mt-5">Debt</h2>
<div class="row">
<div class=" col-12">
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper" style="padding-top: 33.2812px;">
<table class="scroll-table sort-table debt-table fixed-header">
<thead class="hide-scrollbar" style="width: 1448px; position: absolute; top: 0px;">
<tr>
<th data-sort="string" data-clean="Symbol|Company" style="min-width: 459.25px; max-width: 459.25px;">Company</th>
<th data-sort="float" style="min-width: 329.578px; max-width: 329.578px;">Debt-to-Equity Ratio</th>
<th data-sort="float" style="min-width: 329.578px; max-width: 329.578px;">Current Ratio</th>
<th data-sort="float" style="min-width: 329.594px; max-width: 329.594px;">Quick Ratio</th>
</tr>
</thead>
<tbody>
<tr>
<td data-clean="ALNY|Alnylam Pharmaceuticals">
<a class="profile-link" title="Alnylam Pharmaceuticals stock price and analysis" href="/stocks/NASDAQ/ALNY/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="22" width="80" src="https://www.marketbeat.com/logos/thumbnail/alnylam-pharma-logo.png" alt="Alnylam Pharmaceuticals, Inc. stock logo"></div><div class="ticker-area">ALNY</div><div class="title-area">Alnylam Pharmaceuticals</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-dark-red" style="width:100.00%;animation-duration:0.8s;"></div>
<div class="rating-count position-absolute" style="left:105.00%;">31.64</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red-11" style="width:32.24%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:37.24%;">2.75</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red" style="width:34.14%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:39.14%;">2.69</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen stock price and analysis" href="/stocks/NASDAQ/AMGN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-dark-red" style="width:23.86%;animation-duration:0.8s;"></div>
<div class="rating-count position-absolute" style="left:28.86%;">7.55</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red-11" style="width:15.47%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:20.47%;">1.32</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red" style="width:12.18%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:17.18%;">0.96</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="ARGX|argenx">
<a class="profile-link" title="argenx stock price and analysis" href="/stocks/NASDAQ/ARGX/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/argenx-se---american-depositary-shares-logo.jpg" alt="argenx SE stock logo"></div><div class="ticker-area">ARGX</div><div class="title-area">argenx</div></a>
</td>
<td>N/A</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red-11" style="width:100.00%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:105.00%;">8.53</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red" style="width:100.00%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:105.00%;">7.88</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="AZN|AstraZeneca">
<a class="profile-link" title="AstraZeneca stock price and analysis" href="/stocks/NASDAQ/AZN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/astrazeneca-plc-logo.png?v=20231213131257" alt="AstraZeneca PLC stock logo"></div><div class="ticker-area">AZN</div><div class="title-area">AstraZeneca</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-dark-red" style="width:2.24%;animation-duration:0.8s;"></div>
<div class="rating-count position-absolute" style="left:7.24%;">0.71</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red-11" style="width:10.90%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:15.90%;">0.93</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red" style="width:9.01%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:14.01%;">0.71</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="BGNE|BeiGene">
<a class="profile-link" title="BeiGene stock price and analysis" href="/stocks/NASDAQ/BGNE/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="14" width="80" src="https://www.marketbeat.com/logos/thumbnail/beigene-ltd-logo.png?v=20221103144100" alt="BeiGene, Ltd. stock logo"></div><div class="ticker-area">BGNE</div><div class="title-area">BeiGene</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-dark-red" style="width:0.16%;animation-duration:0.8s;"></div>
<div class="rating-count position-absolute" style="left:5.16%;">0.05</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red-11" style="width:22.63%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:27.63%;">1.93</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red" style="width:21.83%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:26.83%;">1.72</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen stock price and analysis" href="/stocks/NASDAQ/BIIB/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-dark-red" style="width:0.88%;animation-duration:0.8s;"></div>
<div class="rating-count position-absolute" style="left:5.88%;">0.28</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red-11" style="width:14.77%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:19.77%;">1.26</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red" style="width:10.15%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:15.15%;">0.80</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="BMRN|BioMarin Pharmaceutical">
<a class="profile-link" title="BioMarin Pharmaceutical stock price and analysis" href="/stocks/NASDAQ/BMRN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="60" width="80" src="https://www.marketbeat.com/logos/thumbnail/biomarin-pharm-logo.png" alt="BioMarin Pharmaceutical Inc. stock logo"></div><div class="ticker-area">BMRN</div><div class="title-area">BioMarin Pharmaceutical</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-dark-red" style="width:0.35%;animation-duration:0.8s;"></div>
<div class="rating-count position-absolute" style="left:5.35%;">0.11</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red-11" style="width:50.06%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:55.06%;">4.27</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red" style="width:33.25%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:38.25%;">2.62</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="BNTX|BioNTech">
<a class="profile-link" title="BioNTech stock price and analysis" href="/stocks/NASDAQ/BNTX/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/biontech-se-logo.png?v=20231226132334" alt="BioNTech SE stock logo"></div><div class="ticker-area">BNTX</div><div class="title-area">BioNTech</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-dark-red" style="width:0.03%;animation-duration:0.8s;"></div>
<div class="rating-count position-absolute" style="left:5.03%;">0.01</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red-11" style="width:85.93%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:90.93%;">7.33</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red" style="width:91.50%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:96.50%;">7.21</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences stock price and analysis" href="/stocks/NASDAQ/GILD/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-dark-red" style="width:3.92%;animation-duration:0.8s;"></div>
<div class="rating-count position-absolute" style="left:8.92%;">1.24</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red-11" style="width:14.77%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:19.77%;">1.26</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red" style="width:13.96%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:18.96%;">1.10</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="GMAB|Genmab A/S">
<a class="profile-link" title="Genmab A/S stock price and analysis" href="/stocks/NASDAQ/GMAB/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="59" width="80" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div><div class="ticker-area">GMAB</div><div class="title-area">Genmab A/S</div></a>
</td>
<td>N/A</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red-11" style="width:60.61%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:65.61%;">5.17</div>
</div>
<div></div>
</div>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-red" style="width:65.36%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:70.36%;">5.15</div>
</div>
<div></div>
</div>
</td>
</tr>
</tbody>
</table>
</div>
</div>
</div>
</div>
<h2 class="mt-5">Ownership</h2>
<div class="row">
<div class=" col-12 col-md-6 mb-3">
<h3 class="mt-0">Institutional Ownership</h3>
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper" style="padding-top: 33.2812px;">
<table class="scroll-table sort-table ownership-table fixed-header">
<thead class="hide-scrollbar" style="width: 708px; position: absolute; top: 0px;">
<tr>
<th data-sort="string" data-clean="Symbol|Company" style="min-width: 412.188px; max-width: 412.188px;">Company</th>
<th data-sort="float" style="min-width: 295.812px; max-width: 295.812px;">Institutional Ownership</th>
</tr>
</thead>
<tbody>
<tr>
<td data-clean="ALNY|Alnylam Pharmaceuticals">
<a class="profile-link" title="Alnylam Pharmaceuticals institutional ownership" href="/stocks/NASDAQ/ALNY/institutional-ownership/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="22" width="80" src="https://www.marketbeat.com/logos/thumbnail/alnylam-pharma-logo.png" alt="Alnylam Pharmaceuticals, Inc. stock logo"></div><div class="ticker-area">ALNY</div><div class="title-area">Alnylam Pharmaceuticals</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue" style="width:92.97%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:97.97%;">92.97%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen institutional ownership" href="/stocks/NASDAQ/AMGN/institutional-ownership/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue" style="width:76.50%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:81.50%;">76.50%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="ARGX|argenx">
<a class="profile-link" title="argenx institutional ownership" href="/stocks/NASDAQ/ARGX/institutional-ownership/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/argenx-se---american-depositary-shares-logo.jpg" alt="argenx SE stock logo"></div><div class="ticker-area">ARGX</div><div class="title-area">argenx</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue" style="width:60.32%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:65.32%;">60.32%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="AZN|AstraZeneca">
<a class="profile-link" title="AstraZeneca institutional ownership" href="/stocks/NASDAQ/AZN/institutional-ownership/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/astrazeneca-plc-logo.png?v=20231213131257" alt="AstraZeneca PLC stock logo"></div><div class="ticker-area">AZN</div><div class="title-area">AstraZeneca</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue" style="width:20.35%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:25.35%;">20.35%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="BGNE|BeiGene">
<a class="profile-link" title="BeiGene institutional ownership" href="/stocks/NASDAQ/BGNE/institutional-ownership/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="14" width="80" src="https://www.marketbeat.com/logos/thumbnail/beigene-ltd-logo.png?v=20221103144100" alt="BeiGene, Ltd. stock logo"></div><div class="ticker-area">BGNE</div><div class="title-area">BeiGene</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue" style="width:48.55%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:53.55%;">48.55%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen institutional ownership" href="/stocks/NASDAQ/BIIB/institutional-ownership/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue" style="width:87.93%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:92.93%;">87.93%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="BMRN|BioMarin Pharmaceutical">
<a class="profile-link" title="BioMarin Pharmaceutical institutional ownership" href="/stocks/NASDAQ/BMRN/institutional-ownership/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="60" width="80" src="https://www.marketbeat.com/logos/thumbnail/biomarin-pharm-logo.png" alt="BioMarin Pharmaceutical Inc. stock logo"></div><div class="ticker-area">BMRN</div><div class="title-area">BioMarin Pharmaceutical</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue" style="width:98.71%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:103.71%;">98.71%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="BNTX|BioNTech">
<a class="profile-link" title="BioNTech institutional ownership" href="/stocks/NASDAQ/BNTX/institutional-ownership/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/biontech-se-logo.png?v=20231226132334" alt="BioNTech SE stock logo"></div><div class="ticker-area">BNTX</div><div class="title-area">BioNTech</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue" style="width:15.52%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:20.52%;">15.52%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences institutional ownership" href="/stocks/NASDAQ/GILD/institutional-ownership/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue" style="width:83.67%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:88.67%;">83.67%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="GMAB|Genmab A/S">
<a class="profile-link" title="Genmab A/S institutional ownership" href="/stocks/NASDAQ/GMAB/institutional-ownership/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="59" width="80" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div><div class="ticker-area">GMAB</div><div class="title-area">Genmab A/S</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue" style="width:7.07%;animation-duration:0.9s;"></div>
<div class="rating-count position-absolute" style="left:12.07%;">7.07%</div>
</div>
<div></div>
</div>
</td>
</tr>
</tbody>
</table>
</div>
</div>
</div>
<div class=" col-12 col-md-6 mb-3">
<h3 class="mt-0">Insider Ownership</h3>
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper" style="padding-top: 33.2812px;">
<table class="scroll-table sort-table ownership-table fixed-header">
<thead class="hide-scrollbar" style="width: 708px; position: absolute; top: 0px;">
<tr>
<th data-sort="string" data-clean="Symbol|Company" style="min-width: 412.188px; max-width: 412.188px;">Company</th>
<th data-sort="float" style="min-width: 295.812px; max-width: 295.812px;">Insider Ownership</th>
</tr>
</thead>
<tbody>
<tr>
<td data-clean="ALNY|Alnylam Pharmaceuticals">
<a class="profile-link" title="Alnylam Pharmaceuticals insider buying and selling" href="/stocks/NASDAQ/ALNY/insider-trades/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="22" width="80" src="https://www.marketbeat.com/logos/thumbnail/alnylam-pharma-logo.png" alt="Alnylam Pharmaceuticals, Inc. stock logo"></div><div class="ticker-area">ALNY</div><div class="title-area">Alnylam Pharmaceuticals</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue-8" style="width:1.50%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:6.50%;">1.50%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen insider buying and selling" href="/stocks/NASDAQ/AMGN/insider-trades/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue-8" style="width:0.69%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:5.69%;">0.69%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="ARGX|argenx">
<a class="profile-link" title="argenx insider buying and selling" href="/stocks/NASDAQ/ARGX/insider-trades/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/argenx-se---american-depositary-shares-logo.jpg" alt="argenx SE stock logo"></div><div class="ticker-area">ARGX</div><div class="title-area">argenx</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue-8" style="width:2.43%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:7.43%;">2.43%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="AZN|AstraZeneca">
<a class="profile-link" title="AstraZeneca insider buying and selling" href="/stocks/NASDAQ/AZN/insider-trades/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/astrazeneca-plc-logo.png?v=20231213131257" alt="AstraZeneca PLC stock logo"></div><div class="ticker-area">AZN</div><div class="title-area">AstraZeneca</div></a>
</td>
<td>N/A</td>
</tr>
<tr>
<td data-clean="BGNE|BeiGene">
<a class="profile-link" title="BeiGene insider buying and selling" href="/stocks/NASDAQ/BGNE/insider-trades/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="14" width="80" src="https://www.marketbeat.com/logos/thumbnail/beigene-ltd-logo.png?v=20221103144100" alt="BeiGene, Ltd. stock logo"></div><div class="ticker-area">BGNE</div><div class="title-area">BeiGene</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue-8" style="width:7.43%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:12.43%;">7.43%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen insider buying and selling" href="/stocks/NASDAQ/BIIB/insider-trades/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue-8" style="width:0.16%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:5.16%;">0.16%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="BMRN|BioMarin Pharmaceutical">
<a class="profile-link" title="BioMarin Pharmaceutical insider buying and selling" href="/stocks/NASDAQ/BMRN/insider-trades/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="60" width="80" src="https://www.marketbeat.com/logos/thumbnail/biomarin-pharm-logo.png" alt="BioMarin Pharmaceutical Inc. stock logo"></div><div class="ticker-area">BMRN</div><div class="title-area">BioMarin Pharmaceutical</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue-8" style="width:1.85%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:6.85%;">1.85%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="BNTX|BioNTech">
<a class="profile-link" title="BioNTech insider buying and selling" href="/stocks/NASDAQ/BNTX/insider-trades/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/biontech-se-logo.png?v=20231226132334" alt="BioNTech SE stock logo"></div><div class="ticker-area">BNTX</div><div class="title-area">BioNTech</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue-8" style="width:19.20%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:24.20%;">19.20%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences insider buying and selling" href="/stocks/NASDAQ/GILD/insider-trades/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue-8" style="width:0.16%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:5.16%;">0.16%</div>
</div>
<div></div>
</div>
</td>
</tr>
<tr>
<td data-clean="GMAB|Genmab A/S">
<a class="profile-link" title="Genmab A/S insider buying and selling" href="/stocks/NASDAQ/GMAB/insider-trades/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="59" width="80" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div><div class="ticker-area">GMAB</div><div class="title-area">Genmab A/S</div></a>
</td>
<td>
<div style="min-width:135px">
<div class="stat-bar-wrapper d-block position-relative my-1">
<div class="stat-bar fill-bar position-absolute h-100 bg-blue-8" style="width:1.54%;animation-duration:1s;"></div>
<div class="rating-count position-absolute" style="left:6.54%;">1.54%</div>
</div>
<div></div>
</div>
</td>
</tr>
</tbody>
</table>
</div>
</div>
</div>
</div>
<h2 class="mt-5">Miscellaneous</h2>
<div class="scroll-table-wrapper-wrapper">
<div class="scroll-table-wrapper" style="padding-top: 33.2812px;">
<table class="scroll-table sort-table misc-table fixed-header">
<thead class="hide-scrollbar" style="width: 1448px; position: absolute; top: 0px;">
<tr>
<th data-sort="string" data-clean="Symbol|Company" style="min-width: 461.031px; max-width: 461.031px;">Company</th>
<th data-sort="int" style="min-width: 217.719px; max-width: 217.719px;">Employees</th>
<th data-sort="int" style="min-width: 273.016px; max-width: 273.016px;">Shares Outstanding</th>
<th data-sort="int" style="min-width: 273.016px; max-width: 273.016px;">Free Float</th>
<th data-sort="string" style="min-width: 223.219px; max-width: 223.219px;">Optionable</th>
</tr>
</thead>
<tbody>
<tr>
<td data-clean="ALNY|Alnylam Pharmaceuticals">
<a class="profile-link" title="Alnylam Pharmaceuticals stock price and analysis" href="/stocks/NASDAQ/ALNY/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="22" width="80" src="https://www.marketbeat.com/logos/thumbnail/alnylam-pharma-logo.png" alt="Alnylam Pharmaceuticals, Inc. stock logo"></div><div class="ticker-area">ALNY</div><div class="title-area">Alnylam Pharmaceuticals</div></a>
</td>
<td>2,100</td>
<td data-sort-value="128981000" data-clean="128981000">128.98 million</td>
<td data-sort-value="127.046">127.05 million</td>
<td>Optionable</td>
</tr>
<tr>
<td data-clean="AMGN|Amgen">
<a class="profile-link" title="Amgen stock price and analysis" href="/stocks/NASDAQ/AMGN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/amgen-inc-logo.jpg?v=20231228113741" alt="Amgen Inc. stock logo"></div><div class="ticker-area">AMGN</div><div class="title-area">Amgen</div></a>
</td>
<td>26,700</td>
<td data-sort-value="537533000" data-clean="537533000">537.53 million</td>
<td data-sort-value="533.824">533.82 million</td>
<td>Optionable</td>
</tr>
<tr>
<td data-clean="ARGX|argenx">
<a class="profile-link" title="argenx stock price and analysis" href="/stocks/NASDAQ/ARGX/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/argenx-se---american-depositary-shares-logo.jpg" alt="argenx SE stock logo"></div><div class="ticker-area">ARGX</div><div class="title-area">argenx</div></a>
</td>
<td>1,148</td>
<td data-sort-value="60368000" data-clean="60368000">60.37 million</td>
<td data-sort-value="58.901">58.90 million</td>
<td>Optionable</td>
</tr>
<tr>
<td data-clean="AZN|AstraZeneca">
<a class="profile-link" title="AstraZeneca stock price and analysis" href="/stocks/NASDAQ/AZN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/astrazeneca-plc-logo.png?v=20231213131257" alt="AstraZeneca PLC stock logo"></div><div class="ticker-area">AZN</div><div class="title-area">AstraZeneca</div></a>
</td>
<td>89,900</td>
<td data-sort-value="3100634000" data-clean="3100634000">3.10 billion</td>
<td>N/A</td>
<td>Optionable</td>
</tr>
<tr>
<td data-clean="BGNE|BeiGene">
<a class="profile-link" title="BeiGene stock price and analysis" href="/stocks/NASDAQ/BGNE/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="14" width="80" src="https://www.marketbeat.com/logos/thumbnail/beigene-ltd-logo.png?v=20221103144100" alt="BeiGene, Ltd. stock logo"></div><div class="ticker-area">BGNE</div><div class="title-area">BeiGene</div></a>
</td>
<td>10,600</td>
<td data-sort-value="97518000" data-clean="97518000">97.52 million</td>
<td data-sort-value="90.195">90.20 million</td>
<td>Optionable</td>
</tr>
<tr>
<td data-clean="BIIB|Biogen">
<a class="profile-link" title="Biogen stock price and analysis" href="/stocks/NASDAQ/BIIB/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="26" width="80" src="https://www.marketbeat.com/logos/thumbnail/biogen-inc-logo.jpg?v=20221024141534" alt="Biogen Inc. stock logo"></div><div class="ticker-area">BIIB</div><div class="title-area">Biogen</div></a>
</td>
<td>7,570</td>
<td data-sort-value="145719000" data-clean="145719000">145.72 million</td>
<td data-sort-value="145.486">145.49 million</td>
<td>Optionable</td>
</tr>
<tr>
<td data-clean="BMRN|BioMarin Pharmaceutical">
<a class="profile-link" title="BioMarin Pharmaceutical stock price and analysis" href="/stocks/NASDAQ/BMRN/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="60" width="80" src="https://www.marketbeat.com/logos/thumbnail/biomarin-pharm-logo.png" alt="BioMarin Pharmaceutical Inc. stock logo"></div><div class="ticker-area">BMRN</div><div class="title-area">BioMarin Pharmaceutical</div></a>
</td>
<td>3,401</td>
<td data-sort-value="190583000" data-clean="190583000">190.58 million</td>
<td data-sort-value="187.057">187.06 million</td>
<td>Optionable</td>
</tr>
<tr>
<td data-clean="BNTX|BioNTech">
<a class="profile-link" title="BioNTech stock price and analysis" href="/stocks/NASDAQ/BNTX/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="44" width="80" src="https://www.marketbeat.com/logos/thumbnail/biontech-se-logo.png?v=20231226132334" alt="BioNTech SE stock logo"></div><div class="ticker-area">BNTX</div><div class="title-area">BioNTech</div></a>
</td>
<td>6,133</td>
<td data-sort-value="237726000" data-clean="237726000">237.73 million</td>
<td data-sort-value="192.083">192.08 million</td>
<td>Optionable</td>
</tr>
<tr>
<td data-clean="GILD|Gilead Sciences">
<a class="profile-link" title="Gilead Sciences stock price and analysis" href="/stocks/NASDAQ/GILD/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="29" width="80" src="https://www.marketbeat.com/logos/thumbnail/Gilead_Sciences_Pty_Ltd.jpg" alt="Gilead Sciences, Inc. stock logo"></div><div class="ticker-area">GILD</div><div class="title-area">Gilead Sciences</div></a>
</td>
<td>18,000</td>
<td data-sort-value="1246266000" data-clean="1246266000">1.25 billion</td>
<td data-sort-value="1244.272">1.24 billion</td>
<td>Optionable</td>
</tr>
<tr>
<td data-clean="GMAB|Genmab A/S">
<a class="profile-link" title="Genmab A/S stock price and analysis" href="/stocks/NASDAQ/GMAB/" _blank=""><div class="company-thumbnail"><img loading="lazy" height="59" width="80" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div><div class="ticker-area">GMAB</div><div class="title-area">Genmab A/S</div></a>
</td>
<td>2,204</td>
<td data-sort-value="661768000" data-clean="661768000">661.77 million</td>
<td data-sort-value="651.577">651.58 million</td>
<td>Optionable</td>
</tr>
</tbody>
</table>
</div>
</div>
<h2 class="mt-5">Pharmaceutical Stocks Headlines</h2>
<div class="row">
<div class="col-12 col-md-6 mb-3">
<div class="section-heading">
<h2 class="m-0 h3 d-inline-block">Recent News About These Companies</h2>
</div>
<div class="headline-row">
<div class="headline-image-div"><img src="/images/news-sites/abmn.png" alt="" loading="lazy" decoding="async" width="50" height="50" class="icon-image"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://www.americanbankingnews.com/?p=29904746">Genmab A/S (NASDAQ:GMAB) Given Average Recommendation of "Moderate Buy" by Analysts</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 20 <span style="text-transform:none">at</span> 3:18 AM | americanbankingnews.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img loading="lazy" height="59" width="80" class="icon-image" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" href="https://www.marketbeat.com/instant-alerts/genmab-as-nasdaqgmab-given-average-rating-of-moderate-buy-by-brokerages-2024-12-20/">Genmab A/S (NASDAQ:GMAB) Given Average Rating of "Moderate Buy" by Brokerages</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 20 <span style="text-transform:none">at</span> 3:17 AM | marketbeat.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img loading="lazy" height="59" width="80" class="icon-image" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" href="https://www.marketbeat.com/instant-alerts/genmab-as-nasdaqgmab-shares-gap-up-time-to-buy-2024-12-18/">Genmab A/S (NASDAQ:GMAB) Shares Gap Up - Time to Buy?</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 18, 2024 | marketbeat.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img loading="lazy" height="59" width="80" class="icon-image" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" href="https://www.marketbeat.com/instant-alerts/genmab-as-nasdaqgmab-short-interest-down-114-in-november-2024-12-17/">Genmab A/S (NASDAQ:GMAB) Short Interest Down 11.4% in November</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 17, 2024 | marketbeat.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img loading="lazy" height="59" width="80" class="icon-image" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" href="https://www.marketbeat.com/instant-alerts/genmab-as-nasdaqgmab-reaches-new-52-week-low-whats-next-2024-12-13/">Genmab A/S (NASDAQ:GMAB) Reaches New 52-Week Low - What's Next?</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 13, 2024 | marketbeat.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img loading="lazy" height="59" width="80" class="icon-image" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" href="https://www.marketbeat.com/instant-alerts/fmr-llc-has-678-million-holdings-in-genmab-as-nasdaqgmab-2024-12-13/">Fmr LLC Has $6.78 Million Holdings in Genmab A/S (NASDAQ:GMAB)</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 13, 2024 | marketbeat.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img src="/images/news-sites/globenewswire.jpg" alt="" loading="lazy" decoding="async" width="50" height="50" class="icon-image"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://www.globenewswire.com/news-release/2024/12/11/2995389/0/en/genmab-to-hold-2024-r-d-update-and-ash-data-review-meeting.html">Genmab to Hold 2024 R&D Update and ASH Data Review Meeting</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 11, 2024 | globenewswire.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img loading="lazy" height="59" width="80" class="icon-image" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" href="https://www.marketbeat.com/instant-alerts/verition-fund-management-llc-purchases-shares-of-29074-genmab-as-nasdaqgmab-2024-12-10/">Verition Fund Management LLC Purchases Shares of 29,074 Genmab A/S (NASDAQ:GMAB)</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 10, 2024 | marketbeat.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img src="/images/news-sites/businesswire.jpg" alt="" loading="lazy" decoding="async" width="50" height="50" class="icon-image"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://www.businesswire.com/news/home/20241208545186/en/Two-Data-Analyses-from-Clinical-Trials-Show-Epcoritamab-DuoBody%C2%AE-CD3xCD20-Induces-Durable-Complete-Responses-as-Monotherapy-and-Combination-Treatment-in-Patients-With-Diffuse-Large-B-Cell-Lymphoma-DLBCL/">Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable, Complete Responses as Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 9, 2024 | businesswire.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img loading="lazy" height="59" width="80" class="icon-image" src="https://www.marketbeat.com/logos/thumbnail/genmab-a-s-logo.png?v=20231227090205" alt="Genmab A/S stock logo"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" href="https://www.marketbeat.com/instant-alerts/two-sigma-advisers-lp-buys-280900-shares-of-genmab-as-nasdaqgmab-2024-12-09/">Two Sigma Advisers LP Buys 280,900 Shares of Genmab A/S (NASDAQ:GMAB)</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 9, 2024 | marketbeat.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img src="/images/news-sites/marketinsider.jpg" alt="" loading="lazy" decoding="async" width="50" height="50" class="icon-image"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://markets.businessinsider.com/news/stocks/genmab-epcoritamab-combo-shows-high-response-rates-in-1b-2-trial-for-r-r-follicular-lymphoma-1034110574">Genmab : Epcoritamab Combo Shows High Response Rates In 1b/2 Trial For R/R Follicular Lymphoma</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 8, 2024 | markets.businessinsider.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img src="/images/news-sites/businesswire.jpg" alt="" loading="lazy" decoding="async" width="50" height="50" class="icon-image"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://www.businesswire.com/news/home/20241208951291/en/investigational-epcoritamab-duobody%c2%ae-cd3xcd20-monotherapy-achieves-high-overall-and-complete-response-rates-in-clinical-trial-of-patients-with-relapsed-or-refractory-rr-chronic-lymphocytic-leukemia-cll-in-preliminary-analysis/">Investigational Epcoritamab (DuoBody® CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 8, 2024 | businesswire.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img src="/images/news-sites/seekingalpha.jpg" alt="" loading="lazy" decoding="async" width="50" height="50" class="icon-image"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://seekingalpha.com/article/4742886-genmab-is-too-attractive-to-ignore">Genmab Is Too Attractive To Ignore</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 8, 2024 | seekingalpha.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img src="/images/news-sites/businesswire.jpg" alt="" loading="lazy" decoding="async" width="50" height="50" class="icon-image"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://www.businesswire.com/news/home/20241207413980/en/investigational-epcoritamab-duobody%c2%ae-cd3xcd20-combination-therapy-demonstrates-high-response-rates-in-clinical-trial-of-patients-with-relapsed-or-refractory-rr-follicular-lymphoma-fl/">Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 7, 2024 | businesswire.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://www.fiercebiotech.com/biotech/genmab-buys-second-anti-glycan-antibody-scancell-bringing-total-tab-over-1-billion">Genmab buys 2nd anti-glycan antibody from Scancell, commits up to $630M in biobucks</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 4, 2024 | fiercebiotech.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://pharmaphorum.com/news/genmab-expands-its-pipeline-630m-scancell-deal">Genmab expands its pipeline with $630m Scancell deal</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 4, 2024 | pharmaphorum.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img src="/images/news-sites/proactive.jpg" alt="" loading="lazy" decoding="async" width="50" height="50" class="icon-image"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://www.proactiveinvestors.co.uk/companies/news/1062067?snapi">Scancell strikes deal worth up to $630m with Genmab</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 4, 2024 | proactiveinvestors.co.uk</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img src="/images/news-sites/globenewswire.jpg" alt="" loading="lazy" decoding="async" width="50" height="50" class="icon-image"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://www.globenewswire.com/news-release/2024/12/03/2991093/0/en/capital-increase-in-genmab-as-a-result-of-employee-warrant-exercise.html">Capital Increase in Genmab as a Result of Employee Warrant Exercise</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 3, 2024 | globenewswire.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img src="/images/news-sites/globenewswire.jpg" alt="" loading="lazy" decoding="async" width="50" height="50" class="icon-image"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://www.globenewswire.com/news-release/2024/12/03/2990460/0/en/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons.html">Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">December 3, 2024 | globenewswire.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img src="/images/news-sites/msn.jpg" alt="" loading="lazy" decoding="async" width="50" height="50" class="icon-image"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://www.msn.com/en-us/money/savingandinvesting/why-is-genmab-as-gmab-among-the-worst-performing-healthcare-stocks-in-2024/ar-AA1uRfXu">Why Is Genmab A/S (GMAB) Among the Worst Performing Healthcare Stocks in 2024?</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">November 27, 2024 | msn.com</div>
</div>
</div>
<div class="headline-row">
<div class="headline-image-div"><img src="/images/news-sites/globenewswire.jpg" alt="" loading="lazy" decoding="async" width="50" height="50" class="icon-image"></div>
<div class="headline-description-div">
<a class="c-black stretched-link d-block mb-1" rel="nofollow noopener" target="_blank" href="https://www.globenewswire.com/news-release/2024/11/25/2986879/0/en/genmab-to-present-at-citi-s-global-healthcare-conference.html">Genmab to Present at Citi's Global Healthcare Conference</a>
<div class="byline mb-1" style="font-size: .7rem;color:#757575;">November 25, 2024 | globenewswire.com</div>
</div>
</div>
</div>
<div class="col-12 col-md-6 mb-3">
<script>
var comparisonFollowerSeries =
"Date,ALNY,AMGN,ARGX,AZN,BGNE,BIIB,BMRN,BNTX,GILD,GMAB\n09/24/2024,0,5,0,5,0,3,4,1,3,0\n10/01/2024,0,2,2,10,0,3,3,1,5,2\n10/08/2024,3,6,3,4,2,10,3,5,6,1\n10/15/2024,1,3,1,3,1,2,2,1,8,0\n10/22/2024,1,3,3,1,0,3,0,1,5,1\n10/29/2024,1,4,3,2,0,4,2,2,3,0\n11/05/2024,0,2,5,8,0,0,1,2,8,0\n11/12/2024,3,11,0,3,1,5,1,20,5,4\n11/19/2024,0,5,2,1,0,0,1,56,3,0\n11/26/2024,5,11,0,13,1,7,1,1,5,0\n12/03/2024,3,9,1,6,0,2,4,4,6,1\n12/10/2024,0,9,2,1,2,5,2,0,4,1\n12/17/2024,1,3,0,1,0,3,1,0,6,1";
var comparisonSentimentSeries =
"Date,ALNY,AMGN,ARGX,AZN,BGNE,BIIB,BMRN,BNTX,GILD,GMAB\n09/24/2024,0.81,0.42,0.73,0.62,0.65,0.38,0.73,1.14,1.00,0.33\n10/01/2024,0.79,0.80,0.47,0.90,0.58,0.36,0.64,0.49,0.86,0.59\n10/08/2024,0.37,0.73,1.11,1.02,0.87,0.41,0.93,0.62,0.64,0.85\n10/15/2024,0.38,0.78,0.31,1.04,0.61,0.19,0.88,0.03,0.61,0.37\n10/22/2024,0.70,0.55,1.03,0.95,0.53,0.46,0.47,0.12,0.73,0.11\n10/29/2024,0.53,0.53,0.70,0.28,0.64,0.28,0.28,1.15,0.75,0.57\n11/05/2024,0.85,0.98,0.83,0.47,0.95,0.38,0.67,0.31,0.78,0.51\n11/12/2024,0.38,0.83,0.86,0.57,0.18,0.84,0.67,0.48,0.93,1.08\n11/19/2024,0.85,1.27,0.33,0.57,0.69,0.54,0.90,0.34,1.19,0.26\n11/26/2024,0.70,0.29,1.16,1.02,1.02,1.01,1.25,0.64,1.14,0.38\n12/03/2024,1.43,0.61,1.14,0.84,0.81,1.01,1.16,0.94,1.01,0.51\n12/10/2024,1.06,0.86,0.93,0.74,0.40,0.54,0.99,0.47,1.04,0.95\n12/17/2024,0.58,0.28,1.00,0.38,0.76,-0.07,1.11,0.32,0.71,1.10";
</script>
<div class="border rounded p-3 mt-2 mb-3">
<div class="section-heading">
<h2 class="m-0 h3 d-inline-block">New MarketBeat Followers Over Time</h2>
</div>
<div class="w-100" style="margin-bottom: -2px;">
<div class="p-2">
<div class="dv-chart-wrapper px-2">
<div id="comparisonFollowerChart" class="dv-chart" style="height:450px"><svg id="svgcomparisonFollowerChart" width="626" height="450"
aria-label="This chart shows a comparison each company's new followers on MarketBeat by week over the past 90 days." data-pastpercentage="1" data-margintop="20" data-marginleft="31">
<g class="underGroup">
<g class="y axis" transform="translate(31,20)" fill="none" font-size="10" font-family="sans-serif" text-anchor="end">
<path class="domain" stroke="#000" d="M525,370.5H0.5V0.5H525"></path>
<g class="tick g-baseline" opacity="1" transform="translate(0,336.8636363636364)">
<line stroke="#000" x2="525"></line><text fill="#000" x="-31" dy="0.32em"></text>
</g>
<g class="tick" opacity="1" transform="translate(0,227.65466351829988)">
<line stroke="#000" x2="525"></line><text fill="#000" x="-31" dy="0.32em"></text>
</g>
<g class="tick" opacity="1" transform="translate(0,118.44569067296342)">
<line stroke="#000" x2="525"></line><text fill="#000" x="-31" dy="0.32em"></text>
</g>
<g class="tick" opacity="1" transform="translate(0,9.23671782762699)">
<line stroke="#000" x2="525"></line><text fill="#000" x="-31" dy="0.32em"></text>
</g>
</g>
</g>
<g class="shadowGroup" transform="translate(31,20)" width="525" height="370" clip-path="url(#comparisonFollowerChartclip)"></g>
<g class="mainGroup" transform="translate(31,20)" width="525" height="0" clip-path="url(#comparisonFollowerChartclip)">
<clipPath class="clip" id="comparisonFollowerChartclip">
<rect transform="translate(-15,-20)" width="555" height="450"></rect>
</clipPath>
<path class="invisible-line"
d="M17.5,0C31.111111111111107,0,44.72222222222222,0,58.33333333333333,0C71.94444444444444,0,85.55555555555554,0,99.16666666666666,0C112.77777777777777,0,126.38888888888889,0,140,0C153.61111111111111,0,167.22222222222223,0,180.83333333333334,0C194.44444444444446,0,208.05555555555554,0,221.66666666666666,0C235.27777777777777,0,248.88888888888889,0,262.5,0C276.1111111111111,0,289.72222222222223,0,303.3333333333333,0C316.94444444444446,0,330.55555555555554,0,344.1666666666667,0C357.77777777777777,0,371.3888888888889,0,385,0C398.6111111111111,0,412.22222222222223,0,425.8333333333333,0C439.4444444444444,0,453.05555555555554,0,466.66666666666663,0C480.27777777777777,0,493.88888888888886,0,507.5,0">
</path>
<g class="x axis quarter-labels" transform="translate(87.5,425)" fill="none" font-size="10" font-family="sans-serif" text-anchor="middle">
<path class="domain" stroke="#000" d="M0.5,2V0.5H525.5V2"></path>
<g class="tick" opacity="1" transform="translate(58.83333333333333,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">Oct</text>
</g>
<g class="tick" opacity="1" transform="translate(239.66666666666666,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">Nov</text>
</g>
<g class="tick" opacity="1" transform="translate(414.66666666666663,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">Dec</text>
</g>
</g>
<g class="info-slider" transform="translate(507.5,0)">
<line class="x-hover-line" stroke-width="2" stroke="#ddd" y1="10" y2="370"></line>
</g>
<g class="x axis year-lines" transform="translate(0,390)" fill="none" font-size="10" font-family="sans-serif" text-anchor="middle">
<path class="domain" stroke="#000" d="M0.5,2V0.5H525.5V2"></path>
<g class="tick" opacity="1" transform="translate(6.333333333333334,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(23.833333333333336,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(41.333333333333336,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(58.83333333333333,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(76.33333333333333,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(93.83333333333334,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(111.33333333333333,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(128.83333333333334,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(146.33333333333334,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(163.83333333333334,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(181.33333333333334,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(198.83333333333331,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(216.33333333333331,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(233.83333333333331,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(239.66666666666666,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(257.1666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(274.6666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(292.1666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(309.6666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(327.1666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(344.6666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(362.1666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(379.6666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(397.16666666666663,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(414.66666666666663,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(432.16666666666663,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(449.66666666666663,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(467.16666666666663,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(484.6666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(502.1666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.875;"></line>
</g>
<g class="tick" opacity="1" transform="translate(519.6666666666667,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.875;"></line>
</g>
</g>
<path class="ALNY-line chart-line"
d="M17.5,336.3636363636364C31.111111111111107,336.3636363636364,44.72222222222222,336.3636363636364,58.33333333333333,336.3636363636364C71.94444444444444,336.3636363636364,85.55555555555554,319.9822904368359,99.16666666666666,319.9822904368359C112.77777777777777,319.9822904368359,126.38888888888889,330.90318772136953,140,330.90318772136953C153.61111111111111,330.90318772136953,167.22222222222223,330.90318772136953,180.83333333333334,330.90318772136953C194.44444444444446,330.90318772136953,208.05555555555554,330.90318772136953,221.66666666666666,330.90318772136953C235.27777777777777,330.90318772136953,248.88888888888889,336.3636363636364,262.5,336.3636363636364C276.1111111111111,336.3636363636364,289.72222222222223,319.9822904368359,303.3333333333333,319.9822904368359C316.94444444444446,319.9822904368359,330.55555555555554,336.3636363636364,344.1666666666667,336.3636363636364C357.77777777777777,336.3636363636364,371.3888888888889,309.06139315230223,385,309.06139315230223C398.6111111111111,309.06139315230223,412.22222222222223,315.4319165682802,425.8333333333333,319.9822904368359C439.4444444444444,324.5326643053916,453.05555555555554,336.3636363636364,466.66666666666663,336.3636363636364C480.27777777777777,336.3636363636364,493.88888888888886,333.633412042503,507.5,330.90318772136953"
stroke-width="3" stroke="#005882" fill="none" opacity="1" stroke-dashoffset="0" stroke-dasharray="518.2843627929688"></path>
<path class="AMGN-line chart-line"
d="M17.5,309.06139315230223C31.111111111111107,317.25206611570246,44.72222222222222,325.4427390791027,58.33333333333333,325.4427390791027C71.94444444444444,325.4427390791027,85.55555555555554,303.60094451003545,99.16666666666666,303.60094451003545C112.77777777777777,303.60094451003545,126.38888888888889,319.9822904368359,140,319.9822904368359C153.61111111111111,319.9822904368359,167.22222222222223,319.9822904368359,180.83333333333334,319.9822904368359C194.44444444444446,319.9822904368359,208.05555555555554,314.52184179456907,221.66666666666666,314.52184179456907C235.27777777777777,314.52184179456907,248.88888888888889,325.4427390791027,262.5,325.4427390791027C276.1111111111111,325.4427390791027,289.72222222222223,276.2987012987013,303.3333333333333,276.2987012987013C316.94444444444446,276.2987012987013,330.55555555555554,309.06139315230223,344.1666666666667,309.06139315230223C357.77777777777777,309.06139315230223,371.3888888888889,276.2987012987013,385,276.2987012987013C398.6111111111111,276.2987012987013,412.22222222222223,287.219598583235,425.8333333333333,287.219598583235C439.4444444444444,287.219598583235,453.05555555555554,287.219598583235,466.66666666666663,287.219598583235C480.27777777777777,287.219598583235,493.88888888888886,303.60094451003545,507.5,319.9822904368359"
stroke-width="3" stroke="#0B824D" fill="none" opacity="0.5" stroke-dashoffset="0" stroke-dasharray="571.475341796875"></path>
<path class="ARGX-line chart-line"
d="M17.5,336.3636363636364C31.111111111111107,332.26829988193623,44.72222222222222,328.1729634002361,58.33333333333333,325.4427390791027C71.94444444444444,322.7125147579693,85.55555555555554,319.9822904368359,99.16666666666666,319.9822904368359C112.77777777777777,319.9822904368359,126.38888888888889,330.90318772136953,140,330.90318772136953C153.61111111111111,330.90318772136953,167.22222222222223,319.9822904368359,180.83333333333334,319.9822904368359C194.44444444444446,319.9822904368359,208.05555555555554,319.9822904368359,221.66666666666666,319.9822904368359C235.27777777777777,319.9822904368359,248.88888888888889,309.06139315230223,262.5,309.06139315230223C276.1111111111111,309.06139315230223,289.72222222222223,336.3636363636364,303.3333333333333,336.3636363636364C316.94444444444446,336.3636363636364,330.55555555555554,325.4427390791027,344.1666666666667,325.4427390791027C357.77777777777777,325.4427390791027,371.3888888888889,336.3636363636364,385,336.3636363636364C398.6111111111111,336.3636363636364,412.22222222222223,332.7233372687918,425.8333333333333,330.90318772136953C439.4444444444444,329.0830381739473,453.05555555555554,325.4427390791027,466.66666666666663,325.4427390791027C480.27777777777777,325.4427390791027,493.88888888888886,330.90318772136953,507.5,336.3636363636364"
stroke-width="3" stroke="#117169" fill="none" opacity="0.5" stroke-dashoffset="0" stroke-dasharray="512.3584594726562"></path>
<path class="AZN-line chart-line"
d="M17.5,309.06139315230223C31.111111111111107,295.41027154663516,44.72222222222222,281.75914994096814,58.33333333333333,281.75914994096814C71.94444444444444,281.75914994096814,85.55555555555554,310.8815426997245,99.16666666666666,314.52184179456907C112.77777777777777,318.16214088941365,126.38888888888889,317.2520661157025,140,319.9822904368359C153.61111111111111,322.7125147579693,167.22222222222223,330.90318772136953,180.83333333333334,330.90318772136953C194.44444444444446,330.90318772136953,208.05555555555554,329.0830381739473,221.66666666666666,325.4427390791027C235.27777777777777,321.8024399842581,248.88888888888889,292.68004722550177,262.5,292.68004722550177C276.1111111111111,292.68004722550177,289.72222222222223,313.61176702085794,303.3333333333333,319.9822904368359C316.94444444444446,326.3528138528139,330.55555555555554,330.90318772136953,344.1666666666667,330.90318772136953C357.77777777777777,330.90318772136953,371.3888888888889,265.3778040141677,385,265.3778040141677C398.6111111111111,265.3778040141677,412.22222222222223,292.6800472255018,425.8333333333333,303.60094451003545C439.4444444444444,314.52184179456907,453.05555555555554,330.90318772136953,466.66666666666663,330.90318772136953C480.27777777777777,330.90318772136953,493.88888888888886,330.90318772136953,507.5,330.90318772136953"
stroke-width="3" stroke="#262682" fill="none" opacity="0.5" stroke-dashoffset="0" stroke-dasharray="601.9534912109375"></path>
<path class="BGNE-line chart-line"
d="M17.5,336.3636363636364C31.111111111111107,336.3636363636364,44.72222222222222,336.3636363636364,58.33333333333333,336.3636363636364C71.94444444444444,336.3636363636364,85.55555555555554,325.4427390791027,99.16666666666666,325.4427390791027C112.77777777777777,325.4427390791027,126.38888888888889,329.0830381739473,140,330.90318772136953C153.61111111111111,332.7233372687918,167.22222222222223,336.3636363636364,180.83333333333334,336.3636363636364C194.44444444444446,336.3636363636364,208.05555555555554,336.3636363636364,221.66666666666666,336.3636363636364C235.27777777777777,336.3636363636364,248.88888888888889,336.3636363636364,262.5,336.3636363636364C276.1111111111111,336.3636363636364,289.72222222222223,330.90318772136953,303.3333333333333,330.90318772136953C316.94444444444446,330.90318772136953,330.55555555555554,336.3636363636364,344.1666666666667,336.3636363636364C357.77777777777777,336.3636363636364,371.3888888888889,330.90318772136953,385,330.90318772136953C398.6111111111111,330.90318772136953,412.22222222222223,336.3636363636364,425.8333333333333,336.3636363636364C439.4444444444444,336.3636363636364,453.05555555555554,325.4427390791027,466.66666666666663,325.4427390791027C480.27777777777777,325.4427390791027,493.88888888888886,330.90318772136953,507.5,336.3636363636364"
stroke-width="3" stroke="#005882" fill="none" opacity="0.5" stroke-dashoffset="0" stroke-dasharray="497.66815185546875"></path>
<path class="BIIB-line chart-line"
d="M17.5,319.9822904368359C31.111111111111107,319.9822904368359,44.72222222222222,319.9822904368359,58.33333333333333,319.9822904368359C71.94444444444444,319.9822904368359,85.55555555555554,281.75914994096814,99.16666666666666,281.75914994096814C112.77777777777777,281.75914994096814,126.38888888888889,325.4427390791027,140,325.4427390791027C153.61111111111111,325.4427390791027,167.22222222222223,321.80243998425817,180.83333333333334,319.9822904368359C194.44444444444446,318.16214088941365,208.05555555555554,314.52184179456907,221.66666666666666,314.52184179456907C235.27777777777777,314.52184179456907,248.88888888888889,336.3636363636364,262.5,336.3636363636364C276.1111111111111,336.3636363636364,289.72222222222223,309.06139315230223,303.3333333333333,309.06139315230223C316.94444444444446,309.06139315230223,330.55555555555554,336.3636363636364,344.1666666666667,336.3636363636364C357.77777777777777,336.3636363636364,371.3888888888889,298.1404958677686,385,298.1404958677686C398.6111111111111,298.1404958677686,412.22222222222223,325.4427390791027,425.8333333333333,325.4427390791027C439.4444444444444,325.4427390791027,453.05555555555554,309.06139315230223,466.66666666666663,309.06139315230223C480.27777777777777,309.06139315230223,493.88888888888886,314.52184179456907,507.5,319.9822904368359"
stroke-width="3" stroke="#9D2A2D" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="585.1957397460938"></path>
<path class="BMRN-line chart-line"
d="M17.5,314.52184179456907C31.111111111111107,317.2520661157025,44.72222222222222,319.9822904368359,58.33333333333333,319.9822904368359C71.94444444444444,319.9822904368359,85.55555555555554,319.9822904368359,99.16666666666666,319.9822904368359C112.77777777777777,319.9822904368359,126.38888888888889,322.7125147579693,140,325.4427390791027C153.61111111111111,328.1729634002361,167.22222222222223,336.3636363636364,180.83333333333334,336.3636363636364C194.44444444444446,336.3636363636364,208.05555555555554,325.4427390791027,221.66666666666666,325.4427390791027C235.27777777777777,325.4427390791027,248.88888888888889,330.90318772136953,262.5,330.90318772136953C276.1111111111111,330.90318772136953,289.72222222222223,330.90318772136953,303.3333333333333,330.90318772136953C316.94444444444446,330.90318772136953,330.55555555555554,330.90318772136953,344.1666666666667,330.90318772136953C357.77777777777777,330.90318772136953,371.3888888888889,330.90318772136953,385,330.90318772136953C398.6111111111111,330.90318772136953,412.22222222222223,314.52184179456907,425.8333333333333,314.52184179456907C439.4444444444444,314.52184179456907,453.05555555555554,322.7125147579693,466.66666666666663,325.4427390791027C480.27777777777777,328.1729634002361,493.88888888888886,329.53807556080284,507.5,330.90318772136953"
stroke-width="3" stroke="#935912" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="500.3001708984375"></path>
<path class="BNTX-line chart-line"
d="M17.5,330.90318772136953C31.111111111111107,330.90318772136953,44.72222222222222,330.90318772136953,58.33333333333333,330.90318772136953C71.94444444444444,330.90318772136953,85.55555555555554,309.06139315230223,99.16666666666666,309.06139315230223C112.77777777777777,309.06139315230223,126.38888888888889,330.90318772136953,140,330.90318772136953C153.61111111111111,330.90318772136953,167.22222222222223,330.90318772136953,180.83333333333334,330.90318772136953C194.44444444444446,330.90318772136953,208.05555555555554,325.4427390791027,221.66666666666666,325.4427390791027C235.27777777777777,325.4427390791027,248.88888888888889,325.4427390791027,262.5,325.4427390791027C276.1111111111111,325.4427390791027,289.72222222222223,276.29870129870125,303.3333333333333,227.15466351829988C316.94444444444446,178.01062573789847,330.55555555555554,30.578512396694293,344.1666666666667,30.578512396694293C357.77777777777777,30.578512396694293,371.3888888888889,330.90318772136953,385,330.90318772136953C398.6111111111111,330.90318772136953,412.22222222222223,314.52184179456907,425.8333333333333,314.52184179456907C439.4444444444444,314.52184179456907,453.05555555555554,336.3636363636364,466.66666666666663,336.3636363636364C480.27777777777777,336.3636363636364,493.88888888888886,336.3636363636364,507.5,336.3636363636364"
stroke-width="3" stroke="#0B824D" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="1006.65185546875"></path>
<path class="GILD-line chart-line"
d="M17.5,319.9822904368359C31.111111111111107,315.88695395513577,44.72222222222222,311.7916174734356,58.33333333333333,309.06139315230223C71.94444444444444,306.33116883116884,85.55555555555554,306.33116883116884,99.16666666666666,303.60094451003545C112.77777777777777,300.87072018890206,126.38888888888889,292.68004722550177,140,292.68004722550177C153.61111111111111,292.68004722550177,167.22222222222223,304.5110192837465,180.83333333333334,309.06139315230223C194.44444444444446,313.61176702085794,208.05555555555554,319.9822904368359,221.66666666666666,319.9822904368359C235.27777777777777,319.9822904368359,248.88888888888889,292.68004722550177,262.5,292.68004722550177C276.1111111111111,292.68004722550177,289.72222222222223,304.5110192837465,303.3333333333333,309.06139315230223C316.94444444444446,313.61176702085794,330.55555555555554,319.9822904368359,344.1666666666667,319.9822904368359C357.77777777777777,319.9822904368359,371.3888888888889,311.7916174734356,385,309.06139315230223C398.6111111111111,306.33116883116884,412.22222222222223,303.60094451003545,425.8333333333333,303.60094451003545C439.4444444444444,303.60094451003545,453.05555555555554,314.52184179456907,466.66666666666663,314.52184179456907C480.27777777777777,314.52184179456907,493.88888888888886,309.06139315230223,507.5,303.60094451003545"
stroke-width="3" stroke="#117169" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="518.6322021484375"></path>
<path class="GMAB-line chart-line"
d="M17.5,336.3636363636364C31.111111111111107,330.90318772136953,44.72222222222222,325.4427390791027,58.33333333333333,325.4427390791027C71.94444444444444,325.4427390791027,85.55555555555554,329.0830381739473,99.16666666666666,330.90318772136953C112.77777777777777,332.7233372687918,126.38888888888889,336.3636363636364,140,336.3636363636364C153.61111111111111,336.3636363636364,167.22222222222223,330.90318772136953,180.83333333333334,330.90318772136953C194.44444444444446,330.90318772136953,208.05555555555554,336.3636363636364,221.66666666666666,336.3636363636364C235.27777777777777,336.3636363636364,248.88888888888889,336.3636363636364,262.5,336.3636363636364C276.1111111111111,336.3636363636364,289.72222222222223,314.52184179456907,303.3333333333333,314.52184179456907C316.94444444444446,314.52184179456907,330.55555555555554,336.3636363636364,344.1666666666667,336.3636363636364C357.77777777777777,336.3636363636364,371.3888888888889,336.3636363636364,385,336.3636363636364C398.6111111111111,336.3636363636364,412.22222222222223,330.90318772136953,425.8333333333333,330.90318772136953C439.4444444444444,330.90318772136953,453.05555555555554,330.90318772136953,466.66666666666663,330.90318772136953C480.27777777777777,330.90318772136953,493.88888888888886,330.90318772136953,507.5,330.90318772136953"
stroke-width="3" stroke="#262682" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="506.47662353515625"></path>
<g class="fade-edges">
<rect transform="translate(-16,-20)" width="559" height="450" mask="url(#comparisonFollowerChartmask)" style="fill: rgb(255, 255, 255);"></rect>
</g>
<rect transform="translate(0,0)" class="overlay" width="525" height="415"></rect>
</g>
<g class="bottomGroup" transform="translate(31,20)" width="525" height="0" clip-path="url(#comparisonFollowerChartclip)"></g>
<g class="yTextGroup">
<g class="y axis top" transform="translate(31,20)" fill="none" font-size="10" font-family="sans-serif" text-anchor="end">
<path class="domain" stroke="#000" d="M525,370.5H0.5V0.5H525"></path>
<g class="tick g-baseline" opacity="1" transform="translate(0,336.8636363636364)">
<line stroke="#000" x2="525"></line><text fill="#000" x="-12" dy="0.32em">0</text>
</g>
<g class="tick" opacity="1" transform="translate(0,227.65466351829988)">
<line stroke="#000" x2="525"></line><text fill="#000" x="-12" dy="0.32em">20</text>
</g>
<g class="tick" opacity="1" transform="translate(0,118.44569067296342)">
<line stroke="#000" x2="525"></line><text fill="#000" x="-12" dy="0.32em">40</text>
</g>
<g class="tick" opacity="1" transform="translate(0,9.23671782762699)">
<line stroke="#000" x2="525"></line><text fill="#000" x="-12" dy="0.32em">60</text>
</g>
</g>
<g transform="translate(606,20)"><text text-anchor="end" class="footnote-top">Week of Dec 17</text></g>
<g class="footnote" transform="translate(556,45)">
<rect height="5" width="10" fill="#005882" opacity="1" x="5"></rect><text height="30" width="95" fill="#005882" x="18" y="8">ALNY</text><text class="footnote-details" height="30" width="95" fill="#005882" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,85)">
<rect height="5" width="10" fill="#0B824D" opacity="0.5" x="5"></rect><text height="30" width="95" fill="#0B824D" x="18" y="8">AMGN</text><text class="footnote-details" height="30" width="95" fill="#0B824D" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,125)">
<rect height="5" width="10" fill="#117169" opacity="0.5" x="5"></rect><text height="30" width="95" fill="#117169" x="18" y="8">ARGX</text><text class="footnote-details" height="30" width="95" fill="#117169" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,165)">
<rect height="5" width="10" fill="#262682" opacity="0.5" x="5"></rect><text height="30" width="95" fill="#262682" x="18" y="8">AZN</text><text class="footnote-details" height="30" width="95" fill="#262682" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,205)">
<rect height="5" width="10" fill="#005882" opacity="0.5" x="5"></rect><text height="30" width="95" fill="#005882" x="18" y="8">BGNE</text><text class="footnote-details" height="30" width="95" fill="#005882" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,245)">
<rect height="5" width="10" fill="#9D2A2D" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#9D2A2D" x="18" y="8">BIIB</text><text class="footnote-details" height="30" width="95" fill="#9D2A2D" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,285)">
<rect height="5" width="10" fill="#935912" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#935912" x="18" y="8">BMRN</text><text class="footnote-details" height="30" width="95" fill="#935912" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,325)">
<rect height="5" width="10" fill="#0B824D" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#0B824D" x="18" y="8">BNTX</text><text class="footnote-details" height="30" width="95" fill="#0B824D" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,365)">
<rect height="5" width="10" fill="#117169" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#117169" x="18" y="8">GILD</text><text class="footnote-details" height="30" width="95" fill="#117169" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,405)">
<rect height="5" width="10" fill="#262682" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#262682" x="18" y="8">GMAB</text><text class="footnote-details" height="30" width="95" fill="#262682" x="18"
y="24"></text>
</g>
</g>
<g class="overGroup" transform="translate(31,20)" width="525" height="370" clip-path="url(#comparisonFollowerChartclip)"></g>
<defs>
<linearGradient id="comparisonFollowerChartpastFutureGradient" x1="0%" x2="100%" y1="100%" y2="100%">
<stop class="start" offset="0%" stop-color="var(--blue-8)" stop-opacity="1"></stop>
<stop class="middle" offset="100%" stop-color="var(--blue-8)"></stop>
<stop class="othermiddle" offset="100%" stop-color="#ccc" stop-opacity="0"></stop>
<stop class="end" offset="100%" stop-color="#ccc" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonFollowerChartfutureBarGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="#888888" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="#888888" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#888888" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonFollowerChartpastBarGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="var(--blue-8)" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="var(--blue-8)" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="var(--blue-8)" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="boughtGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="#0B824D" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="#0B824D" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#0B824D" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonFollowerChartsoldGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="#E84B56" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="#E84B56" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#E84B56" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonFollowerChartLightBlueGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="var(--blue-2)" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="var(--blue-2)" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="var(--blue-2)" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonFollowerChartfadeGradient" x1="0%" x2="100%" y1="100%" y2="100%">
<stop class="start" offset="0%" stop-color="#fff" stop-opacity="1"></stop>
<stop class="middle" offset="2.857142857142857%" stop-color="#000" stop-opacity="1"></stop>
<stop class="othermiddle" offset="97.14285714285714%" stop-color="#000" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#fff" stop-opacity="1"></stop>
</linearGradient>
<mask id="comparisonFollowerChartmask">
<rect x="0" y="0" width="556" height="450" style="fill: url("#comparisonFollowerChartfadeGradient"); opacity: 1;"></rect>
</mask>
<filter id="comparisonFollowerChartinnerShadow" x0="-50%" y0="-50%" width="200%" height="200%">
<feGaussianBlur in="SourceAlpha" stdDeviation="5" result="blur"></feGaussianBlur>
<feOffset dy="10" dx="3"></feOffset>
<feComposite in2="SourceAlpha" operator="arithmetic" k2="-1" k3="1" result="shadowDiff"></feComposite>
<feFlood flood-color="#75a0bb" flood-opacity="0.3"></feFlood>
<feComposite in2="shadowDiff" operator="in"></feComposite>
<feComposite in2="SourceGraphic" operator="over" result="firstfilter"></feComposite>
<feGaussianBlur in="firstfilter" stdDeviation="3" result="blur2"></feGaussianBlur>
<feOffset dy="-10" dx="-3"></feOffset>
<feComposite in2="firstfilter" operator="arithmetic" k2="-1" k3="1" result="shadowDiff"></feComposite>
<feFlood flood-color="#75a0bb" flood-opacity="0.3"></feFlood>
<feComposite in2="shadowDiff" operator="in"></feComposite>
<feComposite in2="firstfilter" operator="over"></feComposite>
</filter>
</defs>
</svg></div>
</div>
</div>
</div>
</div>
<div class="border rounded p-3 mt-2 mb-3">
<div class="section-heading">
<h2 class="m-0 h3 d-inline-block">Media Sentiment Over Time</h2>
</div>
<div class="w-100" style="margin-bottom: -2px;">
<div class="p-2">
<div class="dv-chart-wrapper px-2">
<div id="comparisonSentimentChart" class="dv-chart" style="height:450px"><svg id="svgcomparisonSentimentChart" width="626" height="450"
aria-label="This chart shows a comparison each company's media sentiment by week over the past 90 days." data-pastpercentage="1" data-margintop="20" data-marginleft="49">
<g class="underGroup">
<g class="y axis" transform="translate(49,20)" fill="none" font-size="10" font-family="sans-serif" text-anchor="end">
<path class="domain" stroke="#000" d="M507,370.5H0.5V0.5H507"></path>
<g class="tick g-baseline" opacity="1" transform="translate(0,322.59366391184574)">
<line stroke="#000" x2="507"></line><text fill="#000" x="-49" dy="0.32em"></text>
</g>
<g class="tick" opacity="1" transform="translate(0,220.66528925619832)">
<line stroke="#000" x2="507"></line><text fill="#000" x="-49" dy="0.32em"></text>
</g>
<g class="tick" opacity="1" transform="translate(0,118.73691460055096)">
<line stroke="#000" x2="507"></line><text fill="#000" x="-49" dy="0.32em"></text>
</g>
<g class="tick" opacity="1" transform="translate(0,16.8085399449036)">
<line stroke="#000" x2="507"></line><text fill="#000" x="-49" dy="0.32em"></text>
</g>
</g>
</g>
<g class="shadowGroup" transform="translate(49,20)" width="507" height="370" clip-path="url(#comparisonSentimentChartclip)"></g>
<g class="mainGroup" transform="translate(49,20)" width="507" height="0" clip-path="url(#comparisonSentimentChartclip)">
<clipPath class="clip" id="comparisonSentimentChartclip">
<rect transform="translate(-15,-20)" width="537" height="450"></rect>
</clipPath>
<path class="invisible-line"
d="M16.9,0C30.044444444444444,0,43.18888888888888,0,56.33333333333333,0C69.47777777777777,0,82.62222222222222,0,95.76666666666667,0C108.91111111111111,0,122.05555555555554,0,135.2,0C148.34444444444443,0,161.48888888888888,0,174.63333333333333,0C187.77777777777777,0,200.92222222222222,0,214.06666666666666,0C227.2111111111111,0,240.35555555555555,0,253.5,0C266.64444444444445,0,279.78888888888883,0,292.9333333333333,0C306.0777777777777,0,319.22222222222223,0,332.3666666666667,0C345.5111111111111,0,358.6555555555555,0,371.79999999999995,0C384.9444444444444,0,398.0888888888889,0,411.23333333333335,0C424.3777777777778,0,437.5222222222222,0,450.66666666666663,0C463.8111111111111,0,476.9555555555556,0,490.1,0">
</path>
<g class="x axis quarter-labels" transform="translate(84.5,425)" fill="none" font-size="10" font-family="sans-serif" text-anchor="middle">
<path class="domain" stroke="#000" d="M0.5,2V0.5H507.5V2"></path>
<g class="tick" opacity="1" transform="translate(56.83333333333333,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">Oct</text>
</g>
<g class="tick" opacity="1" transform="translate(231.46666666666667,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">Nov</text>
</g>
<g class="tick" opacity="1" transform="translate(400.46666666666664,0)">
<line stroke="#000" y2="2"></line><text fill="#000" y="-18" dy="0.71em">Dec</text>
</g>
</g>
<g class="info-slider" transform="translate(490.1000061035156,0)">
<line class="x-hover-line" stroke-width="2" stroke="#ddd" y1="10" y2="370"></line>
</g>
<g class="x axis year-lines" transform="translate(0,390)" fill="none" font-size="10" font-family="sans-serif" text-anchor="middle">
<path class="domain" stroke="#000" d="M0.5,2V0.5H507.5V2"></path>
<g class="tick" opacity="1" transform="translate(6.133333333333334,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(23.033333333333335,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(39.93333333333334,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(56.83333333333333,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(73.73333333333332,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(90.63333333333334,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(107.53333333333333,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(124.43333333333332,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(141.33333333333334,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(158.23333333333335,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(175.13333333333333,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(192.03333333333333,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(208.93333333333334,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(225.83333333333331,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(231.46666666666667,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(248.36666666666665,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(265.2666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(282.1666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(299.06666666666666,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(315.9666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(332.8666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(349.76666666666665,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(366.6666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(383.56666666666666,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(400.46666666666664,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(417.3666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(434.26666666666665,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(451.16666666666663,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(468.0666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(484.9666666666667,0)">
<line stroke="#000" y2="2" class="past" style="stroke-width: 21.125;"></line>
</g>
<g class="tick" opacity="1" transform="translate(501.8666666666667,0)">
<line stroke="#000" y2="0" class="past" style="stroke-width: 21.125;"></line>
</g>
</g>
<path class="ALNY-line chart-line"
d="M16.9,156.96969696969694C30.044444444444444,157.64921946740125,43.18888888888888,158.32874196510556,56.33333333333333,161.04683195592284C69.47777777777777,163.76492194674012,82.62222222222222,246.66666666666669,95.76666666666667,246.66666666666669C108.91111111111111,246.66666666666669,122.05555555555554,245.98714416896237,135.2,244.62809917355372C148.34444444444443,243.26905417814507,161.48888888888888,179.3939393939394,174.63333333333333,179.3939393939394C187.77777777777777,179.3939393939394,200.92222222222222,214.04958677685948,214.06666666666666,214.04958677685948C227.2111111111111,214.04958677685948,240.35555555555555,148.8154269972452,253.5,148.8154269972452C266.64444444444445,148.8154269972452,279.78888888888883,244.62809917355372,292.9333333333333,244.62809917355372C306.0777777777777,244.62809917355372,319.22222222222223,148.8154269972452,332.3666666666667,148.8154269972452C345.5111111111111,148.8154269972452,358.6555555555555,179.3939393939394,371.79999999999995,179.3939393939394C384.9444444444444,179.3939393939394,398.0888888888889,30.578512396694236,411.23333333333335,30.578512396694236C424.3777777777778,30.578512396694236,437.5222222222222,77.12580348943992,450.66666666666663,106.00550964187329C463.8111111111111,134.88521579430676,476.9555555555556,169.37098255280077,490.1,203.8567493112948"
stroke-width="3" stroke="#005882" fill="none" opacity="1" stroke-dashoffset="0" stroke-dasharray="998.2968139648438"></path>
<path class="AMGN-line chart-line"
d="M16.9,236.47382920110192C30.044444444444444,197.74104683195594,43.18888888888888,159.00826446280993,56.33333333333333,159.00826446280993C69.47777777777777,159.00826446280993,82.62222222222222,173.27823691460054,95.76666666666667,173.27823691460054C108.91111111111111,173.27823691460054,122.05555555555554,163.0853994490358,135.2,163.0853994490358C148.34444444444443,163.0853994490358,161.48888888888888,207.2543617998163,174.63333333333333,209.97245179063358C187.77777777777777,212.69054178145086,200.92222222222222,214.04958677685948,214.06666666666666,214.04958677685948C227.2111111111111,214.04958677685948,240.35555555555555,122.31404958677686,253.5,122.31404958677686C266.64444444444445,122.31404958677686,279.78888888888883,152.8925619834711,292.9333333333333,152.8925619834711C306.0777777777777,152.8925619834711,319.22222222222223,63.19559228650138,332.3666666666667,63.19559228650138C345.5111111111111,63.19559228650138,358.6555555555555,262.97520661157023,371.79999999999995,262.97520661157023C384.9444444444444,262.97520661157023,398.0888888888889,217.10743801652896,411.23333333333335,197.74104683195594C424.3777777777778,178.37465564738298,437.5222222222222,146.7768595041323,450.66666666666663,146.7768595041323C463.8111111111111,146.7768595041323,476.9555555555556,205.89531680440774,490.1,265.0137741046832"
stroke-width="3" stroke="#0B824D" fill="none" opacity="0.5" stroke-dashoffset="0" stroke-dasharray="1005.5501708984375"></path>
<path class="ARGX-line chart-line"
d="M16.9,173.27823691460054C30.044444444444444,199.77961432506885,43.18888888888888,226.28099173553719,56.33333333333333,226.28099173553719C69.47777777777777,226.28099173553719,82.62222222222222,95.81267217630852,95.76666666666667,95.81267217630852C108.91111111111111,95.81267217630852,122.05555555555554,258.89807162534436,135.2,258.89807162534436C148.34444444444443,258.89807162534436,161.48888888888888,112.12121212121212,174.63333333333333,112.12121212121212C187.77777777777777,112.12121212121212,200.92222222222222,179.3939393939394,214.06666666666666,179.3939393939394C227.2111111111111,179.3939393939394,240.35555555555555,156.96969696969697,253.5,152.8925619834711C266.64444444444445,148.81542699724523,279.78888888888883,146.7768595041323,292.9333333333333,146.7768595041323C306.0777777777777,146.7768595041323,319.22222222222223,254.82093663911846,332.3666666666667,254.82093663911846C345.5111111111111,254.82093663911846,358.6555555555555,85.61983471074382,371.79999999999995,85.61983471074382C384.9444444444444,85.61983471074382,398.0888888888889,86.97887970615245,411.23333333333335,89.69696969696975C424.3777777777778,92.41505968778702,437.5222222222222,132.50688705234163,450.66666666666663,132.50688705234163C463.8111111111111,132.50688705234163,476.9555555555556,125.37190082644629,490.1,118.23691460055096"
stroke-width="3" stroke="#117169" fill="none" opacity="0.5" stroke-dashoffset="0" stroke-dasharray="1134.697998046875"></path>
<path class="AZN-line chart-line"
d="M16.9,195.702479338843C30.044444444444444,173.95775941230488,43.18888888888888,152.21303948576676,56.33333333333333,138.62258953168043C69.47777777777777,125.03213957759411,82.62222222222222,116.87786960514232,95.76666666666667,114.15977961432506C108.91111111111111,111.4416896235078,122.05555555555554,110.08264462809916,135.2,110.08264462809916C148.34444444444443,110.08264462809916,161.48888888888888,116.19834710743801,174.63333333333333,128.42975206611573C187.77777777777777,140.66115702479343,200.92222222222222,265.0137741046832,214.06666666666666,265.0137741046832C227.2111111111111,265.0137741046832,240.35555555555555,236.13406795224975,253.5,226.28099173553719C266.64444444444445,216.42791551882462,279.78888888888883,205.89531680440774,292.9333333333333,205.89531680440774C306.0777777777777,205.89531680440774,319.22222222222223,205.89531680440774,332.3666666666667,205.89531680440774C345.5111111111111,205.89531680440774,358.6555555555555,114.15977961432506,371.79999999999995,114.15977961432506C384.9444444444444,114.15977961432506,398.0888888888889,141.34067952249774,411.23333333333335,150.85399449035816C424.3777777777778,160.36730945821856,437.5222222222222,157.6492194674013,450.66666666666663,171.2396694214876C463.8111111111111,184.83011937557393,476.9555555555556,214.72910927456383,490.1,244.62809917355372"
stroke-width="3" stroke="#262682" fill="none" opacity="0.5" stroke-dashoffset="0" stroke-dasharray="771.2315673828125"></path>
<path class="BGNE-line chart-line"
d="M16.9,189.58677685950414C30.044444444444444,196.72176308539946,43.18888888888888,203.8567493112948,56.33333333333333,203.8567493112948C69.47777777777777,203.8567493112948,82.62222222222222,144.7382920110193,95.76666666666667,144.7382920110193C108.91111111111111,144.7382920110193,122.05555555555554,186.86868686868692,135.2,197.74104683195594C148.34444444444443,208.61340679522496,161.48888888888888,214.04958677685948,174.63333333333333,214.04958677685948C187.77777777777777,214.04958677685948,200.92222222222222,205.89531680440774,214.06666666666666,191.6253443526171C227.2111111111111,177.35537190082647,240.35555555555555,128.42975206611573,253.5,128.42975206611573C266.64444444444445,128.42975206611573,279.78888888888883,285.39944903581267,292.9333333333333,285.39944903581267C306.0777777777777,285.39944903581267,319.22222222222223,209.97245179063367,332.3666666666667,181.43250688705237C345.5111111111111,152.89256198347118,358.6555555555555,114.15977961432506,371.79999999999995,114.15977961432506C384.9444444444444,114.15977961432506,398.0888888888889,135.9044995408631,411.23333333333335,156.96969696969694C424.3777777777778,178.03489439853072,437.5222222222222,240.55096418732782,450.66666666666663,240.55096418732782C463.8111111111111,240.55096418732782,476.9555555555556,203.85674931129478,490.1,167.1625344352617"
stroke-width="3" stroke="#005882" fill="none" opacity="0.5" stroke-dashoffset="0" stroke-dasharray="945.638671875"></path>
<path class="BIIB-line chart-line"
d="M16.9,244.62809917355372C30.044444444444444,246.66666666666669,43.18888888888888,248.70523415977962,56.33333333333333,248.70523415977962C69.47777777777777,248.70523415977962,82.62222222222222,238.51239669421489,95.76666666666667,238.51239669421489C108.91111111111111,238.51239669421489,122.05555555555554,283.3608815426997,135.2,283.3608815426997C148.34444444444443,283.3608815426997,161.48888888888888,228.31955922865015,174.63333333333333,228.31955922865015C187.77777777777777,228.31955922865015,200.92222222222222,265.0137741046832,214.06666666666666,265.0137741046832C227.2111111111111,265.0137741046832,240.35555555555555,258.21854912764,253.5,244.62809917355372C266.64444444444445,231.03764921946743,279.78888888888883,150.85399449035816,292.9333333333333,150.85399449035816C306.0777777777777,150.85399449035816,319.22222222222223,212.01101928374655,332.3666666666667,212.01101928374655C345.5111111111111,212.01101928374655,358.6555555555555,116.198347107438,371.79999999999995,116.198347107438C384.9444444444444,116.198347107438,398.0888888888889,116.198347107438,411.23333333333335,116.198347107438C424.3777777777778,116.198347107438,437.5222222222222,175.31680440771356,450.66666666666663,212.01101928374655C463.8111111111111,248.70523415977965,476.9555555555556,292.53443526170804,490.1,336.3636363636364"
stroke-width="3" stroke="#9D2A2D" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="872.88525390625"></path>
<path class="BMRN-line chart-line"
d="M16.9,173.27823691460054C30.044444444444444,182.45179063360882,43.18888888888888,191.6253443526171,56.33333333333333,191.6253443526171C69.47777777777777,191.6253443526171,82.62222222222222,132.50688705234163,95.76666666666667,132.50688705234163C108.91111111111111,132.50688705234163,122.05555555555554,135.90449954086318,135.2,142.69972451790633C148.34444444444443,149.49494949494948,161.48888888888888,205.8953168044077,174.63333333333333,226.28099173553719C187.77777777777777,246.66666666666666,200.92222222222222,265.0137741046832,214.06666666666666,265.0137741046832C227.2111111111111,265.0137741046832,240.35555555555555,185.50964187327824,253.5,185.50964187327824C266.64444444444445,185.50964187327824,279.78888888888883,185.50964187327824,292.9333333333333,185.50964187327824C306.0777777777777,185.50964187327824,319.22222222222223,158.32874196510562,332.3666666666667,138.62258953168043C345.5111111111111,118.91643709825529,358.6555555555555,67.27272727272731,371.79999999999995,67.27272727272731C384.9444444444444,67.27272727272731,398.0888888888889,76.78604224058769,411.23333333333335,85.61983471074382C424.3777777777778,94.45362718089991,437.5222222222222,120.27548209366392,450.66666666666663,120.27548209366392C463.8111111111111,120.27548209366392,476.9555555555556,108.04407713498622,490.1,95.81267217630852"
stroke-width="3" stroke="#935912" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="730.2518310546875"></path>
<path class="BNTX-line chart-line"
d="M16.9,89.69696969696975C30.044444444444444,155.95041322314052,43.18888888888888,222.20385674931129,56.33333333333333,222.20385674931129C69.47777777777777,222.20385674931129,82.62222222222222,195.702479338843,95.76666666666667,195.702479338843C108.91111111111111,195.702479338843,122.05555555555554,315.9779614325069,135.2,315.9779614325069C148.34444444444443,315.9779614325069,161.48888888888888,309.86225895316807,174.63333333333333,297.63085399449034C187.77777777777777,285.3994490358126,200.92222222222222,87.65840220385678,214.06666666666666,87.65840220385678C227.2111111111111,87.65840220385678,240.35555555555555,258.89807162534436,253.5,258.89807162534436C266.64444444444445,258.89807162534436,279.78888888888883,224.24242424242425,292.9333333333333,224.24242424242425C306.0777777777777,224.24242424242425,319.22222222222223,252.78236914600552,332.3666666666667,252.78236914600552C345.5111111111111,252.78236914600552,358.6555555555555,212.01101928374655,371.79999999999995,191.6253443526171C384.9444444444444,171.2396694214876,398.0888888888889,130.46831955922866,411.23333333333335,130.46831955922866C424.3777777777778,130.46831955922866,437.5222222222222,205.89531680440777,450.66666666666663,226.28099173553719C463.8111111111111,246.66666666666666,476.9555555555556,251.76308539944904,490.1,256.8595041322314"
stroke-width="3" stroke="#0B824D" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="1164.5074462890625"></path>
<path class="GILD-line chart-line"
d="M16.9,118.23691460055096C30.044444444444444,126.39118457300277,43.18888888888888,134.5454545454546,56.33333333333333,146.7768595041323C69.47777777777777,159.00826446281,82.62222222222222,187.5482093663912,95.76666666666667,191.6253443526171C108.91111111111111,195.702479338843,122.05555555555554,197.74104683195594,135.2,197.74104683195594C148.34444444444443,197.74104683195594,161.48888888888888,175.99632690541782,174.63333333333333,173.27823691460054C187.77777777777777,170.56014692378326,200.92222222222222,170.89990817263543,214.06666666666666,169.20110192837464C227.2111111111111,167.50229568411385,240.35555555555555,167.1625344352617,253.5,163.0853994490358C266.64444444444445,159.00826446280993,279.78888888888883,146.43709825528006,292.9333333333333,132.50688705234163C306.0777777777777,118.57667584940314,319.22222222222223,79.50413223140498,332.3666666666667,79.50413223140498C345.5111111111111,79.50413223140498,358.6555555555555,83.58126721763092,371.79999999999995,89.69696969696975C384.9444444444444,95.81267217630858,398.0888888888889,116.198347107438,411.23333333333335,116.198347107438C424.3777777777778,116.198347107438,437.5222222222222,110.08264462809916,450.66666666666663,110.08264462809916C463.8111111111111,110.08264462809916,476.9555555555556,143.71900826446281,490.1,177.35537190082647"
stroke-width="3" stroke="#117169" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="603.3055419921875"></path>
<path class="GMAB-line chart-line"
d="M16.9,254.82093663911846C30.044444444444444,237.15335169880626,43.18888888888888,219.48576675849404,56.33333333333333,201.81818181818184C69.47777777777777,184.15059687786965,82.62222222222222,148.8154269972452,95.76666666666667,148.8154269972452C108.91111111111111,148.8154269972452,122.05555555555554,221.524334251607,135.2,246.66666666666669C148.34444444444443,271.80899908172637,161.48888888888888,299.6694214876033,174.63333333333333,299.6694214876033C187.77777777777777,299.6694214876033,200.92222222222222,205.89531680440774,214.06666666666666,205.89531680440774C227.2111111111111,205.89531680440774,240.35555555555555,218.12672176308538,253.5,218.12672176308538C266.64444444444445,218.12672176308538,279.78888888888883,101.92837465564736,292.9333333333333,101.92837465564736C306.0777777777777,101.92837465564736,319.22222222222223,269.0909090909091,332.3666666666667,269.0909090909091C345.5111111111111,269.0909090909091,358.6555555555555,253.12213039485766,371.79999999999995,244.62809917355372C384.9444444444444,236.13406795224975,398.0888888888889,235.7943067033976,411.23333333333335,218.12672176308538C424.3777777777778,200.45913682277322,437.5222222222222,148.47566574839303,450.66666666666663,128.42975206611573C463.8111111111111,108.38383838383835,476.9555555555556,103.11753902662991,490.1,97.85123966942149"
stroke-width="3" stroke="#262682" fill="none" opacity="0.8" stroke-dashoffset="0" stroke-dasharray="997.8458251953125"></path>
<g class="fade-edges">
<rect transform="translate(-16,-20)" width="541" height="450" mask="url(#comparisonSentimentChartmask)" style="fill: rgb(255, 255, 255);"></rect>
</g>
<rect transform="translate(0,0)" class="overlay" width="507" height="415"></rect>
</g>
<g class="bottomGroup" transform="translate(49,20)" width="507" height="0" clip-path="url(#comparisonSentimentChartclip)"></g>
<g class="yTextGroup">
<g class="y axis top" transform="translate(49,20)" fill="none" font-size="10" font-family="sans-serif" text-anchor="end">
<path class="domain" stroke="#000" d="M507,370.5H0.5V0.5H507"></path>
<g class="tick g-baseline" opacity="1" transform="translate(0,322.59366391184574)">
<line stroke="#000" x2="507"></line><text fill="#000" x="-12" dy="0.32em">0</text>
</g>
<g class="tick" opacity="1" transform="translate(0,220.66528925619832)">
<line stroke="#000" x2="507"></line><text fill="#000" x="-12" dy="0.32em">0.50</text>
</g>
<g class="tick" opacity="1" transform="translate(0,118.73691460055096)">
<line stroke="#000" x2="507"></line><text fill="#000" x="-12" dy="0.32em">1</text>
</g>
<g class="tick" opacity="1" transform="translate(0,16.8085399449036)">
<line stroke="#000" x2="507"></line><text fill="#000" x="-12" dy="0.32em">1.50</text>
</g>
</g>
<g transform="translate(606,20)"><text text-anchor="end" class="footnote-top">Week of Dec 17</text></g>
<g class="footnote" transform="translate(556,45)">
<rect height="5" width="10" fill="#005882" opacity="1" x="5"></rect><text height="30" width="95" fill="#005882" x="18" y="8">ALNY</text><text class="footnote-details" height="30" width="95" fill="#005882" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,85)">
<rect height="5" width="10" fill="#0B824D" opacity="0.5" x="5"></rect><text height="30" width="95" fill="#0B824D" x="18" y="8">AMGN</text><text class="footnote-details" height="30" width="95" fill="#0B824D" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,125)">
<rect height="5" width="10" fill="#117169" opacity="0.5" x="5"></rect><text height="30" width="95" fill="#117169" x="18" y="8">ARGX</text><text class="footnote-details" height="30" width="95" fill="#117169" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,165)">
<rect height="5" width="10" fill="#262682" opacity="0.5" x="5"></rect><text height="30" width="95" fill="#262682" x="18" y="8">AZN</text><text class="footnote-details" height="30" width="95" fill="#262682" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,205)">
<rect height="5" width="10" fill="#005882" opacity="0.5" x="5"></rect><text height="30" width="95" fill="#005882" x="18" y="8">BGNE</text><text class="footnote-details" height="30" width="95" fill="#005882" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,245)">
<rect height="5" width="10" fill="#9D2A2D" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#9D2A2D" x="18" y="8">BIIB</text><text class="footnote-details" height="30" width="95" fill="#9D2A2D" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,285)">
<rect height="5" width="10" fill="#935912" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#935912" x="18" y="8">BMRN</text><text class="footnote-details" height="30" width="95" fill="#935912" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,325)">
<rect height="5" width="10" fill="#0B824D" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#0B824D" x="18" y="8">BNTX</text><text class="footnote-details" height="30" width="95" fill="#0B824D" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,365)">
<rect height="5" width="10" fill="#117169" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#117169" x="18" y="8">GILD</text><text class="footnote-details" height="30" width="95" fill="#117169" x="18"
y="24"></text>
</g>
<g class="footnote" transform="translate(556,405)">
<rect height="5" width="10" fill="#262682" opacity="0.8" x="5"></rect><text height="30" width="95" fill="#262682" x="18" y="8">GMAB</text><text class="footnote-details" height="30" width="95" fill="#262682" x="18"
y="24"></text>
</g>
</g>
<g class="overGroup" transform="translate(49,20)" width="507" height="370" clip-path="url(#comparisonSentimentChartclip)"></g>
<defs>
<linearGradient id="comparisonSentimentChartpastFutureGradient" x1="0%" x2="100%" y1="100%" y2="100%">
<stop class="start" offset="0%" stop-color="var(--blue-8)" stop-opacity="1"></stop>
<stop class="middle" offset="100%" stop-color="var(--blue-8)"></stop>
<stop class="othermiddle" offset="100%" stop-color="#ccc" stop-opacity="0"></stop>
<stop class="end" offset="100%" stop-color="#ccc" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonSentimentChartfutureBarGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="#888888" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="#888888" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#888888" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonSentimentChartpastBarGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="var(--blue-8)" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="var(--blue-8)" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="var(--blue-8)" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="boughtGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="#0B824D" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="#0B824D" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#0B824D" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonSentimentChartsoldGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="#E84B56" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="#E84B56" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#E84B56" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonSentimentChartLightBlueGradient" x1="100%" x2="100%" y1="0%" y2="100%">
<stop class="start" offset="0%" stop-color="var(--blue-2)" stop-opacity="1"></stop>
<stop class="middle" offset="10%" stop-color="var(--blue-2)" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="var(--blue-2)" stop-opacity="0"></stop>
</linearGradient>
<linearGradient id="comparisonSentimentChartfadeGradient" x1="0%" x2="100%" y1="100%" y2="100%">
<stop class="start" offset="0%" stop-color="#fff" stop-opacity="1"></stop>
<stop class="middle" offset="2.9585798816568047%" stop-color="#000" stop-opacity="1"></stop>
<stop class="othermiddle" offset="97.0414201183432%" stop-color="#000" stop-opacity="1"></stop>
<stop class="end" offset="100%" stop-color="#fff" stop-opacity="1"></stop>
</linearGradient>
<mask id="comparisonSentimentChartmask">
<rect x="0" y="0" width="556" height="450" style="fill: url("#comparisonSentimentChartfadeGradient"); opacity: 1;"></rect>
</mask>
<filter id="comparisonSentimentChartinnerShadow" x0="-50%" y0="-50%" width="200%" height="200%">
<feGaussianBlur in="SourceAlpha" stdDeviation="5" result="blur"></feGaussianBlur>
<feOffset dy="10" dx="3"></feOffset>
<feComposite in2="SourceAlpha" operator="arithmetic" k2="-1" k3="1" result="shadowDiff"></feComposite>
<feFlood flood-color="#75a0bb" flood-opacity="0.3"></feFlood>
<feComposite in2="shadowDiff" operator="in"></feComposite>
<feComposite in2="SourceGraphic" operator="over" result="firstfilter"></feComposite>
<feGaussianBlur in="firstfilter" stdDeviation="3" result="blur2"></feGaussianBlur>
<feOffset dy="-10" dx="-3"></feOffset>
<feComposite in2="firstfilter" operator="arithmetic" k2="-1" k3="1" result="shadowDiff"></feComposite>
<feFlood flood-color="#75a0bb" flood-opacity="0.3"></feFlood>
<feComposite in2="shadowDiff" operator="in"></feComposite>
<feComposite in2="firstfilter" operator="over"></feComposite>
</filter>
</defs>
</svg></div>
</div>
</div>
</div>
</div>
<div class="section-heading">
<h2 class="text-capitalize">Top Headlines</h2><a href="/headlines/" class="upper-link">View All <span class="sr-only">Headlines</span></a>
</div>
<ul class="article-list m-0 p-0" style="font-size:0.9rem;">
<li class="entry-card hover-card border-0 news-sidebar d-flex flex-wrap align-items-center p-0 position-relative">
<div class="image-link"><img src="https://www.marketbeat.com/logos/articles/thumb_20241220085635_2-underrated-quantum-computing-companies-starting.jpg"
alt="Quantum computing concept. The inscription on 3d Electronic Circuit Board Chip." decoding="async" loading="lazy" height="580" width="1200"></div>
<div class="description p-2">
<div class="title c-dark-gray font-weight-bold font-small">2 Underrated Quantum Computing Companies Starting to Rally</div>
<div class="d-block font-smaller text-uppercase mt-1 post-time">By Nathan Reiff <span class="d-inline-block mx-1">|</span> December 20, 2024</div>
</div><a class="stretched-link" href="https://www.marketbeat.com/stock-ideas/2-underrated-quantum-computing-companies-starting-to-rally/"><span class="sr-only">View 2 Underrated Quantum Computing Companies Starting to Rally</span></a>
</li>
<li class="entry-card hover-card border-0 news-sidebar d-flex flex-wrap align-items-center p-0 position-relative">
<div class="image-link"><img src="https://www.marketbeat.com/logos/articles/thumb_20241203104554_beyond-nvidia-top-5-semiconductor-stocks-to-watch.jpg" alt="Random access memory and processors on motherboard - stock image"
decoding="async" loading="lazy" height="947" width="1200"></div>
<div class="description p-2">
<div class="title c-dark-gray font-weight-bold font-small">Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025</div>
<div class="d-block font-smaller text-uppercase mt-1 post-time">By Thomas Hughes <span class="d-inline-block mx-1">|</span> December 3, 2024</div>
</div><a class="stretched-link" href="https://www.marketbeat.com/stock-ideas/beyond-nvidia-top-5-semiconductor-stocks-to-watch-for-2025/"><span class="sr-only">View Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025</span></a>
</li>
<li class="entry-card hover-card border-0 news-sidebar d-flex flex-wrap align-items-center p-0 position-relative">
<div class="image-link"><img src="https://www.marketbeat.com/logos/articles/thumb_20241126115017_3-small-cap-stocks-that-are-ready-to-rocket-higher.jpg"
alt="New York, USA - 26 September 2020: Fiverr Freelance Services mobile app logo on phone screen close up, Illustrative Editorial. — Stock Editorial Photography" decoding="async" loading="lazy" height="800" width="1200"></div>
<div class="description p-2">
<div class="title c-dark-gray font-weight-bold font-small">3 Small-Cap Stocks That Are Ready to Rocket Higher</div>
<div class="d-block font-smaller text-uppercase mt-1 post-time">By Chris Markoch <span class="d-inline-block mx-1">|</span> November 27, 2024</div>
</div><a class="stretched-link" href="https://www.marketbeat.com/stock-ideas/3-small-cap-stocks-that-are-ready-to-rocket-higher/"><span class="sr-only">View 3 Small-Cap Stocks That Are Ready to Rocket Higher</span></a>
</li>
<li class="entry-card hover-card border-0 news-sidebar d-flex flex-wrap align-items-center p-0 position-relative">
<div class="image-link"><img src="https://www.marketbeat.com/logos/articles/thumb_20241125130354_2-generic-drug-stocks-ready-to-surge-in-2025.jpg" alt="Medicine background - stock image" decoding="async" loading="lazy" height="900"
width="1200"></div>
<div class="description p-2">
<div class="title c-dark-gray font-weight-bold font-small">2 Generic Drug Stocks Ready to Surge in 2025</div>
<div class="d-block font-smaller text-uppercase mt-1 post-time">By Jea Yu <span class="d-inline-block mx-1">|</span> November 27, 2024</div>
</div><a class="stretched-link" href="https://www.marketbeat.com/stock-ideas/2-generic-drug-stocks-ready-to-surge-in-2025/"><span class="sr-only">View 2 Generic Drug Stocks Ready to Surge in 2025</span></a>
</li>
<li class="entry-card hover-card border-0 news-sidebar d-flex flex-wrap align-items-center p-0 position-relative">
<div class="image-link"><img src="https://www.marketbeat.com/logos/articles/thumb_20241204091413_maritide-is-amgens-fall-after-weight-loss-results.jpg"
alt="Vials of liquid on a white table and the logo Amgen, large pharmaceutical company. March 15, 2021. Barnaul, Russia." decoding="async" loading="lazy" height="800" width="1200"></div>
<div class="description p-2">
<div class="title c-dark-gray font-weight-bold font-small">Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair?</div>
<div class="d-block font-smaller text-uppercase mt-1 post-time">By Leo Miller <span class="d-inline-block mx-1">|</span> December 6, 2024</div>
</div>
<a class="stretched-link" href="https://www.marketbeat.com/originals/amgen-stock-falls-on-weight-loss-drug-data-overreaction-or-fair/"><span class="sr-only">View Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair?</span></a>
</li>
</ul>
</div>
</div>
<h2 class="h3 mt-4">Company Descriptions</h2>
<div class="entry-card d-block d-md-flex flex-wrap align-items-center">
<div class="order-md-2 mb-3 text-center text-md-right" style="-webkit-box-flex: 0 0 250px;-ms-flex: 0 0 250px;flex: 0 0 250px;text-align:center;"><img loading="lazy" height="171" width="600" style="max-width:250px"
src="https://www.marketbeat.com/logos/alnylam-pharma-logo.png" title="Alnylam Pharmaceuticals" alt="Alnylam Pharmaceuticals logo"></div>
<div style="-webkit-box-flex: 1 0 250px;-ms-flex: 1 0 250px;flex: 1 0 250px;" class="order-md-1">
<h3 class="mt-1 h2">Alnylam Pharmaceuticals</h3><a title="Alnylam Pharmaceuticals company profile" class="h3" href="/stocks/NASDAQ/ALNY/">NASDAQ:ALNY</a>
<div class="w-100 mt-2 order-md-3">Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include
ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults
with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran
to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid
angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR
amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by
addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna
Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.</div>
</div>
</div>
<div class="entry-card d-block d-md-flex flex-wrap align-items-center">
<div class="order-md-2 mb-3 text-center text-md-right" style="-webkit-box-flex: 0 0 250px;-ms-flex: 0 0 250px;flex: 0 0 250px;text-align:center;"><img loading="lazy" height="337" width="600" style="max-width:250px"
src="https://www.marketbeat.com/logos/amgen-inc-logo.jpg?v=20231228113741" title="Amgen" alt="Amgen logo"></div>
<div style="-webkit-box-flex: 1 0 250px;-ms-flex: 1 0 250px;flex: 1 0 250px;" class="order-md-1">
<h3 class="mt-1 h2">Amgen</h3><a title="Amgen company profile" class="h3" href="/stocks/NASDAQ/AMGN/">NASDAQ:AMGN</a>
<div class="w-100 mt-2 order-md-3">Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic
arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events
prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory
multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic
colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including
Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis
centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and
commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd.
for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.</div>
</div>
</div>
<div class="entry-card d-block d-md-flex flex-wrap align-items-center">
<div class="order-md-2 mb-3 text-center text-md-right" style="-webkit-box-flex: 0 0 250px;-ms-flex: 0 0 250px;flex: 0 0 250px;text-align:center;"><img loading="lazy" height="166" width="500" style="max-width:250px"
src="https://www.marketbeat.com/logos/argenx-se---american-depositary-shares-logo.jpg" title="argenx" alt="argenx logo"></div>
<div style="-webkit-box-flex: 1 0 250px;-ms-flex: 1 0 250px;flex: 1 0 250px;" class="order-md-1">
<h3 class="mt-1 h2">argenx</h3><a title="argenx company profile" class="h3" href="/stocks/NASDAQ/ARGX/">NASDAQ:ARGX</a>
<div class="w-100 mt-2 order-md-3">argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead
product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease,
bullous pemphigoid, myositis, primary sjögren's syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC;
Empasiprubart for multifocal motor neuropath, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis. The company is developing ARGX-213 targets FcRn; ARGX-121 and
ARGX-220 targets immune system; ARGX-109 targets IL-6; ARGX-118 for inflammation; and ARGX-109, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It owns VYVGART; VYVGART HYTRULO; VYVDURA; ARGENX; ABDEG; NHANCE; SIMPLE ANTIBODY;
and ARGENXMEDHUB. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU
Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., and Shire International GmbH. It has collaboration agreement with Genmab A/S to discover, develop,
and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is
based in Amsterdam, the Netherlands.</div>
</div>
</div>
<div class="entry-card d-block d-md-flex flex-wrap align-items-center">
<div class="order-md-2 mb-3 text-center text-md-right" style="-webkit-box-flex: 0 0 250px;-ms-flex: 0 0 250px;flex: 0 0 250px;text-align:center;"><img loading="lazy" height="335" width="600" style="max-width:250px"
src="https://www.marketbeat.com/logos/astrazeneca-plc-logo.png?v=20231213131257" title="AstraZeneca" alt="AstraZeneca logo"></div>
<div style="-webkit-box-flex: 1 0 250px;-ms-flex: 1 0 250px;flex: 1 0 250px;" class="order-md-1">
<h3 class="mt-1 h2">AstraZeneca</h3><a title="AstraZeneca company profile" class="h3" href="/stocks/NASDAQ/AZN/">NASDAQ:AZN</a>
<div class="w-100 mt-2 order-md-3">AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi,
Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for
cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care
and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and
commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name
to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.</div>
</div>
</div>
<div class="entry-card d-block d-md-flex flex-wrap align-items-center">
<div class="order-md-2 mb-3 text-center text-md-right" style="-webkit-box-flex: 0 0 250px;-ms-flex: 0 0 250px;flex: 0 0 250px;text-align:center;"><img loading="lazy" height="93" width="500" style="max-width:250px"
src="https://www.marketbeat.com/logos/beigene-ltd-logo.png?v=20221103144100" title="BeiGene" alt="BeiGene logo"></div>
<div style="-webkit-box-flex: 1 0 250px;-ms-flex: 1 0 250px;flex: 1 0 250px;" class="order-md-1">
<h3 class="mt-1 h2">BeiGene</h3><a title="BeiGene company profile" class="h3" href="/stocks/NASDAQ/BGNE/">NASDAQ:BGNE</a>
<div class="w-100 mt-2 order-md-3">BeiGene, Ltd., through its subsidiaries, engages in the development and commercialization of oncology medicines worldwide. Its products include BRUKINSA to treat various blood cancers; TEVIMBRA to treat
various solid tumor and blood cancers; PARTRUVIX for the treatment of various solid tumor malignancies; XGEVA to treat bone metastases from solid tumors and multiple myeloma, as well as giant cell tumor of bone; BLINCYTO to treat acute
lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; SYLVANT to treat idiopathic
multicentric castleman disease; QARZIBA to treat neuroblastoma; POBEVCY to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC); BAITUOWEI, to treat breast and prostate cancers; TAFINLAR and MEKINIST to
treat NSCLC and melanoma; VOTRIENT for advance renal cell carcinoma; AFINITOR for advance renal cell carcinoma, NET, SEGA, & breast cancers; and ZYKADIA to treat ALK + NSCLC. The company is also developing inhibitors comprising
Sonrotoclax (BGB-11417), BGB-10188, BGB-21447, Ociperlimab (BGB-A1217), Surzebiclimab (BGB-A425), BGB-15025, BGB-26808, Lifirafenib (BGB-283), BGB-3245, BGB-30813, and BGB-43395; antibodies, including Zanidatamab, BGB-A445, and BGB-A3055,
as well as BGB-16673, a BTK-targeted CDAC, and BGB-24714, a SMAC mimetic. It has collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, Bristol Myers Squibb company, Shandong Luye Pharmaceutical Co., Ltd., Nanjing Leads
Biolabs, Inc., EUSA Pharma, Assembly Biosciences, Inc., Bio-Thera Solutions, Ltd., and Nanjing Leads Biolabs Co., Ltd. The company was incorporated in 2010 and is based in Grand Cayman, the Cayman Islands.</div>
</div>
</div>
<div class="entry-card d-block d-md-flex flex-wrap align-items-center">
<div class="order-md-2 mb-3 text-center text-md-right" style="-webkit-box-flex: 0 0 250px;-ms-flex: 0 0 250px;flex: 0 0 250px;text-align:center;"><img loading="lazy" height="167" width="500" style="max-width:250px"
src="https://www.marketbeat.com/logos/biogen-inc-logo.jpg?v=20221024141534" title="Biogen" alt="Biogen logo"></div>
<div style="-webkit-box-flex: 1 0 250px;-ms-flex: 1 0 250px;flex: 1 0 250px;" class="order-md-1">
<h3 class="mt-1 h2">Biogen</h3><a title="Biogen company profile" class="h3" href="/stocks/NASDAQ/BIIB/">NASDAQ:BIIB</a>
<div class="w-100 mt-2 order-md-3">Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company
provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer's disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept
biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It offers RITUXAN for treating
non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular
lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing
various products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, genetic neurodevelopmental disorders, and biosimilars, which are under
various stages of development. It has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis
Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc., as well as collaboration with Fujirebio to potentially identify and develop blood-based biomarkers for tau pathology in the brain.
The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.</div>
</div>
</div>
<div class="entry-card d-block d-md-flex flex-wrap align-items-center">
<div class="order-md-2 mb-3 text-center text-md-right" style="-webkit-box-flex: 0 0 250px;-ms-flex: 0 0 250px;flex: 0 0 250px;text-align:center;"><img loading="lazy" height="435" width="580" style="max-width:250px"
src="https://www.marketbeat.com/logos/biomarin-pharm-logo.png" title="BioMarin Pharmaceutical" alt="BioMarin Pharmaceutical logo"></div>
<div style="-webkit-box-flex: 1 0 250px;-ms-flex: 1 0 250px;flex: 1 0 250px;" class="order-md-1">
<h3 class="mt-1 h2">BioMarin Pharmaceutical</h3><a title="BioMarin Pharmaceutical company profile" class="h3" href="/stocks/NASDAQ/BMRN/">NASDAQ:BMRN</a>
<div class="w-100 mt-2 order-md-3">BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme
replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic
oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is
delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once
daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it
develops Roctavian, an adeno associated virus vector, for the treatment of patients with severe hemophilia A. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical
wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc. The
company was incorporated in 1996 and is headquartered in San Rafael, California.</div>
</div>
</div>
<div class="entry-card d-block d-md-flex flex-wrap align-items-center">
<div class="order-md-2 mb-3 text-center text-md-right" style="-webkit-box-flex: 0 0 250px;-ms-flex: 0 0 250px;flex: 0 0 250px;text-align:center;"><img loading="lazy" height="337" width="600" style="max-width:250px"
src="https://www.marketbeat.com/logos/biontech-se-logo.png?v=20231226132334" title="BioNTech" alt="BioNTech logo"></div>
<div style="-webkit-box-flex: 1 0 250px;-ms-flex: 1 0 250px;flex: 1 0 250px;" class="order-md-1">
<h3 class="mt-1 h2">BioNTech</h3><a title="BioNTech company profile" class="h3" href="/stocks/NASDAQ/BNTX/">NASDAQ:BNTX</a>
<div class="w-100 mt-2 order-md-3">BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is
in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT114 to treat triple negative breast
cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It develops BNT122, which is in Phase II clinical trial for first-line melanoma and in
Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors; BNT151, BNT152, and BNT153 to
treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I/II clinical trial to treat
multiple solid tumors; and BNT312, which is in Phase 2 clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase III clinical trial to treat ovarian cancer and Phase I/II clinical trial to treat multiple solid
tumors. It develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I/Ib
clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. It has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun
Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A. BioNTech SE was incorporated in 2008 and is based in Mainz, Germany.</div>
</div>
</div>
<div class="entry-card d-block d-md-flex flex-wrap align-items-center">
<div class="order-md-2 mb-3 text-center text-md-right" style="-webkit-box-flex: 0 0 250px;-ms-flex: 0 0 250px;flex: 0 0 250px;text-align:center;"><img loading="lazy" height="185" width="500" style="max-width:250px"
src="https://www.marketbeat.com/logos/Gilead_Sciences_Pty_Ltd.jpg" title="Gilead Sciences" alt="Gilead Sciences logo"></div>
<div style="-webkit-box-flex: 1 0 250px;-ms-flex: 1 0 250px;flex: 1 0 250px;" class="order-md-1">
<h3 class="mt-1 h2">Gilead Sciences</h3><a title="Gilead Sciences company profile" class="h3" href="/stocks/NASDAQ/GILD/">NASDAQ:GILD</a>
<div class="w-100 mt-2 order-md-3">Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company
provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa,
Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension;
and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona
Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly
Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and
is headquartered in Foster City, California.</div>
</div>
</div>
<div class="entry-card d-block d-md-flex flex-wrap align-items-center">
<div class="order-md-2 mb-3 text-center text-md-right" style="-webkit-box-flex: 0 0 250px;-ms-flex: 0 0 250px;flex: 0 0 250px;text-align:center;"><img loading="lazy" height="445" width="600" style="max-width:250px"
src="https://www.marketbeat.com/logos/genmab-a-s-logo.png?v=20231227090205" title="Genmab A/S" alt="Genmab A/S logo"></div>
<div style="-webkit-box-flex: 1 0 250px;-ms-flex: 1 0 250px;flex: 1 0 250px;" class="order-md-1">
<h3 class="mt-1 h2">Genmab A/S</h3><a title="Genmab A/S company profile" class="h3" href="/stocks/NASDAQ/GMAB/">NASDAQ:GMAB</a>
<div class="w-100 mt-2 order-md-3">Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with
multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL
amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and
chronic lymphocytic leukemia; and HexaBody-CD38 and GEN3017 for treating hematological malignancies. In addition, the company develops Inclacumab, which is in Phase 3 trial for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin
lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. It operates various active
pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with argenx to discover, develop, and commercialize novel
therapeutic antibodies with applications in immunology and oncology; and AbbVie for the development of epcoritamab, as well as collaborations with BioNTech, Janssen, and Novo Nordisk A/S. Genmab A/S was founded in 1999 and is
headquartered in Copenhagen, Denmark.</div>
</div>
</div>
</div>
<div class="col-12 order-2">
<div class="row align-content-center justify-content-center display-block mx-0 mt-4">
<div class="col-12 px-0">
<div class="bg-light-gray p-4 p-sm-3 h-100 text-center text-sm-left">
<div class="h2 mt-2">Are you interested in trading pharmaceutical stocks?</div>
<p>Are pharmaceuticals a good potential add-in to your portfolio? Let’s look at how to invest in pharmaceutical companies, step by step. </p>
<a class="sbbutton c-white" style="text-decoration:none" href="https://www.marketbeat.com/learn/how-to-invest-in-pharmaceutical-companies/">Learn more about pharmaceutical stocks</a>
</div>
</div>
</div>
</div>
</div>
<script defer="" src="https://www.marketbeat.com/Scripts/libraries/d3.min.js" charset="utf-8"></script>
<script>
var ScrpRestrict = "108CD7A06C0C0C7D48350545455248D790C75155F3176FAAE29282E653E49A2C317A86DCB18A0FCDAE70B1B23A4BDE84F2EC096BB8A8EBA8D368680724027A57"
</script>
<script defer="" src="/Scripts/charts/dv-charts-min.js?v=20241118" charset="utf-8" type="text/javascript"></script>
<!-- Default Statcounter code for Marketbeat.com - Tools and Reports https://www.marketbeat.com/ -->
<script type="text/javascript">
var sc_project = 11738637;
var sc_invisible = 1;
var sc_security = "2f65063a";
var sc_https = 1;
</script>
<script type="text/javascript" src="https://www.statcounter.com/counter/counter.js"></script>
<noscript>
<div class="statcounter"><a title="Web Analytics" href="https://statcounter.com/" target="_blank">
<img class="statcounter" src="//c.statcounter.com/11738637/0/2f65063a/1/" alt="Web Analytics"></a></div>
</noscript>
<!-- End of Statcounter Code -->
<div id="pnlAllAccessTrial" class="inverse-on-homepage py-3 mb-4">
<div class="container p-0 ">
<div class="bg-dark-blue-accent p-3 rounded pb-5 pb-xl-4">
<div class="row mx-0">
<div class="col-md-7 col-xl-4 my-3 mx-auto c-white mb-5">
<div class="h2 blue-accent-under">Get 30 Days of <span class="d-block" style="font-weight: 800">MarketBeat All Access</span> for Free</div>
<p>Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools.</p>
<a href="/subscribe/all-access/?referraltype=masterfooter" class="btn btn-featured c-white mt-3 mt-md-0 px-5">Start Your 30-Day Trial</a>
</div>
<div class="col-xl-8">
<h2 class="sr-only">MarketBeat All Access Features</h2>
<div class="row narrow-gutter-row">
<div class="col-md-4 my-2">
<a href="/subscribe/all-access/?referraltype=masterfooter" class="card hover-card-blue p-4 h-100">
<div class="feature-icon">
<span class="fa-kit fa-best" style="line-height: 60px;"></span>
</div>
<h3>Best-in-Class Portfolio Monitoring</h3>
<ul>
<li>Get personalized stock ideas.</li>
<li>Compare portfolio to indices.</li>
<li>Check stock news, ratings, SEC filings, and more.</li>
</ul>
</a>
</div>
<div class="col-md-4 my-2">
<a class="card hover-card-blue p-4 h-100" href="/subscribe/all-access/?referraltype=masterfooter">
<div class="feature-icon">
<span class="fa-kit fa-stock-ideas"></span>
</div>
<h3>Stock Ideas and Recommendations</h3>
<ul>
<li>See daily stock ideas from top analysts.</li>
<li>Receive short-term trading ideas from MarketBeat.</li>
<li>Identify trending stocks on social media.</li>
</ul>
</a>
</div>
<div class="col-md-4 my-2">
<a class="card hover-card-blue p-4 h-100" href="/subscribe/all-access/?referraltype=masterfooter">
<div class="feature-icon">
<span class="fa-kit fa-research-tools"></span>
</div>
<h3>Advanced Stock Screeners and Research Tools</h3>
<ul>
<li>Use our seven stock screeners to find suitable stocks.</li>
<li>Stay informed with MarketBeat's real-time news.</li>
<li>Export data to Excel for personal analysis.</li>
</ul>
</a>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div id="HelpersArea" style="opacity: 1; transition: opacity 0.5s; position: relative; z-index: 1001;">
<div id="showHelpers" class="multi-collapse-outer collapse gradient-blue-medium c-white shadow navbar-collapse b-white border font-8 rounded-top" role="button" data-toggle="collapse" data-target=".multi-collapse-outer"
aria-controls="showHelpers pnlHelpers" style="position: fixed; right: 25px; bottom: -1px; z-index: 401; cursor: pointer; padding: 9px 10px;">Get Started</div>
<div id="pnlHelpers" class="multi-collapse-outer shadow collapse show" style="position: fixed; right: 10px; bottom: 10px; width: 310px; background-color: var(--white); z-index: 400;">
<div id="pnlOnboarding">
<div id="divOnboarding">
<div class="gradient-blue-medium c-white px-2 pt-2 pb-1 position-relative rounded-top" id="hdGetStarted">
<span style="cursor: pointer;" role="button" data-toggle="collapse" data-target=".multi-collapse" aria-expanded="true" aria-controls="dvGetStarted">Get Started with MarketBeat <span class="fa-regular fa-angle-right font-12 panel-toggle"
style="transform: rotate(90deg) translateX(-2px); display: none;"></span></span>
<span style="cursor: pointer; padding: 2px 0px;" role="button" id="altCloseHelpers" class="float-right fa-regular fa-xmark font-8" data-toggle="collapse" data-target="#pnlHelpers" aria-expanded="true" aria-controls="pnlHelpers"
title="Hide This"></span>
<span style="cursor: pointer; padding: 6px 4px; font-size: 0.7em; font-weight: 600;" role="button" id="altMinimizeHelpers" class="float-right" data-toggle="collapse" data-target=".multi-collapse-outer" aria-expanded="true"
aria-controls="showHelpers pnlHelpers" title="Minimize This">—</span>
</div>
<div id="dvGetStarted" class="collapse show bg-white shadow">
<div class="p-2">
<table class="w-100">
<tbody>
<tr>
<td style="vertical-align:top;width:30px;padding:.2em .2em .4em .2em;"><span class="c-green fa-regular fa-square-check" aria-hidden="true"></span></td>
<td style="vertical-align:top;padding:.25em;"><a style="font-size:.9rem;" href="/manage/arn-daily-premium/?utm_source=WebsiteInternal&utm_medium=onboarding&utm_campaign=FreeSubscriber">Read Your Daily Newsletter</a></td>
</tr>
<tr>
<td style="vertical-align:top;width:30px;padding:.2em .2em .4em .2em;"><span class="c-green fa-regular fa-square-check" aria-hidden="true"></span></td>
<td style="vertical-align:top;padding:.25em;"><a style="font-size:.9rem;" href="/manage/watchlists/?utm_source=WebsiteInternal&utm_medium=onboarding&utm_campaign=FreeSubscriber">Check Out My MarketBeat</a></td>
</tr>
<tr>
<td style="vertical-align:top;width:30px;padding:.2em .2em .4em .2em;"><span class="c-green fa-regular fa-square-check" aria-hidden="true"></span></td>
<td style="vertical-align:top;padding:.25em;"><a style="font-size:.9rem;" href="/help/?utm_source=WebsiteInternal&utm_medium=onboarding&utm_campaign=FreeSubscriber">Watch Our Tutorial Videos</a></td>
</tr>
<tr>
<td style="vertical-align:top;width:30px;padding:.2em .2em .4em .2em;"><span class="c-red fa-regular fa-square" aria-hidden="true"></span></td>
<td style="vertical-align:top;padding:.25em;"><a style="font-size:.9rem;" href="/manage/watchlists/?utm_source=WebsiteInternal&utm_medium=onboarding&utm_campaign=FreeSubscriber">Add a Stock to Your Watchlist</a></td>
</tr>
<tr>
<td style="vertical-align:top;width:30px;padding:.2em .2em .4em .2em;"><span class="c-red fa-regular fa-square" aria-hidden="true"></span></td>
<td style="vertical-align:top;padding:.25em;"><a style="font-size:.9rem;" href="/manage/watchlists/?utm_source=WebsiteInternal&utm_medium=onboarding&utm_campaign=FreeSubscriber">Set Up an Instant Alert</a></td>
</tr>
<tr>
<td style="vertical-align:top;width:30px;padding:.2em .2em .4em .2em;"><span class="c-green fa-regular fa-square-check" aria-hidden="true"></span></td>
<td style="vertical-align:top;padding:.25em;"><a style="font-size:.9rem;" href="/stocks/?utm_source=WebsiteInternal&utm_medium=onboarding&utm_campaign=FreeSubscriber">View a Company's Profile Page</a></td>
</tr>
<tr>
<td style="vertical-align:top;width:30px;padding:.2em .2em .4em .2em;"><span class="c-green fa-regular fa-square-check" aria-hidden="true"></span></td>
<td style="vertical-align:top;padding:.25em;"><a style="font-size:.9rem;" href="/market-data/?utm_source=WebsiteInternal&utm_medium=onboarding&utm_campaign=FreeSubscriber">View Our Financial Calendars</a></td>
</tr>
<tr>
<td style="vertical-align:top;width:30px;padding:.2em .2em .4em .2em;"><span class="c-green fa-regular fa-square-check" aria-hidden="true"></span></td>
<td style="vertical-align:top;padding:.25em;"><a style="font-size:.9rem;" href="/ratings/USA/latest/?utm_source=WebsiteInternal&utm_medium=onboarding&utm_campaign=FreeSubscriber">View Today's Analyst Ratings</a></td>
</tr>
</tbody>
</table>
<div style="display: none; padding: 0px 10px 8px; text-align: center; background: #F6F8F7;">
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<script>
document.addEventListener("DOMContentLoaded", function() {
$("#HelpersArea").delay(800).queue(function(next) {
$(this).css("opacity", "1");
next();
});
$(".panel-toggle").hide();
$("#altCloseHelpers").show();
$("#altMinimizeHelpers").show();
$('.multi-collapse').removeClass("multi-collapse");
$("#dvGetStarted").addClass("show");
$("#showHelpers").text("Get Started");
if ($(window).width() > 700) {
$("#pnlHelpers").addClass("show");
$("#showHelpers").removeClass("show").text("Get Started");
}
$("#altCloseHelpers").click(function() {
setCookie("HideOnboarding", "Hide", 7);
});
});
</script>
<div id="pnlLoginCreateModal" class="modal fade show">
<div class="modal-dialog modal-dialog-centered" style="max-width: 650px;">
<div class="modal-content">
<div class="modal-body p-0" style="max-height: 95vh;">
<div class="row m-0">
<div class="col-sm-5 p-0 gradient-blue c-white p-3 p-sm-4" style="font-size: 1.05em;">
<div class="d-none d-sm-block">
<div class="font-12 mb-3">Sign in to your <span class="free">free</span> account to enjoy these benefits</div>
<ul class="checkmark-list">
<li>In-depth profiles and analysis for 20,000 public companies.</li>
<li>Real-time analyst ratings, insider transactions, earnings data, and more.</li>
<li>Our daily ratings and market update email newsletter.</li>
</ul>
</div>
<div class="d-sm-none">
<div class="font-12 lh-medium">Sign in to your <span class="free">free</span> account to enjoy all that MarketBeat has to offer.</div>
</div>
</div>
<div class="col-sm-7 p-0 bg-white">
<div class="m-0">
<ul class="nav nav-tabs pl-2" role="tablist" aria-label="Log in or create account">
<li class="nav-item">
<a id="LoginOnModalTab" class="nav-link active" href="#pnlLoginOnModal" role="tab" aria-selected="true" tabindex="0" aria-controls="pnlLoginOnModal" data-toggle="tab" onclick="trapFocusInModal('#pnlLoginCreateModal', 'txtLoginOnModalEmail', 'LoginOnModalTab', 'LastLinkOnLoginTab');" style="pointer-events: auto; cursor: pointer;">Sign In</a>
</li>
<li class="nav-item">
<a id="CreateOnModalTab" class="nav-link" href="#pnlCreate" role="tab" aria-selected="false" tabindex="-1" aria-controls="pnlCreate" data-toggle="tab" onclick="trapFocusInModal('#pnlLoginCreateModal', 'txtCreateOnModalEmail', 'CreateOnModalTab', 'LastLinkOnCreateTab');" style="pointer-events: auto; cursor: pointer;">Create Account</a>
</li>
<li class="nav-item ml-auto">
<a id="CloseModal" class="nav-link special-purpose-nav-link font-15" href="#pnlCreate" role="tab" aria-selected="false" tabindex="-1" data-dismiss="modal" style="padding: 0.7rem; font-size: 1rem; pointer-events: auto; cursor: pointer;" title="Close Login Modal"><i class="fa-regular fa-xmark"></i></a>
</li>
</ul>
<div class="tab-content m-0 p-0" style="box-shadow: none !important;">
<div id="pnlLoginOnModal" class="tab-pane active" role="tabpanel" tabindex="0" aria-labelledby="LoginOnModalTab">
<div class="p-3">
<div id="pnlLoginOnModalInner" onkeypress="javascript:return WebForm_FireDefaultButton(event, 'btnLoginOnModal')">
<label class="bold m-0" for="txtLoginOnModalEmail">Your Email Address:</label>
<input name="ctl00$txtLoginOnModalEmail" type="text" maxlength="300" id="txtLoginOnModalEmail" class="top-labeled-input" autofocus="" style="width:100%;">
<div class="rfv-div-validation-triangle">
<span id="rfvEmail" style="color:#D2333D;display:none;">Email Address Required</span>
</div>
<label class="bold m-0" for="txtLoginOnModalPassword">Your Password:</label>
<input name="ctl00$txtLoginOnModalPassword" type="password" maxlength="300" id="txtLoginOnModalPassword" class="top-labeled-input mb-3" style="width:100%;">
<div class="rfv-div-validation-triangle">
<span id="RequiredFieldValidator1" style="color:#D2333D;display:none;">Password Required</span>
</div>
<a onclick="LoginOnModalSubmit();return false;" id="btnLoginOnModal" class="btn btn-primary allow-loading" usesubmitbehavior="false" href="javascript:WebForm_DoPostBackWithOptions(new WebForm_PostBackOptions("ctl00$btnLoginOnModal", "", true, "Login", "", false, true))" style="display:inline-block;width:100%;">Log In<span class="load loading"></span></a>
<div id="loginOnModalWarning"></div>
</div>
<div style="font-size: 18px; padding-bottom: 13px; text-align: center">
<hr style="margin: 0; position: relative; top: .65em; color: #555;">
<span style="background: var(--white); padding: 0 10px; position: relative; color: #6a6a6a;">or</span>
</div>
<div class="d-flex flex-wrap" style="margin: 0 -2px;">
<a href="#" onclick="helloinit();hello('facebook').login({scope : 'email',force : true}); return false;" class="facebook-login-button zocial facebook">
<img src="/images/facebook-logo-2.png" width="22" height="22" loading="lazy" alt="Facebook icon" style="vertical-align: middle; vertical-align: middle; width: 22px; float: left; margin: 4px;">Sign in with Facebook</a>
<a href="#" onclick="helloinit();hello('google').login({scope : 'email',force : true}); return false;" class="zocial google">
<img src="/images/google-g-logo.png" width="20" height="20" loading="lazy" alt="Google icon" style="vertical-align: middle; width: 20px; float: left; margin: 5px;">Sign in with Google</a>
</div>
<div style="padding-top: 18px; font-size: 14px;"><a id="LastLinkOnLoginTab" href="/forgot-password/">Forgot your password?</a></div>
</div>
</div>
<div id="pnlCreate" class="tab-pane bg-light-gray" role="tabpanel" aria-labelledby="CreateOnModalTab">
<div class="p-3">
<div id="pnlCreateInner" onkeypress="javascript:return WebForm_FireDefaultButton(event, 'btnOnEnterCreateOnModal')">
<label class="bold m-0" for="txtCreateOnModalEmail">Your Email Address:</label>
<input name="ctl00$txtCreateOnModalEmail" type="text" maxlength="300" id="txtCreateOnModalEmail" class="top-labeled-input" style="width:100%;">
<div class="rfv-div-validation-triangle">
<span id="RequiredFieldValidator2" style="color:#D2333D;display:none;">Please enter your email address.</span>
</div>
<div class="rfv-div-validation-triangle">
<span id="rgxEmail" style="color:#D2333D;display:none;">Please enter a valid email address</span>
</div>
<label class="bold m-0" for="txtCreateOnModalPassword" title="Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.">Choose a Password:</label>
<input name="ctl00$txtCreateOnModalPassword" type="password" maxlength="300" id="txtCreateOnModalPassword" class="top-labeled-input mb-3" style="width:100%;">
<div class="rfv-div-validation-triangle">
<span id="RequiredFieldValidator3" style="color:#D2333D;display:none;">Please enter your password.</span>
</div>
<div class="rfv-div-validation-triangle" style="line-height: 1; padding-top: 5px;">
<span id="Regex1" style="color:#D2333D;display:none;">Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.</span>
</div>
<button type="button" id="createOnModalVisibleButton" class="btn btn-primary w-100 g-recaptcha allow-loading" data-sitekey="6Lddn5keAAAAAPlD91bDkOh-lnZZxsz5b4ddp3Mw" data-callback="CreateOnModalSubmit"
data-action="submit">Create My Account (Free)<span class="load loading"></span></button>
<div id="createOnModalWarning" class="mb-2" style="display: none;"></div>
<div class="d-none">
<input type="submit" name="ctl00$btnOnEnterCreateOnModal" value="Submit the Form"
onclick="$('#createOnModalVisibleButton').click();WebForm_DoPostBackWithOptions(new WebForm_PostBackOptions("ctl00$btnOnEnterCreateOnModal", "", true, "Signup", "", false, false))"
id="btnOnEnterCreateOnModal" style="width:100%;">
<input type="submit" name="ctl00$btnCreateOnModal" value="Create My Account (Free)"
onclick="javascript:WebForm_DoPostBackWithOptions(new WebForm_PostBackOptions("ctl00$btnCreateOnModal", "", true, "Signup", "", false, false))" id="btnCreateOnModal"
style="width:100%;">
</div>
</div>
<div style="padding-top: 15px; font-size: 18px; padding-bottom: 13px; text-align: center">
<hr style="margin: 0; position: relative; top: .65em; color: #555;">
<span style="padding: 0 10px; position: relative; color: #6a6a6a;" class="bg-light-gray">or</span>
</div>
<div class="d-flex flex-wrap" style="margin: 0 -2px;">
<a href="#" onclick="helloinit();hello('facebook').login({scope : 'email',force : true}); return false;" class="facebook-login-button zocial facebook">
<img src="/images/facebook-logo-2.png" width="22" height="22" loading="lazy" alt="Facebook icon" style="vertical-align: middle; vertical-align: middle; width: 22px; float: left; margin: 4px;">Sign in with Facebook</a>
<a href="#" onclick="helloinit();hello('google').login({scope : 'email',force : true}); return false;" class="zocial google">
<img src="/images/google-g-logo.png" width="20" height="20" loading="lazy" alt="Google icon" style="vertical-align: middle; vertical-align: middle; width: 20px; float: left; margin: 5px;">Sign in with Google</a>
</div>
<div style="padding-top: 18px; font-size: 13px;">By creating a free account, you agree to our <a href="/terms/" target="_blank">terms of service.</a> This site is protected by reCAPTCHA and the Google
<a rel="nofollow" href="https://policies.google.com/privacy">Privacy Policy</a> and <a rel="nofollow" id="LastLinkOnCreateTab" href="https://policies.google.com/terms">Terms of Service</a> apply.</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<script type="text/javascript">
//<![CDATA[
var Page_Validators = new Array(document.getElementById("rfvEmail"), document.getElementById("RequiredFieldValidator1"), document.getElementById("RequiredFieldValidator2"), document.getElementById("rgxEmail"), document.getElementById(
"RequiredFieldValidator3"), document.getElementById("Regex1"));
//]]>
</script>
<script type="text/javascript">
//<![CDATA[
var rfvEmail = document.all ? document.all["rfvEmail"] : document.getElementById("rfvEmail");
rfvEmail.controltovalidate = "txtLoginOnModalEmail";
rfvEmail.errormessage = "Email Address Required";
rfvEmail.display = "Dynamic";
rfvEmail.validationGroup = "Login";
rfvEmail.evaluationfunction = "RequiredFieldValidatorEvaluateIsValid";
rfvEmail.initialvalue = "";
var RequiredFieldValidator1 = document.all ? document.all["RequiredFieldValidator1"] : document.getElementById("RequiredFieldValidator1");
RequiredFieldValidator1.controltovalidate = "txtLoginOnModalPassword";
RequiredFieldValidator1.errormessage = "Password Required";
RequiredFieldValidator1.display = "Dynamic";
RequiredFieldValidator1.validationGroup = "Login";
RequiredFieldValidator1.evaluationfunction = "RequiredFieldValidatorEvaluateIsValid";
RequiredFieldValidator1.initialvalue = "";
var RequiredFieldValidator2 = document.all ? document.all["RequiredFieldValidator2"] : document.getElementById("RequiredFieldValidator2");
RequiredFieldValidator2.controltovalidate = "txtCreateOnModalEmail";
RequiredFieldValidator2.errormessage = "Please enter your email address.";
RequiredFieldValidator2.display = "Dynamic";
RequiredFieldValidator2.validationGroup = "Signup";
RequiredFieldValidator2.evaluationfunction = "RequiredFieldValidatorEvaluateIsValid";
RequiredFieldValidator2.initialvalue = "";
var rgxEmail = document.all ? document.all["rgxEmail"] : document.getElementById("rgxEmail");
rgxEmail.controltovalidate = "txtCreateOnModalEmail";
rgxEmail.errormessage = "Please enter a valid email address";
rgxEmail.display = "Dynamic";
rgxEmail.validationGroup = "Signup";
rgxEmail.evaluationfunction = "RegularExpressionValidatorEvaluateIsValid";
rgxEmail.validationexpression = "\\w+([-+.\']\\w+)*@\\w+([-.]\\w+)*\\.\\w+([-.]\\w+)*";
var RequiredFieldValidator3 = document.all ? document.all["RequiredFieldValidator3"] : document.getElementById("RequiredFieldValidator3");
RequiredFieldValidator3.controltovalidate = "txtCreateOnModalPassword";
RequiredFieldValidator3.errormessage = "Please enter your password.";
RequiredFieldValidator3.display = "Dynamic";
RequiredFieldValidator3.validationGroup = "Signup";
RequiredFieldValidator3.evaluationfunction = "RequiredFieldValidatorEvaluateIsValid";
RequiredFieldValidator3.initialvalue = "";
var Regex1 = document.all ? document.all["Regex1"] : document.getElementById("Regex1");
Regex1.controltovalidate = "txtCreateOnModalPassword";
Regex1.errormessage = "Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.";
Regex1.display = "Dynamic";
Regex1.validationGroup = "Signup";
Regex1.evaluationfunction = "RegularExpressionValidatorEvaluateIsValid";
Regex1.validationexpression = "^(?=.*[A-Za-z])(?=.*\\d)(?=.*[$@$!%*#?&])[A-Za-z\\d$@$!%*#?&-]{8,}$";
//]]>
</script>
<script type="text/javascript">
//<![CDATA[
var Page_ValidationActive = false;
if (typeof(ValidatorOnLoad) == "function") {
ValidatorOnLoad();
}
function ValidatorOnSubmit() {
if (Page_ValidationActive) {
return ValidatorCommonOnSubmit();
} else {
return true;
}
}
//]]>
</script>
</form>
Text Content
Skip to main content Gift Opening $200 Off MarketBeat All Access Thanks for being one of our best subscribers! You are eligible for a limited-time discount. * 1days * 23Hours * 59Minutes * 53Seconds Claim Your Discount × QQQ 522.87 (+0.81%) Dow Jones: A Relevant Benchmark or a Relic of the Past? The Crypto Secret Wall Street Doesn’t Want You to Know (Ad) 3 Big-Name Stocks Just Announced Big-Time Dividend Increases Government regulators close investigation into Ford Focus recalls URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Time to Board Carnival Cruise Lines' Stock Price Rally Breaking Down Where Wall Street Sees the S&P 500 Going in 2025 The #1 Crypto for AI (Ad) Market Overreaction: 2 Stocks to Buy on the Way Down Industrial Chemicals: 3 Stocks Poised for Growth in the New Year QQQ 522.87 (+0.81%) Dow Jones: A Relevant Benchmark or a Relic of the Past? The Crypto Secret Wall Street Doesn’t Want You to Know (Ad) 3 Big-Name Stocks Just Announced Big-Time Dividend Increases Government regulators close investigation into Ford Focus recalls URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Time to Board Carnival Cruise Lines' Stock Price Rally Breaking Down Where Wall Street Sees the S&P 500 Going in 2025 The #1 Crypto for AI (Ad) Market Overreaction: 2 Stocks to Buy on the Way Down Industrial Chemicals: 3 Stocks Poised for Growth in the New Year * Research Tools * All Access Research Tools * Live News Feed * Momentum Alerts * Idea Engine * Export Data (CSV) * See All Research Tools * My MarketBeat * My Portfolio * My Newsletter * My Account * Calculators * Dividend Calculator * Dividend Yield Calculator * Market Cap Calculator * Options Profit Calculator * Stock Average Calculator * Stock Split Calculator * Stock Profit Calculator * Stock Screeners * Stock Screener * ETF Screener * Trending Stocks * Trending MarketBeat Stocks * Trending Media Mentions * High Media Sentiment Stocks * Trending WallStreetBets Stocks * Premium Reports * All Reports * 7 Election Stocks to Own * 7 Magnificent Stocks in 2024 * 10 Best AI Stocks * Best Stocks for 2025 Report * Guide To High Short Interest Stocks * Elon Musk's Next Move * Next 7 Blockbuster Stocks * Stock Picks from Top Analysts * Financial Calendars * Calendars and Market Data * Market Data * All Market Data and Financial Calendars * Analyst Ratings * Recent Analyst Ratings * Stock Ratings Screener * Top-Rated Stocks * Lowest-Rated Stocks * Top-Rated Analysts * Top-Rated Brokerages * Most-Upgraded Stocks * Free Ratings Newsletter * Congressional Data * Recent Trades * Most Bought Stocks * Members of Congress * Corporate Events * Corporate Buybacks * Economic Reports * Initial Public Offerings (IPOs) * IPO Lockup Expirations * SEC Filings * Stock Splits * Dividends * Today's Announcements * Ex-Dividend Calendar * Dividend Increases * Dividend Achievers * Dividend Aristocrats * Best Dividend Stocks * High-Yield Dividend Stocks * Top-Rated Dividend Stocks * Dividend Screener * Free Dividend Newsletter * Earnings * Today's Announcements * Tomorrow's Announcements * Next Week's Announcements * Upcoming Earnings Calls * Earnings Call Transcripts * Earnings Screener * Insider Trades * Today's Insider Trades * Top Insider Buying Stocks * Top Insider Selling Stocks * Insider Trades Screener * Insider Trades Newsletter * Stock Market Holidays * Cryptocurrencies * All Cryptocurrencies * Cryptocurrency Headlines * Cryptocurrency Newsletter * Gainers & Decliners * Percentage Gainers * Percentage Decliners * Breakout Stocks * High & Low PE * High PE Stocks * Low PE Stocks * Highs & Lows * 52-Week Highs * 52-Week Lows * Most Active * Most Active Stocks * Most Volatile Stocks * Unusual Trading Volume * Trading Halts * Options * Unusual Call Volume * Unusual Put Volume * Sector Performance * Short Interest * Largest Short Positions * Short Interest Increases * Short Interest Decreases * Stock Lists * All Stock Lists * Stocks by Interest * 5G Stocks * Blue Chip Stocks * Biotech Stocks * FAANG Stocks * Gold Stocks * Large Cap Stocks * Marijuana Stocks * Oil Stocks * REITs * Russell 2000 Stocks * Small Cap Stocks * Warren Buffett Stocks * Low Priced Stocks * Stocks Under $0.50 * Stocks Under $1 * Stocks Under $2 * Stocks Under $5 * Penny Stocks * Most Active Penny Stocks * Most Popular Penny Stocks * Top Penny Stocks Today * Stocks by Exchange * NYSE Stocks * NASDAQ Stocks * OTCMKTS Stocks * TSX Stocks * LSE Stocks * Stocks by Sector * Automotive Stocks * Aerospace Stocks * Basic Materials Stocks * Business Services Stocks * Consumer Discretionary Stocks * Consumer Staples Stocks * Construction Stocks * Energy Stocks * Finance Stocks * Industrial Stocks * Manufacturing Stocks * Medical Stocks * Real Estate Stocks * Retail Stocks * Technology Stocks * Transportation Stocks * Utilities Stocks * Technical Indicators * Death Cross Stocks * Golden Cross Stocks * RSI Overbought Stocks * RSI Oversold Stocks * Stock Comparisons * Premium Stock Lists * Top MarketRank™ Stocks * Top ESG Stocks * Top-Rated Stocks * Top-Rated Dividend Stocks * Top-Rated Small-Cap Stocks * Top-Rated Tech Stocks * Headlines * MarketBeat TV * Why Energy Stocks Are Poised for Explosive Growth in 2025 * Why Energy Stocks Are Poised for Explosive Growth in 2025 * From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash * From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash * The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop * The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop * Best ETFs for 2025: Growth, Stability, and AI-Driven Investing * Best ETFs for 2025: Growth, Stability, and AI-Driven Investing * Featured Articles * Dow Jones: A Relevant Benchmark or a Relic of the Past? * 3 Big-Name Stocks Just Announced Big-Time Dividend Increases * Market Overreaction: 2 Stocks to Buy on the Way Down * Time to Board Carnival Cruise Lines' Stock Price Rally * Is Warner Bros. Discovery Stock a Buy After Recent Drop? * Industrial Chemicals: 3 Stocks Poised for Growth in the New Year * Rising Freight Rates: The Carrier's Comeback in a Shifting Market * Why Value Stocks Are the Best Bet Today—and Goldman Sachs Agrees * More Featured Articles * News * All Headlines * Instant News Alerts * Research Surveys * Real-Time News Feed * Investing Slideshows * Education * Featured Topic: Options Trading * Neos S&P 500(R) High Income ETF Harnesses the Power of Options * Options Traders Bet Big on These 3 Tech Stocks * How to Play New Options Trading With Bitcoin ETFs * Albemarle Stock Call Options Surge: What It Means for Lithium * How to Execute the Wheel Strategy to Generate Options Income * 3 Options Strategies to Play a Stock’s Uptrend if Bullish * Learn Read investment guides, how-to articles, and explainers. * Stock Ideas Looking for ideas for stocks to invest in? These stocks are poised to move. * Financial Terms Learn the language of investment with our glossary of over 200 financial terms. * Help View our library of help videos to learn how to use the tools on the MarketBeat website. My Account Free Trial Search → Mysterious drone activity triggers massive 1,366% surge (From Insiders Exposed) (Ad) PHARMACEUTICAL STOCKS LIST Compare pharmaceutical stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas * Agriculture Stocks * Airline Stocks * Apparel Stocks * Artificial Intelligence Stocks * Automotive Stocks * Bank Stocks * Bitcoin Stocks * Blockchain Stocks * Canadian Stocks * Cannabis Stocks * Casino Stocks * ChatGPT Stocks * Chinese Stocks * Cloud Storage Stocks * Coronavirus Therapeutics Stocks * Cryptocurrency Stocks * Cybersecurity Stocks * Defense Stocks * Digital Media Stocks * Dividend Stocks * Dow 30 Stocks * Ecommerce Stocks * Electric Vehicles Stocks * Energy Stocks * Entertainment Stocks * eSports Stocks * EV Charging Stocks * Fertilizer Stocks * Gold Stocks * Grocery Stocks * Growth Stocks * Healthcare Stocks * High Dividend Stocks * Home Office Stocks * Hotel Stocks * Large Cap Stocks * Leisure Stocks * Lithium Stocks * Magnificent Seven Stocks * MATANA Stocks * Mega Cap Stocks * Meme Stocks * Metaverse Stocks * Mid Cap Stocks * Mining Stocks * Music Industry Stocks * Nanotechnology Stocks * NFT Stocks * Oil Stocks * Outdoor Activities Stocks * Pharmaceutical Stocks * Renewable Energy Stocks * Restaurant Stocks * Retail Stocks * Semiconductor Stocks * Social Media Stocks * Solar Stocks * Space Stocks * Stay-At-Home Stocks * Technology Stocks * Telecom Stocks * Toy Stocks * Utility Stocks * Vaccine Stocks * Video Game Stocks * Virtual Reality Stocks * WallStreetBets Stocks Stocks to Compare Sections All Sections Selected * Performance Chart * Price & Volume * MarketRank * Analyst Ratings * Sales & Book Value * Profitability & Earnings * Dividends * Debt * Ownership * Miscellaneous * Headlines * About Compare Share Link copied to clipboard. NASDAQ:ALNYNASDAQ:AMGNNASDAQ:ARGXNASDAQ:AZNNASDAQ:BGNENASDAQ:BIIBNASDAQ:BMRNNASDAQ:BNTXNASDAQ:GILDNASDAQ:GMAB COMPARATIVE PRICE PERFORMANCE OVER TIME 1 day7 days30 days90 days365 days 2225Dec 14710131619-10%0%10%Dec 20ARGXGILDBMRNALNYBNTXAZNGMABBIIBBGNEAMGN COMPARE STOCKS - PRICE & VOLUME CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume ALNY Alnylam Pharmaceuticals $242.26 -1.3%$263.01 $141.98 ▼ $304.39 $31.66B0.32860,843 shs718,087 shs AMGN Amgen $264.00 +0.2%$296.20 $253.30 ▼ $346.85 $141.91B0.552.70 million shs3.03 million shs ARGX argenx $628.32 +0.7%$592.94 $349.86 ▼ $644.97 $37.66B0.59308,013 shs153,614 shs AZN AstraZeneca $66.63 +2.0%$69.02 $60.47 ▼ $87.68 $206.60B0.455.35 million shs8.18 million shs BGNE BeiGene $177.70 +0.7%$200.00 $126.97 ▼ $248.16 $17.33B0.57284,673 shs230,640 shs BIIB Biogen $149.38 +2.0%$167.48 $145.07 ▼ $268.30 $21.77B-0.081.22 million shs1.53 million shs BMRN BioMarin Pharmaceutical $66.27 +0.9%$66.58 $61.15 ▼ $99.25 $12.63B0.291.81 million shs1.11 million shs BNTX BioNTech $113.51 +0.4%$113.25 $76.53 ▼ $131.49 $26.98B0.22808,219 shs413,831 shs GILD Gilead Sciences $93.40 +0.9%$90.64 $62.07 ▼ $98.90 $115.37B0.187.12 million shs4.81 million shs GMAB Genmab A/S $20.76 +2.2%$21.80 $19.85 ▼ $32.88 $13.74B0.96753,579 shs1.38 million shs Investing Strategies To Help Grow Your Retirement Income Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates. Get This Free Report PRICE PERFORMANCE Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance ALNY Alnylam Pharmaceuticals 0.00%0.00%+0.22%-9.71%+28.49% AMGN Amgen 0.00%-2.68%-10.58%-21.52%-7.31% ARGX argenx 0.00%+2.74%+2.95%+18.04%+67.29% AZN AstraZeneca 0.00%-1.85%-0.43%-15.28%-1.42% BGNE BeiGene 0.00%-1.59%-7.35%-12.32%+0.22% BIIB Biogen 0.00%-2.37%-7.24%-25.20%-43.22% BMRN BioMarin Pharmaceutical 0.00%-0.53%+2.18%-5.02%-31.75% BNTX BioNTech 0.00%-6.06%-0.04%+0.03%+7.36% GILD Gilead Sciences 0.00%+0.78%+2.64%+10.22%+16.21% GMAB Genmab A/S 0.00%+0.69%-1.65%-15.87%-35.40% Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad) You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss. Click Here to get the full details about Crypto’s Hidden Gem MARKETRANK™ CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation ALNY Alnylam Pharmaceuticals 4.3477 of 5 stars3.44.00.04.32.02.50.6 AMGN Amgen 4.4613 of 5 stars3.22.01.73.92.41.71.9 ARGX argenx 2.9927 of 5 stars2.54.00.00.03.31.71.9 AZN AstraZeneca 4.0482 of 5 stars3.55.02.50.01.90.02.5 BGNE BeiGene 2.6172 of 5 stars3.43.00.00.02.81.70.6 BIIB Biogen 4.6305 of 5 stars4.23.00.03.71.71.71.9 BMRN BioMarin Pharmaceutical 4.9837 of 5 stars4.43.00.03.32.82.54.4 BNTX BioNTech 2.0236 of 5 stars3.44.00.00.01.80.80.0 GILD Gilead Sciences 4.4175 of 5 stars2.33.01.74.12.62.51.9 GMAB Genmab A/S 4.2425 of 5 stars3.35.00.00.02.30.04.4 ANALYST RATINGS CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price ALNY Alnylam Pharmaceuticals 2.71 Moderate Buy$298.0923.05% Upside AMGN Amgen 2.40 Hold$319.6721.09% Upside ARGX argenx 2.91 Moderate Buy$639.781.82% Upside AZN AstraZeneca 2.91 Moderate Buy$89.7534.70% Upside BGNE BeiGene 2.75 Moderate Buy$253.6942.76% Upside BIIB Biogen 2.45 Hold$242.6862.46% Upside BMRN BioMarin Pharmaceutical 2.74 Moderate Buy$94.2042.15% Upside BNTX BioNTech 2.82 Moderate Buy$140.7624.01% Upside GILD Gilead Sciences 2.67 Moderate Buy$96.433.25% Upside GMAB Genmab A/S 2.56 Moderate Buy$45.20117.73% Upside CURRENT ANALYST RATINGS 051015202530ALNYAMGNARGXAZNBGNEBIIBBMRNBNTXGILDGMABSellHoldBuyStrong Buy LATEST PHARMACEUTICAL STOCKS ANALYST RATINGS DateCompanyBrokerageActionRatingPrice TargetDetails12/20/2024 BIIB Biogen BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform$230.00 ➝ $164.0012/19/2024 ARGX argenx Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$639.00 ➝ $723.0012/16/2024 BIIB Biogen Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$175.0012/12/2024 BMRN BioMarin Pharmaceutical Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.0012/11/2024 BNTX BioNTech Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$170.0012/11/2024 GILD Gilead Sciences Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$80.00 ➝ $80.0012/11/2024 GILD Gilead Sciences Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSector Perform ➝ Sector Perform$84.00 ➝ $84.0012/10/2024 AMGN Amgen Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderperform$256.0012/10/2024 BIIB Biogen Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral$178.0012/10/2024 GILD Gilead Sciences Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$105.00 ➝ $115.0012/10/2024 GILD Gilead Sciences Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy$109.00 (Data available from 12/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.) SALES & BOOK VALUE CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book ALNY Alnylam Pharmaceuticals $2.09B14.92N/AN/A($1.76) per share-137.65 AMGN Amgen $32.53B4.36$25.46 per share10.37$11.65 per share22.66 ARGX argenx $1.86B20.41N/AN/A$69.22 per share9.08 AZN AstraZeneca $51.21B4.03$5.40 per share12.34$12.63 per share5.28 BGNE BeiGene $3.32B5.22N/AN/A$37.10 per share4.79 BIIB Biogen $9.61B2.27$17.49 per share8.54$102.14 per share1.46 BMRN BioMarin Pharmaceutical $2.75B4.59$1.80 per share36.88$26.29 per share2.52 BNTX BioNTech $3.04B8.88$4.82 per share23.54$92.17 per share1.23 GILD Gilead Sciences $28.30B4.11$9.04 per share10.33$18.26 per share5.12 GMAB Genmab A/S $19.84B0.69$1.19 per share17.38$6.95 per share2.99 PROFITABILITY & EARNINGS CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date ALNY Alnylam Pharmaceuticals -$440.24M-$2.62N/AN/AN/A-15.86%N/A-8.38%N/A AMGN Amgen $6.72B$7.8133.8012.972.9113.00%168.35%11.18%N/A ARGX argenx -$295.05M-$0.88N/A72.47N/A-2.11%-1.45%-1.29%N/A AZN AstraZeneca $5.96B$2.0931.8814.121.1912.68%30.01%11.42%N/A BGNE BeiGene -$881.71M-$8.24N/AN/AN/A-25.94%-25.12%-14.95%N/A BIIB Biogen $1.16B$11.0713.498.871.8316.81%14.98%8.59%N/A BMRN BioMarin Pharmaceutical $167.65M$1.6739.6821.940.6511.71%8.53%6.40%N/A BNTX BioNTech $1.01B-$2.10N/AN/AN/A-15.16%-2.35%-2.05%N/A GILD Gilead Sciences $5.67B$0.091,037.7812.502.380.45%29.00%9.83%N/A GMAB Genmab A/S $631.91M$1.0320.1614.030.6723.49%14.64%12.37%N/A LATEST PHARMACEUTICAL STOCKS EARNINGS DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/12/2024Q3 2024 AZN AstraZeneca $1.01$1.04+$0.03$1.62$13.08 billion$13.57 billion11/12/2024Q3 2024 BGNE BeiGene -$1.11-$1.15-$0.04-$1.15$983.26 million$1.00 billion11/6/2024Q3 2024 GILD Gilead Sciences $1.58$2.02+$0.44$3.04$7.01 billion$7.55 billion11/6/2024Q3 2024 GMAB Genmab A/S $0.32$0.29-$0.03$0.29$838.20 million$816.10 million11/4/2024Q3 2024 BNTX BioNTech -$1.26$0.81+$2.07$0.89$514.08 million$1.24 billion10/31/2024Q3 2024 ALNY Alnylam Pharmaceuticals -$0.51-$0.87-$0.36-$0.87$532.91 million$500.90 million10/31/2024Q3 2024 ARGX argenx $0.10$1.39+$1.29$1.39$543.29 million$588.88 million10/30/2024Q3 2024 AMGN Amgen $5.11$5.58+$0.47$5.94$8.50 billion$8.50 billion10/30/2024Q3 2024 BIIB Biogen $3.77$4.08+$0.31$5.50$2.43 billion$2.47 billion10/29/2024Q3 2024 BMRN BioMarin Pharmaceutical $0.78$0.55-$0.23$0.93$703.37 million$746.00 million DIVIDENDS CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth ALNY Alnylam Pharmaceuticals N/AN/AN/AN/AN/A AMGN Amgen $9.523.61%+10.01%121.90%N/A ARGX argenx N/AN/AN/AN/AN/A AZN AstraZeneca $0.981.47%+1.18%46.89%N/A BGNE BeiGene N/AN/AN/AN/AN/A BIIB Biogen N/AN/AN/AN/AN/A BMRN BioMarin Pharmaceutical N/AN/AN/AN/AN/A BNTX BioNTech $1.531.35%N/AN/A N/A GILD Gilead Sciences $3.083.30%+3.32%3,422.22%N/A GMAB Genmab A/S N/AN/AN/AN/AN/A LATEST PHARMACEUTICAL STOCKS DIVIDENDS AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date12/10/2024 AMGN Amgen quarterly$2.383.45%2/14/20252/14/20253/7/202510/30/2024 GILD Gilead Sciences Quarterly$0.773.15%12/13/202412/13/202412/30/202410/25/2024 AMGN Amgen quarterly$2.252.84%11/18/202411/18/202412/9/2024 (Data available from 1/1/2013 forward) DEBT CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio ALNY Alnylam Pharmaceuticals 31.64 2.75 2.69 AMGN Amgen 7.55 1.32 0.96 ARGX argenx N/A 8.53 7.88 AZN AstraZeneca 0.71 0.93 0.71 BGNE BeiGene 0.05 1.93 1.72 BIIB Biogen 0.28 1.26 0.80 BMRN BioMarin Pharmaceutical 0.11 4.27 2.62 BNTX BioNTech 0.01 7.33 7.21 GILD Gilead Sciences 1.24 1.26 1.10 GMAB Genmab A/S N/A 5.17 5.15 OWNERSHIP INSTITUTIONAL OWNERSHIP CompanyInstitutional Ownership ALNY Alnylam Pharmaceuticals 92.97% AMGN Amgen 76.50% ARGX argenx 60.32% AZN AstraZeneca 20.35% BGNE BeiGene 48.55% BIIB Biogen 87.93% BMRN BioMarin Pharmaceutical 98.71% BNTX BioNTech 15.52% GILD Gilead Sciences 83.67% GMAB Genmab A/S 7.07% INSIDER OWNERSHIP CompanyInsider Ownership ALNY Alnylam Pharmaceuticals 1.50% AMGN Amgen 0.69% ARGX argenx 2.43% AZN AstraZeneca N/A BGNE BeiGene 7.43% BIIB Biogen 0.16% BMRN BioMarin Pharmaceutical 1.85% BNTX BioNTech 19.20% GILD Gilead Sciences 0.16% GMAB Genmab A/S 1.54% MISCELLANEOUS CompanyEmployeesShares OutstandingFree FloatOptionable ALNY Alnylam Pharmaceuticals 2,100128.98 million127.05 millionOptionable AMGN Amgen 26,700537.53 million533.82 millionOptionable ARGX argenx 1,14860.37 million58.90 millionOptionable AZN AstraZeneca 89,9003.10 billionN/AOptionable BGNE BeiGene 10,60097.52 million90.20 millionOptionable BIIB Biogen 7,570145.72 million145.49 millionOptionable BMRN BioMarin Pharmaceutical 3,401190.58 million187.06 millionOptionable BNTX BioNTech 6,133237.73 million192.08 millionOptionable GILD Gilead Sciences 18,0001.25 billion1.24 billionOptionable GMAB Genmab A/S 2,204661.77 million651.58 millionOptionable PHARMACEUTICAL STOCKS HEADLINES RECENT NEWS ABOUT THESE COMPANIES Genmab A/S (NASDAQ:GMAB) Given Average Recommendation of "Moderate Buy" by Analysts December 20 at 3:18 AM | americanbankingnews.com Genmab A/S (NASDAQ:GMAB) Given Average Rating of "Moderate Buy" by Brokerages December 20 at 3:17 AM | marketbeat.com Genmab A/S (NASDAQ:GMAB) Shares Gap Up - Time to Buy? December 18, 2024 | marketbeat.com Genmab A/S (NASDAQ:GMAB) Short Interest Down 11.4% in November December 17, 2024 | marketbeat.com Genmab A/S (NASDAQ:GMAB) Reaches New 52-Week Low - What's Next? December 13, 2024 | marketbeat.com Fmr LLC Has $6.78 Million Holdings in Genmab A/S (NASDAQ:GMAB) December 13, 2024 | marketbeat.com Genmab to Hold 2024 R&D Update and ASH Data Review Meeting December 11, 2024 | globenewswire.com Verition Fund Management LLC Purchases Shares of 29,074 Genmab A/S (NASDAQ:GMAB) December 10, 2024 | marketbeat.com Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable, Complete Responses as Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) December 9, 2024 | businesswire.com Two Sigma Advisers LP Buys 280,900 Shares of Genmab A/S (NASDAQ:GMAB) December 9, 2024 | marketbeat.com Genmab : Epcoritamab Combo Shows High Response Rates In 1b/2 Trial For R/R Follicular Lymphoma December 8, 2024 | markets.businessinsider.com Investigational Epcoritamab (DuoBody® CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis December 8, 2024 | businesswire.com Genmab Is Too Attractive To Ignore December 8, 2024 | seekingalpha.com Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) December 7, 2024 | businesswire.com Genmab buys 2nd anti-glycan antibody from Scancell, commits up to $630M in biobucks December 4, 2024 | fiercebiotech.com Genmab expands its pipeline with $630m Scancell deal December 4, 2024 | pharmaphorum.com Scancell strikes deal worth up to $630m with Genmab December 4, 2024 | proactiveinvestors.co.uk Capital Increase in Genmab as a Result of Employee Warrant Exercise December 3, 2024 | globenewswire.com Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons December 3, 2024 | globenewswire.com Why Is Genmab A/S (GMAB) Among the Worst Performing Healthcare Stocks in 2024? November 27, 2024 | msn.com Genmab to Present at Citi's Global Healthcare Conference November 25, 2024 | globenewswire.com NEW MARKETBEAT FOLLOWERS OVER TIME OctNovDec0204060Week of Dec 17ALNYAMGNARGXAZNBGNEBIIBBMRNBNTXGILDGMAB MEDIA SENTIMENT OVER TIME OctNovDec00.5011.50Week of Dec 17ALNYAMGNARGXAZNBGNEBIIBBMRNBNTXGILDGMAB TOP HEADLINES View All Headlines * 2 Underrated Quantum Computing Companies Starting to Rally By Nathan Reiff | December 20, 2024 View 2 Underrated Quantum Computing Companies Starting to Rally * Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025 By Thomas Hughes | December 3, 2024 View Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025 * 3 Small-Cap Stocks That Are Ready to Rocket Higher By Chris Markoch | November 27, 2024 View 3 Small-Cap Stocks That Are Ready to Rocket Higher * 2 Generic Drug Stocks Ready to Surge in 2025 By Jea Yu | November 27, 2024 View 2 Generic Drug Stocks Ready to Surge in 2025 * Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair? By Leo Miller | December 6, 2024 View Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair? COMPANY DESCRIPTIONS ALNYLAM PHARMACEUTICALS NASDAQ:ALNY Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. AMGEN NASDAQ:AMGN Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. ARGENX NASDAQ:ARGX argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease, bullous pemphigoid, myositis, primary sjögren's syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC; Empasiprubart for multifocal motor neuropath, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis. The company is developing ARGX-213 targets FcRn; ARGX-121 and ARGX-220 targets immune system; ARGX-109 targets IL-6; ARGX-118 for inflammation; and ARGX-109, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It owns VYVGART; VYVGART HYTRULO; VYVDURA; ARGENX; ABDEG; NHANCE; SIMPLE ANTIBODY; and ARGENXMEDHUB. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., and Shire International GmbH. It has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands. ASTRAZENECA NASDAQ:AZN AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. BEIGENE NASDAQ:BGNE BeiGene, Ltd., through its subsidiaries, engages in the development and commercialization of oncology medicines worldwide. Its products include BRUKINSA to treat various blood cancers; TEVIMBRA to treat various solid tumor and blood cancers; PARTRUVIX for the treatment of various solid tumor malignancies; XGEVA to treat bone metastases from solid tumors and multiple myeloma, as well as giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; POBEVCY to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC); BAITUOWEI, to treat breast and prostate cancers; TAFINLAR and MEKINIST to treat NSCLC and melanoma; VOTRIENT for advance renal cell carcinoma; AFINITOR for advance renal cell carcinoma, NET, SEGA, & breast cancers; and ZYKADIA to treat ALK + NSCLC. The company is also developing inhibitors comprising Sonrotoclax (BGB-11417), BGB-10188, BGB-21447, Ociperlimab (BGB-A1217), Surzebiclimab (BGB-A425), BGB-15025, BGB-26808, Lifirafenib (BGB-283), BGB-3245, BGB-30813, and BGB-43395; antibodies, including Zanidatamab, BGB-A445, and BGB-A3055, as well as BGB-16673, a BTK-targeted CDAC, and BGB-24714, a SMAC mimetic. It has collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, Bristol Myers Squibb company, Shandong Luye Pharmaceutical Co., Ltd., Nanjing Leads Biolabs, Inc., EUSA Pharma, Assembly Biosciences, Inc., Bio-Thera Solutions, Ltd., and Nanjing Leads Biolabs Co., Ltd. The company was incorporated in 2010 and is based in Grand Cayman, the Cayman Islands. BIOGEN NASDAQ:BIIB Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer's disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing various products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, genetic neurodevelopmental disorders, and biosimilars, which are under various stages of development. It has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc., as well as collaboration with Fujirebio to potentially identify and develop blood-based biomarkers for tau pathology in the brain. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. BIOMARIN PHARMACEUTICAL NASDAQ:BMRN BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops Roctavian, an adeno associated virus vector, for the treatment of patients with severe hemophilia A. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc. The company was incorporated in 1996 and is headquartered in San Rafael, California. BIONTECH NASDAQ:BNTX BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT114 to treat triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors; BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I/II clinical trial to treat multiple solid tumors; and BNT312, which is in Phase 2 clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase III clinical trial to treat ovarian cancer and Phase I/II clinical trial to treat multiple solid tumors. It develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I/Ib clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. It has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A. BioNTech SE was incorporated in 2008 and is based in Mainz, Germany. GILEAD SCIENCES NASDAQ:GILD Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California. GENMAB A/S NASDAQ:GMAB Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and GEN3017 for treating hematological malignancies. In addition, the company develops Inclacumab, which is in Phase 3 trial for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. It operates various active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with argenx to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology; and AbbVie for the development of epcoritamab, as well as collaborations with BioNTech, Janssen, and Novo Nordisk A/S. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark. Are you interested in trading pharmaceutical stocks? Are pharmaceuticals a good potential add-in to your portfolio? Let’s look at how to invest in pharmaceutical companies, step by step. Learn more about pharmaceutical stocks Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MARKETBEAT ALL ACCESS FEATURES BEST-IN-CLASS PORTFOLIO MONITORING * Get personalized stock ideas. * Compare portfolio to indices. * Check stock news, ratings, SEC filings, and more. STOCK IDEAS AND RECOMMENDATIONS * See daily stock ideas from top analysts. * Receive short-term trading ideas from MarketBeat. * Identify trending stocks on social media. ADVANCED STOCK SCREENERS AND RESEARCH TOOLS * Use our seven stock screeners to find suitable stocks. * Stay informed with MarketBeat's real-time news. * Export data to Excel for personal analysis. Get Started Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits * In-depth profiles and analysis for 20,000 public companies. * Real-time analyst ratings, insider transactions, earnings data, and more. * Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. * Sign In * Create Account * Your Email Address: Email Address Required Your Password: Password Required Log In -------------------------------------------------------------------------------- or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) -------------------------------------------------------------------------------- or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Featured By Empowering Individual Investors 345 N Reid Place, Suite 620, Sioux Falls, SD 57103 contact@marketbeat.com (844) 978-6257 * Twitter * Facebook * YouTube * LinkedIn ABOUT MARKETBEAT * About * Editorial Guidelines * Authors * Press Room * Careers * Contact * FAQ * Help MARKETBEAT PRODUCTS * Compare Products * MarketBeat All Access * Customer Reviews * MarketBeat Daily Ratings * MarketBeat Daily Canada * MarketBeat CryptoBeat * MarketBeat Mobile App POPULAR TOOLS * Stock Lists * Compare Stocks * Dividend Calculator * My MarketBeat * Stock Screener FINANCIAL CALENDARS * Analyst Ratings * Dividends * Earnings * Insider Trades * Stock Market Holidays TERMS & INFO * Advertising * Accessibility Statement * Do Not Sell My Information * Privacy Policy * RSS Feeds * Terms of Service * Sitemap © MarketBeat Media, LLC 2010-2024. All rights reserved. © 2024 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer. My Account - verdacht@safeonweb.be * My MarketBeat * My Newsletter * My Alerts * My Subscriptions * My Account Settings * My Payment Settings * Log Out × URGENT: This Altcoin Opportunity Won’t Wait – Act Now (ad)The crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most explosive phase of the cycle.Click Here For More on >> Register for the Free WaveBot Workshop Now